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SUMMARY
The aim of the work described in this thesis was to 
investigate the effects of over-expression of normal ras proteins 
upon lipid signalling pathways in cultured NIH-3T3 fibroblasts.
The ras oncogene family has been implicated in the growth and 
development of a high percentage of human tumours, but despite 
extensive research the mechanism of action of ras is still
unknown. It has been proposed that p21--- proteins function in a
G-protein-like manner mediating the effects of certain growth 
factors, by coupling their receptors to the stimulation of PIC.
T*&S
To study the role of p21---- in regulating second
messengers as part of a signal transduction mechanism, NIH-3T3
fibroblasts, transformed by constitutive over-expression of the
c-Ha-ras-1. c-Ki-ras-2 or N-ras genes, were used. The study also
utilised a clone of NIH-3T3 cells which over-expressed the 
Hd^ rfis
p21   proto-oncogene in .the presence of a glucocorticoid
inducer; this allowed the study of short term transformation by the
ras proto-oncogene. Wild-type NIH-3T3 fibroblasts which express
Ha-, Ki- or N-ras at very low levels were used as a control.
Data obtained from these studies indicate clearly that 
raS
over-expression of p21 in NIH-3T3 cells is associated with 
increased cell proliferation and transformation. The results
ITdS
suggest that p21  can function at a post receptor level to
enhance growth factor stimulated inositol phosphate generation,
without causing a change in the basal levels of inositol
phosphates. This data supports the proposal that p21--- is
coupled to PtdIns(4,5)P2 hydrolysis and demonstrates that
I* s s
over-expression of normal p21--- proteins causes an amplification
of growth factor stimulated inositol phosphate generation which may 
act as an initial signal for cell proliferation.
NIH-3T3 cells transformed by over-expression of ras genes 
demonstrated reduced PGF- -stimulated inositol phosphate 
generation. The ras-induced desensitization to PGF is not dueZOs
to any reduction in receptor number, or change in Ka or Kd and thus
would appear to be due to a reduced coupling of the agonist receptor
complex to PIC. The desensitization of P G F ^  induced inositol
phospholipid turnover is associated with proliferative state, since
the desensitization is observed both in the transformed cells and in
rapidly proliferating, non-contact inhibited NIH-3T3 cells. PKC
catalysed phosphorylation of the PGF receptors appears to be the
zw
most likely explanation of this phenomenon as NIH-3T3 cells c 
incubated in the presence of TPA show a reduced response to 
PGF- . PKC catalysed phosphorylation of receptors may play a
Z (A
. . .  2+
crucial role m  a negative feedback regulation of the Ca
mobilising pathway.
This led to an investigation of the role of inositol 
phospholipid turnover in the stimulation of cell proliferation.
The results indicate that, in some cell lines breakdown of inositol 
phospholipids is either, not obligatory for the onset of mitosis, or 
in itself not a complete signal.
The effect of over-expression of normal Ha-, Ki- and N-ras 
genes in NIH-3T3 cells, upon both stimulated and basal PtdCho 
metabolism was also examined. The data presented in this section 
of the work suggests that stimulation of PKC either directly (e.g. 
by TPA) or indirectly, via activation of PtdIns(4,5)P2 hydrolysis 
(e.g. by P G F ^  and serum) may stimulate breakdown of PtdCho by 
PLD. The results show that in ras transformed cells PtdCho 
turnover is increased apparently both by PLD and phospholipase A^ 
pathways.
(xxi)
The activation of PKC in NIH-3T3 cells may lead to both the
desensitization of Ptdlns(4y5)P^ hydrolysis and to the stimulation
of PtdCho breakdown, thus potentiating its own activation whilst
2+
reducing the increase m  intracellular free Ca concentration.
It is possible that the stimulation of PtdCho breakdown in response
to PGF__ is activated by the increase in PKC activity as a 
2 c*.
consequence of prior PtdlnstAjSJP^ hydrolysis although a direct
receptor activated effect cannot be ruled out. It appears that
x*ss
over-expression of p21--- may induce rapid proliferation and hence
transformation of fibroblasts by the modulation of second messenger 
production via both Ptdlns(4,5)P^ and PtdCho hydrolysis.
CHAPTER 1 
INTRODUCTION
1.
1 INTRODUCTION
1.1 The cell cycle
Cells grow by progressing through the phases of the cell 
cycle: G^, S, and M. The replication of DNA and the
synthesis of the histone proteins occurs only in the DNA-synthesis,
S phase of interphase. The S phase is preceded and followed by two 
growth phases G^ and G^, respectively, during which there is no 
net synthesis of DNA. In the G^ phase, a cell contains two 
copies of each chromosome present in the G^ phase. Throughout 
interphase there is continued cellular growth and synthesis of other 
cellular macromolecules such as RNA, protein and membranes. The 
cell finally divides during M, the mitosis phase.
Different mammalian cells and cells in culture have similar 
durations for S, G^ and M about 7, 3 and lh, respectively 
(Fawcett, 1981). The G^ phase can be as short as 2 to 3h and as 
long as several days. Cells grown in culture can be made to enter 
a quiescent or non-proliferating phase (Gq ) by either withdrawing 
serum growth factors from the culture medium, or by allowing the 
cells to reach confluency so that all the available growth factors 
are depleted and the cells are contact inhibited. Withdrawing 
growth factors from cultures in exponential growth, does not stop 
proliferation immediately. Those cells in or beyond late G^, are 
committed to division and complete the cycle (Zetterberg & Larson, 
1985). When these progeny enter early G^ they and the other 
cells in the culture progress no further and the culture, therefore, 
then consists solely of quiescent Gq cells. Quiescent cells have 
the potential to re-enter the cell cycle at the G^ stage and 
divide in response to appropriate mitogenic signals (i.e. addition 
of serum or defined growth factors).
2.
Two major pathways have been implicated in the control of 
cell proliferation. Certain growth factors, of which epidermal 
growth factor (EGF) is a classic example, act on receptors which 
have an intrinsic protein tyrosine kinase activity. The 
phosphorylation of certain proteins on tyrosine residues is thought 
to be a stimulus which leads to DNA synthesis. The alternative 
pathway, which is the subject of this introduction is utilised by 
those growth factors which stimulate the hydrolysis of inositol 
phospholipids. Initial mitogen-induced biochemical changes are 
discussed in the following sections.
1.2 Mitogen induced ion changes
One of the initial events following growth factor
stimulation of quiescent fibroblasts is an increase in the activity
of the amiloride-sensitive Na*/H* antiporter, implicating
cytoplasmic pH as a potential 'messenger* (Moolenaar et al.,
1983). Activation of Na /H exchange may bring about the
elevation of intracellular pH (by approximately 0.2 units) thought
necessary for DNA synthesis to occur (Schuldiner & Rozengurt,
1982). The internal Na* concentration is maintained by its
efflux via the ouabain-sensitive Na*/K* pump. Mitogen induced
increases in pH have been detected in several cell types, for
example, human fibroblasts (Moolenaar et al., 1983), Swiss 3T3
fibroblasts (Ives & Daniel, 1987) and mouse thymocytes (Hesketh et
al.. 1985). Hesketh et al. (1985) demonstrated that mitogen
stimuli capable of bypassing receptors, the Ca^* ionophore A23187
and the protein kinase C(PKC) activating phorbol ester
12-0-tetradecanoyl phorbol 13-acetate (TPA), can also induce an
increase in cytoplasmic pH. Owen et al. (1989) demonstrated that
2+
NIH-3T3 cells use both an inositol trisphosphate, Ca -mediated
4- 4*
pathway and a PKC-dependent pathway to regulate Na -H exchange
3.
and suggested that one pathway is not more important than the
other. Ives and Daniel (1987), however, have shown that
mitogen-induced alkalinisation of the cell by activation of the
Na*/H* antiporter is independent of changes in intracellular 
2+
Ca . It has not yet been determined, however, whether the 
raised pH values associated with exponentially growing cells is a 
regulatory signal or if it is a consequence of cell proliferation.
Perona and Serrano (1988) transfected fibroblasts with the 
yeast plasma membrane H -ATPase; an H -pumping ATPase which 
regulates intracellular pH in fungi and plants. The resulting 
fibroblasts demonstrated a sustained increase in intracellular pH 
and acquired the growth characteristics of transformed cells. This 
experimental technique bypassed the requirement for growth factor 
stimulation and demonstrated that sustained elevation of 
intracellular pH directly influences cell proliferation.
However, early studies on pH modulation utilised a 
HCO^-free buffer. Ganz et al. (1989) have now demonstrated 
that a range of growth factors stimulate mitosis in a 
HCO^-containing buffer with no subsequent change in pH. As
the Na+/H* antiporter is active under these conditions, this 
demonstrated that cytosolic pH is tightly regulated and suggests 
that it is the influx in Na* ions rather than a change in 
intracellular pH which is important in mitogenesis.
The major ionic change in mitosis is in intracellular
2+Ca concentration. Using Quin 2 fluorescence, Hesketh et al.
(1985) demonstrated that vasopressin and prostaglandin
(PGF ) in Swiss 3T3 cells and concanavalin A (Con A) in
thymocytes caused a rapid, transient increase in intracellular 
2+Ca concentration which was only partly sensitive to the removal
2+ 2 + 
of external Ca . The Con A induced Ca concentration
increase in quiescent thymocytes declined following the achievement
of the peak value of about 250nM (from lOOnM in the control) to a
2+
new plateau of about 150nM. After removal of external Ca by
the addition of EGTA to the medium. Con A induced a smaller
transient signal of 150nM which returned to resting level within 8
2+
minutes. EGF, however, induced a slower rise m  internal Ca
concentration which peaked after 2 minutes and was absolutely
24-
dependent upon the presence of external Ca . Blakely et al.
(1989) demonstrated that in Swiss 3T3 cells bombesin-stimulated
45 24- 24-
efflux of Ca was independent of extracellular Ca , but
that platelet derived growth factor (PDGF)-stimulated efflux was
24-
markedly inhibited by chelation of external Ca by EGTA. Thus
24-
two different mechanisms of increasing [Ca ]. , appear to be
int.
2+
operating, one involving release of internal stores of Ca and
24-the other involving Ca entry (see Section 1.5).
1.3 Stimulation of second messenger metabolism
Many growth factors, for example bombesin, bind to specific 
cell surface receptors which are linked via a GTP-binding protein 
(G-protein) to the stimulation of a phosphoinositide-specific 
phospholipase C (PIC). On stimulation PIC catalyses the hydrolysis 
of phosphatidylinositol 4 ,5-bisphosphate (Ptdlns(4,5)P^), a lipid 
located in the inner leaflet of the plasma membrane, to generate two 
second messenger molecules, sn-l«2-diacylglycerol (DAG) and inositol 
1,4,5-trisphosphate (Ins(l,4,5)P3). Both DAG and Ins(l,4,5)P3 
are part of a signal transduction mechanism which controls a variety 
of cellular processes including secretion, metabolism, contraction, 
neural activity and cell proliferation (Downes & Michell, 1985; 
Berridge & Irvine, 1989). DAG activates PKC which leads to the 
phosphorylation of a range of cellular proteins, including the 
Na /H antiporter (Hesketh et al., 1985). Specific binding of
5.
Ins(l,4,5)P2 to receptors on the smooth endoplasmic reticulum
2+
(Spat et al.,, 1986) causes a transient efflux of Ca which
elicits a variety of secretory, metabolic and mitogenic processes.
. . .  24-
Receptors which do not mobilise intracellular Ca do not
stimulate inositol phospholipid catabolism.
1.3.1 The inositol phospholipid pathway
Figure 1.1 shows the routes of metabolism of compounds
containing inositol and phosphate.
Synthesis of phosphatidylinositol (Ptdlns; reaction 1,2 & 3, Fig. 
1.1)
Phosphorylation of DAG by DAG kinase results in the 
formation of phosphatidic acid (reaction 1), which subsequently 
reacts with CTP to form CDP-diacylglycerol, catalysed by 
phosphatidate cytidyltransferase (reaction 2). Inositol is added 
to CDP-diacylglycerol, catalysed by CDP-diacylglycerol: inositol
phosphatidyl-transferase, to form Ptdlns (reaction 3).
Synthesis of polyphosphoinositides (reactions 4 & 5, Fig.1.1)
Ptdlns is phosphorylated at the 4 position on the inositol 
ring by an ATP-requiring PtdIns-4-kinase (reaction 4) to form 
phosphatidylinositol 4-phosphate (PtdIns(4)P). This is in turn 
phosphorylated on the 5-position by PtdIns(4)P-5-kinase (reaction 5) 
to generate Ptdlns(4,5)?^.
Degradation of inositol phospholipids (reactions 6,7 & 8, Fig.1.1) 
The pathways of degradation of inositol phospholipids are 
the dephosphorylation of Ptdlns(4,5)?^ by the sequential action of 
Ptdlns(4,5)?2 5-phosphomonoesterase (reaction 6) and a PtdIns(4)P 
4-phosphomonoesterase (reaction 7) and removal of the entire 
inositol phosphate head group by phosphodiesterase enzymes (reaction 
8).
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Hydrolysis by phospholipase C (reaction 8, Fig.1.1)
PIC occupies a central position in the signal transduction 
pathway, since it catalyses the hydrolysis of Ptdlns(4,5)P2 to 
generate the two second messenger molecules Ins(l,4,5)P^ and DAG 
(Berridge & Irvine, 1984; Majerus et al., 1986). A cytosolic PIC 
was first detected in pancreas (Dawson, 1959), but has since been 
found in all mammalian cells examined in addition to higher plants 
and some bacteria (Irvine et al., 1980; Irvine, 1982; Shukla,
1982). Recent isolation, purification and determination of the 
nucleotide sequences encoding phospholipase C proteins have 
demonstrated that PIC is not a single protein but, a large family of 
potentially diverse proteins. These enzymes derived from a variety 
of tissues, have molecular masses ranging from 56kDa to 154kDa, and 
exist both as soluble and membrane-associated proteins (Boyer et 
al., 1989).
Examples of PIC enzymes purified are the three isoenzymes 
from bovine brain. These have molecular weights of 150kDa, 145kDa 
and 85kDa (Ryu et al., 1987); a 65kDa form from bovine brain 
membrane (Katan & Parker, 1987); a 62kDa form from pig uterus 
(Bennett & Crooke, 1987) and an 88kDa form from bovine brain cytosol 
(Rebecchi & Rosen, 1987). The relationship between these multiple 
forms is not clear.
When soluble PIC activity was assessed using pure lipid
substrates all three inositol phospholipids were hydrolysed with
equal facility. Under ill vitro conditions cytosolic PICs from
21-
brain showed considerable activity at luM Ca when 
PtdIns(4,5)P2 was presented as a component of a lipid mixture such 
as would be present in the inner bilayer of intact cells; 
hydrolysis of PtdIns(4,5)P2 was about 100 times more rapid than 
that of Ptdlns (Irvine et al., 1984a). However, at the higher
8.
2+ionic strength pertaining in vivo m  the presence of Mg , the
2+
enzyme shows no activity below lOOuM Ca , and is maximal at ImM 
2+
Ca . When Ptdlns(4,5)?^ is presented m  a non-bilayer 
configuration, the enzyme catalyses the hydrolysis of 
Ptdlns(4,5)P2 under ionic conditions similar to those i_n vivo.
From the basic characteristics of the soluble PIC, it has been 
suggested that on receptor activation, a change in the presentation 
of the substrate by perturbation of the lipid bilayer could control 
enzyme activity (Irvine et al., 1984a).
For a reaction controlled by receptors, Irvine and Dawson 
(1978) proposed that an alternative possibility would be for the 
occupied receptor to interact with a plasma membrane-bound PIC.
The first unequivocal demonstration for a membrane-bound PIC came 
from work with human erythrocytes (Downes & Michell, 1982). Later 
evidence for a membrane-bound PIC was found in synaptosomes (Van 
Rooijen et al., 1983), neutrophils (Cockcroft et al., 1984) and 
liver (Seyfred & Wells, 1984). However, the enzyme is probably 
only loosely membrane-associated and not an integral protein.
Occupancy of EGF and PDGF receptors stimulates their 
tyrosine kinase activity and recent evidence has suggested that at 
least one isoenzyme of PIC (PIC- ) is a substrate for the tyrosine 
kinase activity of growth factor receptors known to stimulate 
Ptdlns(4,5)P^ hydrolysis (Meisenhelder et al., 1989).
Metabolism of inositol phosphates
Ins(l,4«5)P^ and 105(1.3.4.5)?^ 5-phosphatase(reactions 9 & 10,
Fig.1.1)
The first step in the catabolism of Ins(l,4,5)P^ and 
inositol 1,3,4,5-tetrakisphosphate (Ins(l,3,4,5)P^) is removal of 
the 5-phosphate (Batty et al., 1985) to yield inositol
1,4-bisphosphate (Insd^)?^) (reaction 9) and inositol
9.
1,3,4-trisphosphate (Ins(l,3,4)P3 ) (reaction 10), respectively.
2+
These reactions appear to be catalysed by the same Mg -dependent 
5-phosphatase (Connolly et al.., 1987).
In permeabilised hepatocytes Joseph et al. (1987) observed 
that Ins(l,4,5)P3 hydrolysis was inhibited by Ins(l,3,4,5)P^ 
implying that, in these cells at least, there is competition of both 
substrates for a single phosphatase. This may have the effect of
extending the intracellular half-life of Ins(l,4,5)P^ and thus
2+ . .
prolong Ca mobilisation.
Ins(l.4«5)P^-3-kinase (reaction 11, Fig.1.1)
The ATP-dependent kinase, Ins(l,4,5)P2~3-kinase which
converts Ins(l,4,5)P^ to Ins(l,3,4,5)P^ (reaction 11) probably
plays a key role in regulating Ins(l,4,5)P^ metabolism. The
Ins(l,4,5)P^-3-kinase has an approximate 10-fold higher affinity
for Ins(l,4,5)P^ than the 5-phosphatase and is in some cells 
2+
activated by Ca -calmodulin (Biden et al., 1987; Morris et al.. 
1987a). Thus it is possible that this enzyme may be regulated by 
receptor-mediated changes in cytosolic [Ca^+] which would result 
in a feed-forward mechanism promoting Ins(l,3,4,5)P^ production 
(the possible functions of Ins(l,3,4,5)P^ are discussed in Section 
1.5.1).
Ins(l,4)P^ 4-phosphatase (reaction 12, Fig.1.1);
Ins(lT4)P^ and Ins(l,3,4)P^ 1-phosphatase (reactions 13 & 14,
Fig.1.1)
Ins(l,4)P2 can be metabolised iii vitro to either inositol 
1-monophosphate (Ins(l)P) (reaction 12) or inositol 4-monophosphate 
(Ins(4)P) (reaction 13) by enzymes which may (Storey et al.., 1984) 
or may not (Ackerman et al., 1987) exhibit differential sensitivity 
to Li+ . Evidence from many cell types now indicates that less 
than 5% of I n s d ^ P ^  dephosphorylation is performed by a
10.
4-phosphatase (Morris et al., 1988b; Balia et al., 1988).
Ins(l,4)P2 and Ins(l,3,4)P3 are hydrolysed to Ins(4)P (reaction 
13) and inositol 3,4-bisphosphate (Ins(3,4)P ) (reaction 14), 
respectively by the same inositol 1-phosphatase (Inhorn & Majerus, 
1987).
Ins(1.3.4)P^ 4-phosphatase (reaction 15, Fig.1.1) and
Ins(3«4)P^ 4-phosphatase (reaction 16, Fig.1.1)
Both Ins(l,3,4)Pg and Ins(3,4)P^ can be hydrolysed by a
4-phosphatase (Shears et fQ., 1987a; Inhorn & Majerus, 1988), but
it has not yet been determined if these reactions are catalysed by a
single enzyme. These phosphatase activities are both Mg^+
independent, which is unusual amongst the inositol phosphatases with
the exception of the Ins(l,3)P^ 3-phosphatase. Inhorn and
2 +
Majerus (1988) exploited the Mg independence of the
Ins(l,3,4)P^ 4-phosphatase to determine the contribution this
enzyme made to Ins(l,3,4)P2 metabolism. Ins(l,3,4)P^
dephosphorylation in homogenates of a number of tissues was assayed
2+
m  the presence and absence of Mg and in the brain the 
4-phosphatase accounted for 72% of the total. In every other 
tissue analysed, the 4-phosphatase route was a minor pathway ( -^20% 
of total).
Ins(l«3)P^ 3-phosphatase (reaction 17, Fig.1.1).
The 3-phosphatase hydrolysis of InsdjSJP^ has been 
32
characterised using P-labelled substrates (Bansal et a^., 1987) 
and is Mg^*-independent.
Inositol monophosphatase (reactions 18,19 & 20, Fig.1.1)
It has now been proven that a single enzyme 
dephosphorylates Ins(l)P (reaction 18), inositol 3-monophosphate 
(Ins(3)P) (reaction 19) and Ins(4)P (reaction 20) (Gee et al., 1988).
11.
1.4 Signal transduction bv mammalian G-proteins
Although it appears that a G-protein is involved in control
of PIC, this protein has not been identified. G-proteins transduce
a diverse series of extracellular signals by regulating a number of
effector systems which are either ion channels or enzymes able to
modulate the rate of synthesis of intracellular second messengers.
The G-protein family includes several well-characterised
members, each associated with the plasma membrane, for example:-
(a) G , which mediates hormonal stimulation of adenylate cyclase 
s
(Gilman, 1984); (b) G., which mediates hormonal inhibition of
adenylate cyclase (Gilman, 1984) and (in some cells) stimulation of 
Ptdlns(4,5)P^ hydrolysis (Gierschik & Jakobs, 1987); (c) G^,
which mediates receptor regulation of certain classes of Ca^+ 
channels (Hescheler et al., 1987); (d) TD1 and TD2 which activate
cGMP phosphodiesterase in retinal rods and cones respectively 
(Stryer, 1986).
Identified G-proteins consist of an alpha, beta and gamma 
subunit heterotrimer. In the resting state the G-protein exists in 
the holomeric form with GDP bound to the nucleotide binding site of 
the alpha subunit. Hormone-receptor complexes activate specific 
G-proteins by enhancing the rate of release of GDP, the rate 
limiting step in G-protein activation/deactivation, with the 
released GDP being exchanged for GTP (Gilman, 1987). Binding of 
GTP to the G-protein alpha subunit causes it to dissociate from the 
beta/gamma dimer, thereby generating two potentially active 
subunits, alpha-GTP and beta/gamma, which are then able to interact 
with the catalytic moiety of a particular second messenger 
generating system and alter the rate of synthesis of a second 
messenger. The alpha subunits also possess a site for 
NAD+-dependent ADP-ribosylation by bacterial toxins (see Section
12.
1.4.1.4). Hydrolysis of the terminal phosphate of the bound GTP by 
the intrinsic GTPase activity deactivates the alpha subunit and in 
this GDP-bound form it reassociates with beta/gamma subunits 
restoring the G-protein to the deactivated state.
1.4.1 G-protein coupling in the inositol phospholipid pathway 
The first indication that a G-protein was involved in the
stimulation of Ptdlns(4,5)P^ hydrolysis came from studies of 
Goodhart et al. (1982) who demonstrated a shift in the binding curve 
for o<^-adrenergic receptors when poorly hydrolysed GTP analogues 
were added to membrane preparations of hepatocytes. There is now 
an increasing ambunt of evidence supporting involvement of 
G-proteins in receptor stimulated Ptdlns(4,5)P^ hydrolysis. This 
is summarised briefly as follows:
1.4.1.1 Activation of PIC by GTP and its poorly hydrolysed analogues 
Litosch et al. (1985) found that a crude plasma membrane
preparation of blowfly salivary glands produced Ins (1,4,5)P^ in 
response to 5-hydroxytryptamine, only in the presence of GTP. This 
work has been extended to demonstrate that activation of PIC by GTP 
and its poorly hydrolysed analogues, can stimulate the hydrolysis of 
Ptdlns(4,5)P^ in the absence of agonists, in neutrophil plasma 
membranes (Cockcroft & Gomperts, 1985), pancreatic cells (Merritt et 
al., 1986) and rat hepatocytes (Wallace & Fain, 1985; Uhing et al.,
1986). These results suggest a regulatory role for a G-protein in 
the inositol phospholipid signalling pathway.
1.4.1.2 GTP and its poorly hydrolysed analogues decrease the 
affinity of receptors for their agonists
Examples of GTP induced reduction in agonist affinity are 
the hepatocyte vasopressin receptor (Cantou et al., 1980), the 
f-Met-leu-Phe receptor of neutrophil membranes (Koo et al., 1983) 
and the substance P receptor in submaxillary glands (Bahouth & 
Musacchio, 1985).
1.4.1.3 Potentiation of receptor-stimulated events by GTP and its
poorly hydrolysed analogues
Haslam and Davidson (1984) demonstrated that a poorly
hydrolysed analogue of GTP (GTP S) stimulated DAG formation from
permeabilised platelets. Poorly hydrolysed GTP analogues have been
2+ . . .
shown to stimulate Ca mobilisation m  mast cells (Gomperts,
1983) and to activate Limulus photoreceptors on microinjection 
(Bolsover & Brown, 1982). Poorly hydrolysed GTP analogues have 
also been shown to stimulate Ins(l,4,5)P^ generation and 
synergistically augment the effect of Ca^*-mobilising receptor 
agonists in permeabilised platelets (Baldessare & Fisher, 1986).
Harden et a^. (1988) demonstrated that addition of GTP 
S to turkey erythrocyte membranes enhanced Ptdlns(4,5)P^ 
hydrolysis resulting in the rate of generation of inositol bis-, 
tris- and tetrakis-phosphate to be increased 20-50 fold compared to 
basal. The P^-receptor agonist 2-methylthioadenosine
triphosphate greatly increased inositol phosphate generation and
3 3
decreased [ H]PtdIns(4)P and [ H]PtdIns(4,5)?^ in the presence
of a low (O.luM) concentration of GTP S. This work represents a
major step forward as turkey erythrocyte membranes stimulated
through P^y receptors are the best isolated membrane system yet
identified for analysis of receptor-PIC coupling. These data
further suggest that a G-protein is involved in the coupling of
certain receptors to PIC.
1.4.1.4 Modulation of receptor-stimulated events by bacterial toxins 
Pertussis toxin and cholera toxin (from Bordetella 
pertussis and Vibrio cholerae, respectively) catalyse the transfer 
of an ADP-nbose group from NAD to the alpha subunit of 
particular G-proteins and have been a major tool in the isolation 
and preliminary identification of G-proteins. Each toxin has a
14.
similar subunit structure consisting of an A (active) subunit and 
a more complex B (binding) subunit. In each case the B subunit 
binds to a cell surface receptor and thereby allows the A subunit to 
enter the cell. Once inside the cell, the A subunit of cholera 
toxin catalyses ADP-ribosylation of the alpha subunit of Gg, 
inhibits its intrinsic GTPase activity, and thereby leads to 
persistent activation of adenylate cyclase. The alpha subunit of 
G. is a substrate for ADP-ribosylation by the A subunit of 
pertussis toxin/and this prevents its interaction with receptor 
agonists. However, attempts to identify a G-protein essential to 
PIC activation by this method have been confusing.
In some cell types a pertussis-toxin-sensitive G-protein 
appears to be involved, for example in mast cells, macrophages, 
neutrophils and lymphocytes, receptor coupling to PIC is attenuated 
by pre-treatment of the cells with pertussis toxin (Cockcroft,
1987). Pre-treatment of cells such as neutrophils (Verghese et 
al♦, 1985) and CCL39 fibroblasts (Paris & Pouyssegur, 1986) with 
pertussis toxin resulted in the ADP-ribosylation of a 40kDa 
G-protein and approximately 50% inhibition of agonist-stimulated 
Ptdlns(4,5)P2 hydrolysis. Pertussis toxin is without effect on 
PIC activation in other cells, including GH^ cells (Martin et al♦, 
1986), pancreas, liver, heart, adipocyte cells (Cockcroft, 1987) and 
skeletal myoblasts (Gardner et al., 1989).
Low and Hughes (1987) suggested the existence of a novel 
cholera-toxin sensitive G-protein involved in the coupling of 
receptors to PIC in pituitary clonal cells, since pre-treatment of 
these cells with cholera toxin inhibited certain agonist stimulated 
inositol phosphate generation. A similar inhibition of inositol 
phospholipid metabolism was observed when L6 cells pre-treated with 
cholera toxin were stimulated with vasopressin. However, this
15.
effect has been demonstrated to be cAMP mediated and to be a 
consequence of a reduction in agonist binding sites (Gardner et al., 
1989).
As bacterial toxins are of limited use in identifying a
G-protein essential to PIC activation more selective probes were
required. In the cases where a pertussis-toxin-sensitive G-protein
appears to be involved, the G-protein is likely to be one of G.l,
G.2, G.3 or G . As the alpha-subunits of each of these
1 1 o
G-proteins are extremely similar, the use of polyclonal antisera
against purified G-protein fractions, while providing more
information, did not allow an unequivocable identification of the
individual species. Mitchell et al. (1989) used a series of highly
selective anti-peptide antisera against sequences which are unique
to the various ’G.-like* G-proteins together with oligonucleotide
probes to the mRNAs to assess the expression of G-proteins in
membranes of rat adipocytes. They were able to detect each of the
specific alpha subunits of G.l, G.2, G.3 and G . The
1 1 1  o
availability of such highly selective probes will allow detection of
these G-proteins in other systems and should now enable greater
progress to be made in assigning a role to each of these G-proteins.
In the majority of cells, pre-treatment with either
pertussis toxin or with cholera toxin does not modify agonist
generation of inositol phosphates, and no convenient probe is
available to identify the relevant G-protein. It is clear that
none of the well-characterised G-proteins can be universally
responsible for mediating receptor-PIC coupling. The identity of
this G-protein (G ) and the demonstration of its action in a 
P
reconstituted system has yet to be achieved.
16.
1.5 The function of the second messengers
The importance of the inositol phospholipid pathway in the
activation of mitosis is demonstrated by experiments where
microinjection of anti-PtdIns(4,5)?^ antibodies into NIH-3T3 cells
abolished the stimulation of DNA synthesis in response to PDGF and
bombesin (Matuoka et al., 1988).
The hydrolysis of Ptdlns(4,SJP^ represents a bifurcation
in the signal pathway because both Ins(l,4,5)P^ and DAG function
as second messengers, controlling the two major ionic events which
occur prior to the onset of DNA synthesis. Ins(l,4,5)P^
24-
regulates intracellular Ca , whereas the DAG/PKC limb activates
•J* -4* t
the membrane-bound Na /H antiporter.
1.5.1 Ins(1.4.5)P3 and Ins(l,3.4.5)P4
A characteristic feature of many growth stimuli is that
they induce a dramatic increase in the intracellular level of
2+  24-
Ca . Evidence for Ins(l,4,5)P3 being the Ca mobilising
second messenger came from Streb et a^. (1983) who first
demonstrated that Ins(l,4,5)P3 applied to permeabilised pancreatic
24-
accinar cells caused a rapid release of Ca from a vesicular
store, thought to be the smooth endoplasmic reticulum. These
studies have been repeated on many cell types (including insulinoma,
GH^ and Swiss 3T3 cell lines, hepatocytes and artery smooth muscle
cells) and have all shown rapid release of a fraction of the 
24-
sequestered Ca by Ins(l,4,5)P3 , with a half maximal response 
in the range 0.2-0.8uM (see Berridge & Irvine, 1984). The receptor 
to Ins(l,4,5)P3 has been characterised by using labelled 
Ins(l,4,5)P3 (Guillemette et al., 1988) and purified from brain 
homogenates (Supattapone et al., 1988). Using antibodies directed 
against a purified Ins(l,4,5)P3~receptor glycoprotein in electron 
microscope immunocytochemical studies of rat cerebellar Purkinje
cells, Ross et al. (1989) demonstrated that the Ins(l,4,5)P^
receptor is localised to endoplasmic reticulum, including portions
of the rough endoplasmic reticulum and possibly other smooth
surfaced structures but not mitochondria or the cell membrane.
Furuichi et al^ . (1989) have now cloned and expressed a functional
P400 Pro*-e*n cerebellar Purkinje neurons and have
demonstrated that this protein is a receptor for Ins(l,4,5)P2*
24-
Occupancy of these receptors stimulates the release of Ca into
2+
the cytosol from an Ins(l,4,5)P^-sensitive Ca pool via a
mechanism which does not require a G-protein (Palmer & Wakelam,
1989). The vicinal phosphates at the 4,5-positions on the inositol
2+
ring are essential for mobilising Ca whereas the phosphate at
the 1-position enhances the affinity of the molecule for its
receptor. Three molecules of Ins(l,4,5)P^ are required to open 
24-
one Ca -channel (Meyer et al., 1988). A characteristic feature
of the Ins(l,4,5)P^ receptor is that it does not desensitize.
24-
Any decline m  the release of Ca can usually be attributed
either to the rapid metabolism of Ins(l,4,5)P^ or the transfer of
the mobilised Ca^+ to an Ins(l,4,5)P^-insensitive pool.
Ins(l,4,5)P^ possesses the characteristics of a classical
second messenger in that it is produced, degraded and brings about
its effect rapidly at very low concentrations (<luH). Jackson et
al. (1987) have demonstrated similar time-courses for 103(1,4,5)?^
production and the increase in Ca^* concentration with
24-
Ins(l,4,5)P^-mduced Ca release occurring within 2 secs.
Kirk et al. (1987) have estimated the half life of Ins(l,4,5)P^ in 
liver cells to be 1.2 secs.
24-
Cells responding to Ca -mobilising agonists that act
through the hydrolysis of PtdIns(4,5)P2» draw upon both
24- 24-
mtracellular and extracellular sources of Ca . The Ca
mobilised from intracellular stores appears to be derived from the
Ins(l,4,5)P^-sensitive non-mitochondrial pool. Only part of this
intracellular pool seems to be Ins(l,4,5)P^-sensitive, with
Ins(l,4,5)P2 stimulating the release of approximately 30-50% of 
24-
the Ca taken up by the non-mitochondrial store, the remainder
24-
can be released by Ca lonophores. This suggests that separate
2 +
mechanisms exist for Ca uptake and release from vesicular
stores. The anatomical location and identity of the
Ins(l,4,5)P^-sensitive and-insensitive pools are uncertain. The
hypothesis that the endoplasmic reticulum is the Ins(l,4,5)P^- 
24-
sensitive Ca pool has recently been challenged. Volpe et al.
(1988) have shown that the calcium binding protein calsequestrin is
present within small membrane vesicles termed calciosomes. These
vesicles which are found in non-muscle cells, have some properties
characteristic of the sarcoplasmic reticulum of muscle. It is
still not clear how calciosomes are related to the
Ins(l,4,5)P2~sensitive or -insensitive stores. It is not known
whether or not the Ins(l,4,5)P^-insensitive pool can contribute to 
24-
Ca signals initiated by Ins(l,4,5)P . Studies on
24-
permeabilised cells have demonstrated that GTP can release Ca 
from both pools independently of Ins(l,4,5)P2 (Chueh & Gill, 1986) 
and that this release can be blocked by treatments that have no 
effect on the Ins(l,4,5)P2-sensitive system. With the relative 
constant levels of GTP in cells, the physiological significance of 
GTP-induced calcium release in intact cells is doubtful. It has, 
however, been suggested that GTP may somehow enlarge the 
Ins(l,4,5)P^-sensitive pool at the expense of the 
Ins(l,4,5)p2~insensitive pool (Ghosh et al., 1989) and this 
process may be controlled by Ins(l,3,4,5)P^ (Irvine et al.,
1988), The Ins(l,4 ^ P^-insensitive pool may also help to
19.
amplify and propagate the calcium signal derived from the 
Ins(l,4,5)P3-sensitive store by a mechanism of calcium-induced 
calcium release.
2+
Receptor-stimulated changes in intracellular Ca
demonstrates two components; a large initial, but transient
2 +
increase m  intracellular Ca dependent on Ins(l,4,5)P2- 
24-
mediated Ca release from the internal pool and a delayed phase
2+
more dependent on Ca influx (Putney, 1986). Both
Ins(l,4,5)P3 and Ins(1,3,4,5)P^ have been implicated in
controlling this slow entry of external calcium. An association
between the Ins(l,4,5)P3-sensitive pool and the plasma membrane is
implicated in several models proposed to account for the sustained 
2+
mflux of Ca m  agonist-stimulated cells, and for the reloading 
2+
phase of the Ca pool after agonist stimulation. In the
24-
capacitative model proposed by Putney (1986), Ca enters the cell 
through the Ins(l,4,5)P^-sensitive Ca^+ pool; Ins(l,4,5)P^ 
controls a channel in an endomembraneous compartment which 
indirectly regulates calcium entry across the plasma membrane 
through the operation of a negative-feedback loop.
Ins(l,3,4,5)P at low concentrations increases intracellular
24- .
Ca concentrations provided that a calcium-mobilising inositol
tris-phosphate is present (Irvine & Moor, 1986; Irvine, 1989).
2+
Irvine and Hoor (1986) demonstrated that Ca -mediated sea urchin
egg fertilisation envelope formation required the microinjection of
both Ins(l,4,5)P2 and Ins(l,3,4,5)P^. This was demonstrated by
making use of Ins(2,4,5)P2 which can act at the Ins(l,4,5)P^
24-
receptor to stimulate the release of Ca , but unlike 
Ins(l,4,5)P^, is not a substrate for Ins(l,4,5)P^-3-kinase and 
thus cannot be used to generate Ins(l,3,4,5)P^ in the cell.
Irvine et al. (1988) proposed an extension of Putney's capacitative
20.
model to include a role for Ins(l,3,4,5)P4 suggesting that
2 +
Ins(l,3,4,5)P. controls the transfer of Ca between 
4
intracellular pools. The contribution of Ins(l,3,4,5)P^ to 
2+
intracellular Ca mobilisation is as yet unknown.
1.5.2 The DAG/PKC limb of the pathway
PKC is not a single enzyme but exists as a large family of
multiple isoforms with closely related structures (Nishizuka, 1988),
that may have a distinct tissue expression and intracellular
localisation. Molecular cloning techniques have identified at least
seven isoforms within a given species (o(, ^1,^11, t , S , £ ,cf). The
general structure of PKC isoforms consists of a single polypeptide
chain with four conserved (C) regions and five variable (V)
regions. PKCs ct>, pi, p H  and / show similar effector dependence
and substrate specificity, although there are relative differences
that are likely to affect cellular responses. The apparent K
m
2 +
values for ATP and Mg and the K values for phosphatidylsenne
3
are similar for PKC, o( , pi, y0II and K . PKC &  , ft I , fill and / 
isoforms are all dependent upon DAG or phorbol ester for activation 
(Huang et al., 1988). However, under different experimental 
conditions there is a variation in the response of PKC isoforms to 
DAG and phorbol ester implying that there may be differences between 
the isoforms in the binding of these effectors. In vivo this may 
depend upon the composition of the membranes with which the PKCs 
interact.
Recent work by Nishizuka*s laboratory has indicated that
the acyl chain structures of the DAGs which activate the multiple
forms of PKC may be different (Nishizuka, 1988). There may be
other mechanisms to activate PKC; in. vitro the ^-isoform (major
form in brain) has been shown to be activated by oleic acid,
arachidonic acid and the arachidonate-derived eicosanoid lipoxin
2 +
A. The lack of a requirement for Ca or DAG in this activation
implies additional mechanisms of PKC regulation that are not
necessarily linked to inositol phospholipid turnover. The nature
of the activation by fatty acids is complex. However, Seifert et
al♦ (1988) have shown (on a mixture of PKC isoforms) that they may
act simply to provide a lipid environment by substitution for
phosphatidylserine. Some substrates can be phosphorylated in a 
24-
Ca -independent manner, the implication being that the absolute 
24-
requirement of Ca in. vivo m  the activation of PKC isoforms may
24-
depend upon the particular substrate. The Ca dependence of the
PKC isoforms appears to be complex as different research groups have
24-
obtained different K& values for Ca with the PKC o( , fiI, fill
and 'i isoforms e.g. 200nM (Jaken & Kiley, 1987) to 500nM (Huang et
al., 1988). This covers a range from near-resting to
near-maximally stimulated levels for most cells. Thus mobilisation 
24-
of Ca would be likely to influence the extent to which these PKC
isoforms can be activated in response to DAG, at least with respect
24-
to substrates that are *Ca -dependent*in their phosphorylation.
PKCs 6 * 6 ,  and £  have only been identified through cDNA
cloning (e.g. Schaap et al., 1989) and much less is known about
their kinetic and physical properties. Schaap et al. (1989) have
shown that both the phorbol binding and kinase activities of PKC-£.
24-
are independent of Ca
The pleiotropic effects of PKC in cell regulation may be
shared by the various isoforms, which might control distinct
signalling pathways, and/or transduce specific extracellular signals.
DAG generated as a result of mitogen-stimulated
Ptdlns(4,5)P^ hydrolysis is the physiological activator of the 
24-
Ca - and phospholipid-dependent (particularly phosphatidylserine)
PKC (Nishizuka, 1984). In keeping with its role as a second 
messenger, very rapid increases in the level of DAG have been
measured upon stimulation (Wright et al., 1988; Cook et al..
1989), The DAG is present in membranes only transiently; within a
minute of formation DAG is rapidly removed by re-cycling into Ptdlns
or by lipases which de-acylate it to generate arachidonic acid for
synthesis of prostaglandins, thromboxanes and leukotriens (Irvine,
1982) which may have effects on DNA synthesis. With the rapid
metabolism of DAG, PKC is active for only a short time after
stimulation of the receptor. However, the consequence of this
enzyme activation may persist for a long time depending on the
biological stability of the phosphate that is covalently attached to
each substrate protein molecule. It has been proposed that upon
generation of DAG, PKC is translocated from the cytosol (where it is
normally inactive) to the membrane (see e.g. Farrar et al., 1985)
where it can actively phosphorylate its substrates on selected
threonine and serine residues. However, the precise intracellular
topography of PKC is unknown since the enzyme is usually extracted
2+
m  the presence of high concentrations of a Ca chelator to
2 +
prevent proteolysis by the Ca dependent protease, calpain.
Recent immunocytochemical analysis using monoclonal antibodies
against PKC indicates that intracellular localisation of this enzyme
varies with cell types. Therefore, more detailed studies of the
2+
precise location of the interaction of the Ca /phospholipid 
dependent PKC with DAG are required and it seems more likely that 
PKC is plasma membrane associated and simply more firmly bound as a 
result of its interaction with DAG. Following proteolysis by 
calpain, two fragments are obtained; a 51kDa catalytically active 
domain and a 26kDa hydrophobic domain which encompasses the 
regulatory and membrane binding regions.
DAG molecules with an sn,l,2 configuration with various 
fatty acids of different chain length are capable of activating PKC,
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with those having an unsaturated fatty acid at either position 1 or
2 being most active (Hori et al., 1982). It is postulated that one
molecule of DAG can activate one molecule of PKC in the presence of
greater than four but less than ten molecules of phosphatidylserine.
The effect of DAG is to increase the apparent affinity of PKC for 
2+
Ca (Kishimoto et al., 1980). However, prior elevation of 
2+
intracellular Ca can augment the activation by DAG (Dougherty &
2+
Niedel, 1986). The fact that PKC is Ca dependent demonstrates
the interaction of the two limbs of the phospholipid signalling
pathway i.e. the effect of Ca^+ and DAG on PKC.
Mitogenesis only occurs if there is persistant activation
of PKC, which requires a maintained increase in cellular DAG levels,
and it is important to note that the inositol phospholipid pathway
(See Fig. 1.2).
is not the only stimulated source of DAG in cells a Many agonists 
that stimulate PtdIns(4,5)P2 metabolism have now also been shown 
to activate the hydrolysis of phosphatidylcholine (PtdCho) in 
various cell types (see Pelech & Vance, 1989 for review). The 
phorbol ester TPA can itself stimulate PtdCho breakdown (Grove & 
Schimmel, 1982; Muir & Murray, 1987). This suggests that 
stimulation of PKC by DAG could lead to further generation of DAG by 
activating PtdCho breakdown. Mitogen-stimulated Ptdlns(4 ,5^^ 
hydrolysis has been demonstrated to be a transient effect which is 
desensitised within a few minutes (Brown et al., 1987). However, a 
detailed examination of Ins(l,4,5)P^ and sn-1, 2-diacylglycerol 
levels within bombesin stimulated Swiss 3T3 cells has demonstrated 
that the DAG level remained elevated for at least 60 min whilst the 
Ins(l,4,5)P^ had returned to basal levels within 5 min (Cook et 
al.. 1989). The finding that inositol phospholipids are not the 
sole source of DAG for PKC activation and the fact that particular 
isoforms may be specific for particular types of DAG supports the
23a.
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Figure 1.2 Pathways of Phosphatidylcholine metabolism
The figure shows the PtdCho cycles for generation of DAG. The DAG can be 
generated directly via PtdCho specific phospholipase C or by the action of PLD to yield 
phosphatidic acid, which is cleaved to DAG by phosphatidic acid phosphohydrolase 
(PAP). PtdCho can also be hydrolysed by phospholipase A2 to yield Lyso-PtdCho and 
arachidonic acid. Lyso-PtdCho may be re-esterified to PtdCho or catabolized to 
GroPCho, which can be further degraded to glycerol 3-phosphate (G3P) and Cho.
G3P can be converted back to DAG via phosphatidic acid synthesis. Phosphorylation 
of Cho by choline kinase results in the formation of ChoP, which subsequently reacts 
with CTP to form CDP-Cho, catalysed by CTP : ChoP cytidylyltransferase (CT).
DAG can react with CDP-Cho to complete another PtdCho turnover cycle.
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possibility that the various PKC isoforms relate to different 
signalling pathways.
PKC is a ubiquitous enzyme which plays a pivotal role in 
cell adjustment to the environment. The importance of PKC in the 
stimulation of cell proliferation is demonstrated by the fact that 
tumour-promoting phorbol esters, when intercalated into the cell 
membrane, may substitute for DAG and permanently activate PKC, since 
they bind to the regulatory domain of the enzyme. A further 
indication that PKC is involved in cell growth is the observation 
that the anti-neoplastic lipoidal amine CP-46, 665-1 is a potent 
inhibitor of this enzyme (Shoji et al., 1985). While there is 
convincing evidence for the involvement of PKC in the control of 
cell proliferation, the targets of the enzyme remain mostly 
undetermined. An important site of action of PKC is the activation 
of the Na+/H* antiporter (see Section 1.2). Vinculin is also 
phosphorylated in vivo (Werth & Pastan, 1984) and it is possible 
that this phosphorylation is involved in cytoskeletal 
reorganisation, an event stimulated by tumour promoting phorbol 
esters (Schliwa et al., 1984).
PKC activation exerts both positive and negative effects on 
cellular events; one function of PKC appears to be intimately 
related to negative feedback control of cell surface receptors 
coupled to Ptdlns(4,5)?2 hydrolysis and also receptors of other 
signalling systems. Phosphorylation of adrenergic receptors by PKC 
and/or protein kinase A (mediator of cAMP action) is thought to play 
an important role in the modulation of adrenergic transmission. 
Leeb-Lundberg et al. (1986) showed that agonist-mediated 
desensitization of the cx^-adrenergic receptor (AR), coupled to 
Ptdlns(4,5)P^ hydrolysis, is associated with increased 
phosphorylation of CX^-AR. Stimulation of DDT^ MF-2 cells
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(smooth muscle cells) with bradykinin, lead to desensitization and 
phosphorylation of the °(^-AR. Phorbol esters, which activate 
PKC, also promote phosphorylation of the c< ^ -AR and its uncoupling 
from stimulation of Ptdlns(4,5)P^ hydrolysis in DDT^ MF-2 cells 
(Leeb-Lundberg et al., 1985). Bouvier et al. (1987) demonstrated 
that o( and j3^-kR purified from DDT^ MF-2 cells and hamster 
lungs respectively, can be directly phosphorylated in vitro by both 
protein kinase A and PKC. Although protein kinase A phosphorylates 
the 0(^-AR, p^-AR agonists do not promote this reaction 
(Bouvier et al., 1987). The functional significance of this 
phosphorylation is unknown. Phorbol esters promote phosphorylation 
of jS^-kR in conjunction with modulation of 
stimulated adenylate cyclase activity in avain erythrocytes 
(Kelleher et al., 1984). This suggests that PKC activated by 
Ptdlns(4,5)P^ hydrolysis, stimulated by various receptors, may 
also contribute to some forms of heterologous phosphorylation and 
desensitization of the AR. Both sensitization (e.g. Sugden
et al., 1985) and desensitization (e.g. Kelleher et al., 1984) of 
the adenylate cyclase system have been reported following phorbol
protein kinase A and PKC. However, agonist occupancy of the two 
receptors facilitates their phosphorylation only by the protein 
kinase coupled to their own signal transduction pathway. The 
phosphorylation occurs almost exclusively on serine residues and 
amounts to 2-3 moles phosphate/mol receptor. Phosphorylation of 
the o(^-AR by PKC or phosphorylation of the ^ 2-AR by protein 
kinase A is without effect on its agonist binding properties (Sibley 
et al., 1987).
ester treatment. Both o( ^ -AR and 0  ^ -KR are substrates for
These observations support the notion that PKC contributes
to the desensitization of the of - and
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transduction pathways respectively. Negative feedback control by
PKC also extends to the EGF receptor, where PKC phosphorylates the
receptor (Hunter et al., 1984) inhibiting receptor tyrosine kinase
activity (Downward et al., 1985) and decreasing the apparent binding
affinity of the receptor for EGF (e.g. Brown et al., 1984).
2+
1.5.3 Interaction between Ins(1,4,5)P^/Ca and DAG/PKC 
pathways
The two limbs of the inositol phospholipid signal 
transduction pathway may act separately to produce their individual 
physiological responses, but they can also act synergistically.
The cooperative effect of both signal pathways has been shown by the
\
use of Ca^+ ionophores and phorbol esters to activate cellular
processes normally activated by an agonist (Berridge, 1987b).
Nishizuka (1984) demonstrated that, in platelets, the combination of
2+
a phorbol ester and a Ca lonophore induces a maximal secretion
of 5-hydroxytryptamine at concentrations that have no effect when
2+
each drug is administered alone. Combination of a Ca ionophore
and phorobol ester have since been shown to activate many different
cellular processes, including DNA synthesis and cell proliferation
(see Berridge, 1987b). The relative importance of each pathway may
also vary with time, in that calcium may be responsible for
initiation whereas DAG may be more important in maintaining a
2+
physiological response. The interaction between Ca and PKC can
4- 4-
be demonstrated by their effects on the Na /H antiporter.
Owen et al. (1989) demonstrated that NIH-3T3 cells use both an
2+
inositol trisphosphate, Ca -mediated pathway and a PKC-dependent 
pathway to regulate Na+/H* exchange. In Swiss 3T3 cells, PDGF
and bombesin caused a rapid cytoplasmic acidification, due to
2+ . . .
increased cytoplasmic Ca , followed by a slower alkalmisation
(Ives & Daniel, 1987). Protons are generated by cellular
metabolism which is enhanced by growth factors and it has been shown
that an increase in the internal concentration of H+ can activate
the Na+/H* antiporter of plasma membrane vesicles of renal
proximal tubule cells (Aaronson et al., 1982) and intact human
fibroblasts (Hoolenaar et al., 1982) in a cooperative fashion.
However, it has been demonstrated that mitogen-induced
alkalinisation of cells by activation of the Na+/H* antiporter
2+ 2+
is not affected directly by Ca or Ca /Calmodulin changes
(Ives & Daniel, 1987; Hitsuhashi & Ives, 1988), but reduced 
2+
intracellular Ca will reduce growth factor induced activation of
4* 4*the Na /H antiporter m  vascular smooth muscle cells
(Mitsuhashi & Ives, 1988). This is most likely due to the fact 
2+
that PKC is a Ca dependent enzyme and only when there is
2+ . 
sufficient Ca will PKC activate the antiporter via a
phosphorylation reaction. Transformed cells have the capacity to
2+
grow in lower concentrations of Ca , which may mean either that
2+
they have elevated levels of Ca or that their responsiveness to 
2+
Ca has been enhanced.
Growth factors such as PDGF stimulate the rapid
transcription of oncogenes such as c-myc (Kaibuchi et al., 1986) and
c-fos (Grinstein et al., 1988). Their expression can also be
induced by stimulating cells either with a phorbol ester (Kelly et
2+
al.« 1983) or with a Ca ionophore (Greenberg & Ziff, 1984).
The fact that myc and fos are oncoproteins capable of cell 
transformation provides further evidence to support the idea that 
the inositol lipid signal pathway plays a significant role in 
controlling cell proliferation.
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1.6 The involvement of oncogenes in signal transduction
As discussed in the previous sections, the actions of 
certain growth factors are mediated via the activation of the 
inositol phospholipid signal transduction pathway. Therefore, loss 
of normal regulation of the pathway may lead to a loss in regulation 
of mitogenesis and conceivably to the uncontrolled growth and 
structural transformation typical of cancer. About 25 transforming 
genes or oncogenes have been identified and it is thought that 
certain oncogenes subvert the normal functioning of the inositol 
phospholipid pathway to bring about uncontrolled cellular growth.
The identification of the proteins encoded by oncogenes and an 
investigation into what functions they serve will enable a greater 
understanding of the molecular events that convert normal cells to 
cancer cells. This section examines the evidence for the effects 
of oncogene products upon signal transduction.
1.6.1 Autocrine stimulation of growth
Mammalian cell growth is under three types of control: 
endocrine, paracrine and autocrine. These can be exerted either 
alone or in combination with each other. In endocrine control, 
hormones are released from endocrine organs such as the pituitary 
gland and carried by the blood to target receptors some distance 
from the endocrine organ. Paracrine control is exerted by one cell 
on adjacent cells by the release of growth factors. For example,
in response to wounding, platelets release PDGF which acts on 
receptors of neighbouring epithelial cells and fibroblasts to 
stimulate cell proliferation and wound healing.
In autocrine control, cells respond to substances that they 
themselves release. Autocrine signalling is usually confined to 
pathological conditions. Certain tumour cells, for instance, 
synthesise and release growth factors that are required for normal
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cellular growth and division, but these growth factors stimulate the 
uncontrolled proliferation of the tumour cell itself, as well as 
adjacent normal cells, in a paracrine fashion and cause a tumour to 
f orm.
It has been demonstrated that multiple growth factors are 
required for the maximum stimulation of proliferation (Pledger et 
al., 1978; Leof et al., 1982). Unless the cells are 
neoplastically transformed, more than one growth factor supplement 
is necessary for growth (Barnes & Sato, 1980). Van, Zoelen et al. 
(1988) demonstrated that in normal rat kidney (NRK) cells none of 
the growth factors tested (EGF, type transforming growth factor 
(TGF-^ ), PDGF and retinoic acid) was able to induce loss of 
density-dependent inhibition of growth by itself, but a strong 
synergism was observed when combinations of three of the above four 
growth factors were tested. Therefore, exposure of a cell to one 
growth factor can lower the threshold for mitogenicity of a second 
growth factor (Wharton et al., 1983).. Moreover, growth factors 
operate at different points of the cell cycle. For example, 
transient treatment of fibroblasts with PDGF will induce a stable 
state ’competence* whereby cells are responsive to other circulating 
plasma-derived factors (O’Keefe & Pledger, 1983).
The most commonly produced autocrines by tumour cells 
include type (\ transforming growth factor (TGF-cO, peptides 
related to PDGF, bombesin and TGF-/0 . Loss of requirement for 
specific growth factors is a common property of many types of cancer 
cell (Kaplan et al., 1982) and may be mediated by (a) the activation 
of autocrine growth factor synthesis , (b) synthesis of an altered 
growth factor receptor, or (c) activation of a post-receptor pathway 
that bypasses the growth factor receptor requirement.
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1.6.1.1 Activation of autocrine growth factor synthesis
PDGF is a polypeptide sufficient in some cells to induce
both DNA synthesis and cell division. It is thought that most
transformed mesenchymal cells produce PDGF or PDGF-like molecules
(Shipley et al., 1985). The first demonstration of a direct
involvement of an oncogene product with the inositol phospholipid
pathway came from the observation that the sequence of the protein
encoded by the sis oncogene is almost identical with the N-terminal
109 amino acid residues of the ^-chain of PDGF.
Expression of this oncogene can cause increased stimulation
of hydrolysis of Ptdlns(4,5)?^ via PDGF receptors and provides
direct evidence for the role of polypeptide growth factors in
cellular transformation (Leal et al., 1985).
TGF-d is a secreted polypeptide that was discovered in the
medium of certain retrovirus-transformed fibroblasts (Delarco &
Todaro, 1978). Expression of the TGF-<rt gene has been demonstrated
in a variety of tumours which are mostly carcinomas. The
consistent expression of the TGF-c( gene in squamous cell carcinomas
and renal carcinomas is frequently accompanied by elevated EGF
receptor expression. The effects of TGF-o( are mediated through
the EGF receptor, but the release and action of TGF-<?( and its
relationship to transformation is unclear.
Experiments with cells expressing temperature sensitive
mutant rodent sarcoma viruses demonstrate the relationship between
the release of TGF-c^ and transformation. In these experiments,
TGF-o( was not released into the medium unless cells were grown at a
temperature permissive for transformation. Thus, the strict
dependency of TGF-0( secretion on the transformed state of these
sarcoma cells suggests that viral oncogene products such as p37™~S_
Jci —rss
and p21 ---  control TGF-<s( synthesis at either the
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transcriptional or translational level (Ozanne et al., 1980;
Delarco et al., 1981; Kaplan et al.., 1982). These observations, 
together with the fact that TGF-<^ and -y3 cause the induction of 
reversible phenotypic transformation of NRK fibroblasts, have 
reinforced the belief that TGF-o( synthesis is associated with 
malignant transformation.
TGF-yB (Anzano et al., 1985) and PDGF-like molecules 
(Bowen-Pope et al.., 1984) are also released from rodent cells 
transformed by Moloney, Harvey or Kirsten viruses. The PDGF-like 
molecules bind to the PDGF receptor(s) and activate both 
Ptdlns(4jSJP^ hydrolysis and the receptor associated tyrosine 
kinase.
The mode of action of TGF-y0 is however less clear. It 
has been demonstrated both to stimulate the growth of fibroblasts 
(Tucker et tQ., 1983) and to inhibit cell proliferation of, for 
example, normal and certain tumour-derived epithelial cell lines 
(Tucker et al., 1984). The expression of these two activities is 
modulated by other growth factors and is not solely dependent on 
cell type or conditions of anchorage-dependent versus 
anchorage-independent growth. In myc transfected rat fibroblasts 
TGF-)S can stimulate anchorage-independent growth in the presence of 
PDGF, but it is anti-proliferative in the presence of EGF (Roberts 
et al., 1985). The effect of TGF-£ upon cellular signalling is 
unclear although a recent report has suggested that it may activate 
PKC by an unidentified mechanism in immature rat brain (Markovac & 
Goldstein, 1988). This effect upon PKC could explain the 
inhibition of EGF-stimulated growth through a mechanism involving 
phosphorylation and transmodulation of the EGF receptor.
The importance of autocrines in maintaining the malignant 
state is demonstrated by the use of the polyanionic drug suramin.
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This drug has been shown to block the binding of EGF, TGF-CA and 
PDGF to their receptors. It also causes dissociation of these 
growth factors prebound to their receptors (Betsholtz et al.,
1986). Suramin was used to demonstrate that growth and 
transformation of fibroblasts by the sis oncogene is dependent upon 
growth factor-receptor interaction, whereas transformation by viral 
ras is not.
The inhibition of growth of cancer cells by a receptor 
antagonist has also been accomplished with small-cell lung carcinoma 
cells in culture. These 'oat cell' cancers secrete 
gastrin-releasing peptide which is thought to be the mammalian 
equivalent of the amphibian peptide bombesin (Moody et al., 1981). 
This peptide is a potent mitogen and stimulates Ptdlns(4,5)P^ 
hydrolysis in both Swiss 3T3 and NIH-3T3 cells (Brown et al.«
1984); Wakelam et al., 1986). A monoclonal antibody raised 
against bombesin inhibits the growth of 'oat cell* cultures and the 
development of tumours in nude mice can be prevented by injection of 
this antibody (Cuttitta et al., 1985).
1.6.1.2 OncoRene products as receptors
Cells can be transformed by increasing receptor number or 
by modifying existing receptors. Some oncogene products have been
found to be cell surface receptors or an altered form of the 
receptor.
Activation of receptors can sometimes occur in the absence 
of growth factors. Sequence homology between the v-erb-B gene 
product and the cellular receptor for EGF (Downward et al., 1984) 
suggests that the erb-B product resembles a truncated EGF receptor, 
which lacks the EGF binding and autophosphorylation domains. The
tyrosine kinase domain is intact and seems integral to cell 
transformation (Livneh et al., 1986). The erb-B product may mimic
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the receptor's activity without the appropriate signal from EGF.
Evidence confirming this came from experiments involving 
the integration of an intact ALV genome into the c-erb-B locus in a 
manner that would lead to the over-expression of a truncated EGF 
receptor under control of the introduced ALV promoter (Raines et 
al.. 1985). Cells expressing a truncated growth factor receptor 
might be constitutively activated to generate mitogenic signals, 
independent of its ligand.
The protein product of the c-fms oncogene has been 
identified as the cell surface receptor for the heomatopoietic stem 
cell growth factor CSF-1 (Sherr et al., 1985); the v-fms oncogene 
may encode an altered form of the receptor.
1.6.1.3 Activation of post receptor pathways that bypass the 
requirement for Rrowth factors
Many oncogenes exert their effects via tyrosine 
phosphorylation. However, the major substrates for these kinases 
remain to be identified. Some of the src-related proto-oncogenes 
may encode enzymes involved in the increased intracellular formation 
of Ins(l,4,5)P^ and DAG (Berridge & Irvine, 1984). Treatment of 
fibroblasts with PDGF causes a 40-fold increase in c-mvc mRNA levels 
within 2h (Kelly et al., 1983) and a similar increase in c-fos mRNA 
levels within 45 min (Greenberg & Ziff, 1984). Recent evidence has 
implicated the expression of c-mvc and c-fos in the control of DNA 
synthesis as they bind to DNA at specific sites (Heldin et al.,
1987). These oncogenes are co-expressed with other oncogene 
products, for example, c-myc and the ras oncogene are co-expressed 
in transformed primary and secondary rat embryo cells (Land et al.,
1983). Thompson et al. (1989) introduced myc and ras oncogenes 
via infection with recombinant retroviruses into controlled, but 
small, numbers of cells fromtmurine urogenital sinus with subsequent
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reconstitution of these cells into differentiated prostate in
vivo. When ras and myc oncogenes were introduced alone,
alterations resembling different types of premalignant lesions
resulted. However, when introduced together agressively growing
tumours of various cell types occurred, even when less than 100 out
of 1.5 x 10^ cells initially became infected. This indicates
that oncogene co-operativity is a necessary event for cell
transformation in some systems. The existence of oncogene products
as either growth factors, growth factor receptors and the
post-receptor machinery (i.e. p21^^, p55C p75C and
c-myc
p58 “ ) indicates that the growth factor regulatory pathways are
crucial in the development and maintenance of tumourogenesis and 
indicates the importance of tight regulation of these pathways in 
normal cell growth.
1.6.2 Negative regulators of cell Rrowth
Malignant transformation may be the result not only of 
excessive production, expression and action of positive autocrine 
growth factors, but also of the failure to express or respond to 
specific negative regulators of cell growth.
TGF-p is a growth regulator that may function in an
autocrine manner and it is bifunctional having both stimulatory and 
inhibitory growth regulatory activities depending on the cell type 
(Roberts et al., 1985). TGF-J5 has been shown to inhibit the
proliferation of MCF-7 breast cancer cells (Sporn et al., 1987) and
has been demonstrated to inhibit the growth of NIH-3T3 cells (Liboi 
et al.., 1988). Sporn and Roberts (1985) proposed that TGF-JB could 
be oncogenic ’by defect' if a decrease in its expression or activity 
were to release cells from proliferative constraints that TGF-j3 may 
normally impose.
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A fibroblast growth regulator (FGR) has been isolated from 
medium conditioned by exposure to density-inhibited Swiss-3T3 cells 
that will inhibit growth in an autocrine manner. A rat antibody 
(2A4) specifically bound FGR and was found to neutralise the growth 
inhibitory effect of FGR in a concentration-dependent fashion (Hsu 
et al., 1984).
Other growth inhibitors have been partially purified and 
characterised. These include (i) a glycopeptide from bovine 
cerebral cortex cells, that inhibits protein synthesis and cell 
growth of normal but not transformed cells (Kinders & Johnson, 
1982); (ii) a heparin-like molecule, produced by cultured 
endothelial cells, that inhibits the growth of smooth muscle cells 
(Willems et al., 1982) and (iii) a lipid molecule on the plasma 
membrane of lymphoid tumour cells (Stallcup et al., 1984).
These growth inhibitors may act by binding to cell surface 
receptors triggering an intracellular signal that regulates the 
initiation of DNA synthesis and cell division. Alternatively, the 
growth inhibitor may modulate/counteract the mitogenic action of 
growth factors by altering the concentration of free growth factor 
available for interaction with its specific growth factor receptor.
1.7 The involvement of the ras Rene products in signal
transduction
Three functional ras genes are found in the human genome, 
c-Ha-ras-1, C-Ki-ras-2 and c-N-ras, and all are expressed at low 
levels in most cells (Hall et al., 1983). Their classification 
depends on the extent of homology with the oncogenes of the Harvey 
and Kirsten sarcoma viruses, and with the transforming gene first 
encountered in the SK-N-SH neuroblastoma cell line. Around 10-20% 
of human tumours have been shown to contain ras genes, with the 
majority of these being mutated genes. Approximately 1% have been
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detected as having amplified normal cellular genes (proto-oncogenes) 
(Barbacid, 1987).
Bach ras gene encodes a similar 21kDa protein, termed
1?HS
p21--- . The ras proteins contain 189 amino acids (188 in the
case of Ki-ras-2) and are identical for the first 85 amino acid 
residues. The next 80 amino acid N-terminal residues are highly 
conserved being approximately 85% homologous. In contrast, the 
final C-terminal amino acids share little homology, except for the 
last four amino acids where a conserved cysteine residue is found at 
position 186. Cysteine 186 is post-translationally palmitoylated,
I*3S
and this acylation is essential for association of the p21---
proteins with the plasma membrane and their function. Mutation of
cysteine 186 to serine has been shown to abolish acylation, membrane
binding and transformation (Willumsen et al., 1984). Magee et al.
(1987) proposed that an active acylation-deacylation cycle exists
and suggested that in vivo acylation may act transiently during
N-ras
signalling to modify the interaction of p21 --- with the
membrane. Alternatively, interaction with other components of a 
signal-transducing mechanism without actual dissociation from the 
membrane could be modified.
l?aS
The precise function of p21---- is still unclear, although
evidence exists for a role in signal transduction pathways 
(Feramisco & Gross, 1984; Wakelam et al., 1986; Fleischman et al., 
1986; Lloyd et a^., 1989). Their biochemical properties are 
similar to the properties of the alpha subunit of the G-proteins.
I*3S
Both p21--- and the alpha subunit of G-proteins bind guanine
nucleotides (GTP and GDP) (Willingham et al., 1980) and display an 
intrinsic GTPase activity at similar rates (e.g. Gibbs et al.,
1984). Both are attached to the inner leaflet of the plasma 
membrane and also share some sequence homology.
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The binding of GTP appears to be crucial for the ability of
FdS
p21---- to promote cell proliferation and malignant
transformation. Microinjection of antibodies directed against a 
putative GTP binding domain of p21 inhibits GTP binding and reverses 
the malignant phenotype of NIH-3T3 cells transformed by ras 
oncogenes (Feramisco et al., 1985). Many mutations are known to
Fft S
activate the oncogenic potential of p21---  by causing severely
impaired GTPase activity; these include any change at residue 12
except proline, threonine at residue 59 and lysine, leucine or
arginine at position 61 (Gibbs et al., 1985). Amino acid sequences
show that the glycine at the position corresponding to residue 12 of
raS
c-Ha-ras is conserved in p21---, G ^  and the alpha
subunit of Gs » supporting the idea that the two sets of proteins
are functionally homologous.
Lacal et al. (1986), in a series of deletion experiments 
H &-r& s
using p21  , demonstrated that regions 5-23 and 152-165 were
absolutely required both for GTP binding and cell transformation.
The transforming mutants of ras genes are characterised by 
having a greatly reduced GTPase activity and this led to the
F&S
proposal that transformation by p21---- is the result of abnormal
raS
levels of p21--- in an active, GTP bound state. However,
analysis of GTPase activities associated with a large number of p21
mutants failed to reveal a quantitative relationship between GTPase
activity and transforming activity. A cytosolic protein, GTPase
activating protein (GAP), which has been found in all cells
examined, stimulates the GTPase activity of normal glycine 
N-ras
12-p21 ---, but is without effect upon its transforming mutants
N-ras
aspartic 12 and valine 12-p21   (Trahey & McCormick, 1987).
It appears that the major effect of position 12 mutations is to 
prevent this protein from stimulating p21-GTPase activity, thereby
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allowing these mutants to remain in the active GTP-bound state.
GAP has been purified from the cytosolic fraction of bovine brain
and human placenta and the complementary DNA cloned (Gibbs et al..,
1988; Vogel et al., 1988). GAP is a 125kDa monomeric polypeptide
that catalytically stimulates normal ras GTPase activity 100-fold.
The GTP complexes, but not the GDP complexes, of normal and
oncogenic ras proteins bind to GAP with micromolar affinities (Vogel
et al.. 1988). The oncogenicity of mutant p21--- may be due to
the conformational change induced at the mutation site which prevent
GAP binding, thus leading to persistent GTP binding to the ras
protein. The GAP protein is thought to act at a region between
amino acids 30-40 on p21--- as this interaction of GAP at this ■
r8S
’effector site* is attenuated in p21--- with effector site
mutations (Cales et al., 1988; Adari et al., 1988). These results 
strongly implicate that GAP is a candidate for a ras effector 
protein, and functions downstream in a signal transduction 
pathway. Regions of GAP share amino acid similarity with the 
non-catalytic domain of adenylate cyclase from the yeast 
Saccharomyces cerevisiae. This might explain the paradox that ras 
proteins from mammalian and yeast cells can function in heterologous 
systems through different effectors (DeFeo-Jones, 1985). If the 
sequence similarity is functionally significant, then GAP might act
as an intermediate between p21--- and the catalytic domain of some
effector. The presence within GAP of sequences conserved among the 
non-receptor tyrosine kinases, the crk oncogene product and 
phospholipase C-148 raises the possibility that GAP shares certain 
of the functional, perhaps regulatory, properties of these effector 
molecules.
r s s
The role of p21  in cell proliferation, transformation
raS
and differentiation is not yet understood. Oncogenic p21--- , but
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raS % 
not normal p21--- proteins, can induce terminal differentiation of
a rat pheochromocytoma cell line (Bar-Sagi & Feramisco, 1985).
Both oncogenic p21--- and nerve growth factors induce
differentiation after a lag of 15-24h. Therefore it is possible
that ras oncogenes may switch on the same signal transduction
pathway used by nerve growth factors. Such a conclusion is
supported by the observation that the anti-ras antibody (Y13-259)
inhibits neurite formation induced by nerve growth factors (Hagag et
al., 1986).
Mulcahey et al. (1985) demonstrated that NIH-3T3 cells
induced to divide by adding serum to the culture medium are unable
to enter the S phase of the cell cycle after microinjection of
rdS
anti-ras antibody, demonstrating that p21--- plays an important
role in regulating entry into S phase. The p21--- proteins are
also necessary for transformation with other oncogenes: for
example, NIH-3T3 cells transformed by v-src cannot enter S phase 
when microinjected with anti-ras Y13-259 antibodies (Smith et al., 
1986).
r*&s
Several lines of evidence support the idea that p21---
functions in a G-protein-like manner coupling the receptors for 
certain growth factors to the stimulation of PIC. This proposal 
was raised when it was realised that PIC activation is important in 
control of growth by normal proliferative stimuli and by oncogenes 
(Berridge & Irvine, 1984). Support for an effect on PIC is the 
observation that transformation of Balb-3T3 fibroblasts with the 
EJ-Ha-ras oncogene increases the responsiveness of PIC to 
carbamylcholine stimulation, resulting in elevated levels of 
inositol phosphates compared to control cells (Chiarugi et al.,
1985). Fleishman et al. (1986) showed that both NRK and NIH-3T3 
cells stably transformed by three different ras genes always display
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a steady state increase in the levels of DAG and inositol phosphates
relative to their precursor PtdIns(4,5)P2. Preiss et al. (1986)
and Lacal et al. (1987a) have also demonstrated that there are
raised levels of DAG in cells transformed by ras genes. Wakelam et
al. (1986) showed that an amplification of the PIC response to
growth factors can also be achieved by the over-production of normal 
N-ras
p21-----, under the control of a steroid inducible promoter. In
the presence of the inducer dexamethasone, p21N is
over-expressed and the cells (T15*) become transformed (McKay et
al.. 1986). T15 cells over-expressing p21  showed no
change in basal inositol phosphate production, but exhibited an
increased responsiveness to several growth factors, particularly
bombesin, compared to cells grown in the absence of the inducer
(T15 ). This increase is observed with no accompanying change in
the number or affinity of the bombesin receptors on each cell. It
has now been shown that the elevated inositol phosphate response to
bombesin is a consequence of increased Ptdlns(4,5)?^ hydrolysis
24-leading to an elevated release of intracellular stored Ca (Lloyd 
et al., 1989). These results are consistent with the proposal that
p21--- may directly or indirectly increase the coupling of certain
growth factor receptors to PIC and that in normal cells the 
concentration of this protein is an important factor that regulates 
the intensity of signalling through the inositol phospholipid 
pathway.
Transformation of NIH-3T3 cells with activated, 
point-mutated N- or Ha-ras did not increase the apparent coupling of 
receptors to PIC, but it appeared to constitutively activate PIC 
resulting in an enhanced basal rate of production of total inositol 
phosphates (Hancock et al., 1988; Wakelam, 1988). Transformation 
or differentiation in experimental systems can be induced by mutant
41 .
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p21--- , but it requires larger amounts of normal p21--- to
achieve the same effects. The mutated ras proteins may transform 
cells by providing a necessary limiting factor for the constitutive 
activation of signal transduction pathways or by suppressing 
inhibitory control mechanisms.
The role of the ras proteins in amplifying inositol 
phospholipid turnover has, however, been questioned as differences 
in inositol phospholipid metabolism have been reported for ras 
transformed cells. Parries et al. (1987) showed that 
transformation of NIH-3T3 cells by viral Ha- or Ki-ras caused the 
desensitization of the PDGF-stimulated inositol phosphate response 
with a markedly attenuated mitogenic response while the bradykinin 
response was amplified. Receptor binding studies demonstrated that 
the number of high affinity bradykinin binding sites was increased 
in the v-Ha-ras transformed cells, whilst there was no change in 
PDGF binding. Benjamin et al. (1988) observed a similar 
desensitization in EJ-ras transformed NIH-3T3 cells and they suggest 
that EJ-ras p21 may uncouple the PDGF receptor from PIC resulting in 
inhibition of PDGF-stimulated activity of PIC, Ins(l,4,5)P2 
generation and Ca^+ mobilisation. The bombesin-stimulated 
inositol phosphate response in T15+ cells is desensitized by high 
density culturing (Wakelam, 1988). This desensitization can be 
reversed by culturing in the presence of the growth factor 
antagonist suramin and it has been suggested (Wakelam, 1988) that 
the effect is induced by the known secretion of autocrines by 
ras.-transformed cells (Owen & Ostrowski , 1987). This effect of 
autocrines is probably mediated by PKC since phorbol esters can 
mimic the desensitization induced by high density culturing.
Morris et al. (1989) have demonstrated that activation of PKC occurs 
within 10 min of treatment with TPA or scrape-loading
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[val-1 2 ]p2l££JL into Swiss 3T3 cells. Price et al. (1989)
F&S
demonstrated that this activation of PKC by TPA or [val-12]p21'---
leads to a desensitization of growth factor-stimulated inositol
phosphate generation. Brown et al. (1987) demonstrated that
prolonged treatment of Swiss 3T3 cells with TPA, to down regulate
PKC levels, leads to an increase in both basal and growth
factor-stimulated levels of inositol phosphates, presumably due to a
decrease in feedback regulation of phosphoinositide metabolism.
The variability of effects of transfecting ras proteins into
fibroblasts upon inositol phospholipid metabolism may therefore be
due to desensitization mediated by PKC.
Increased DAG levels have been consistently observed in
ras-transformed cells. Wolfman and Macara (1987) show that NIH-3T3
cells transformed by Ha- or Ki-ras possess elevated DAG levels
without significant increases in the level of inositol phosphates.
Wolfman and Macara (1987) also demonstrate that the basal
phosphorylation of the PKC substrate 80kDa protein was significantly
increased in all the ras transformed cells examined. However, when
the ras transformed cells were incubated with TPA, phosphorylation
of the 80kDa protein was reduced, suggesting that DAG elevation
induces partial down-regulation of PKC activity in these cells.
Lacal et al. (1987c) demonstrated the importance of PKC activity in
ras induced transformation. They demonstrated that the mitogenic
Hd^rds
activity of the Ha-ras oncogene in p21 ----microinjected
quiescent Swiss 3T3 cells is markedly reduced under conditions in 
which PKC is down-regulated by chronic phorbol ester treatment.
The mitogenic activity was restored when both Ha-ras and purified 
PKC were co-injected, demonstrating that the mitogenic response to 
Ha-ras requires functional PKC. Lacal et al. (1987b) have also 
examined the effects of microinjection of Ha-ras into Xenopus
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oocytes. Increases in inositol phosphate generation were 
detectable within 2 min and reached a maximum after 6 min, but then 
appeared to be desensitized. DAG levels examined in parallel 
experiments demonstrated a similar rapid increase. However, the 
increased DAG generation was maintained for at least 20 min 
post-injection. Lacal et al. (1987a) demonstrated reproducible 
increases in DAG levels in the absence of detectable increases in 
inositol phosphates in Ha-ras transformed NIH-3T3 cells. These 
observations suggest that DAG might be generated from the metabolism 
of phospholipids other than Ptdlns(4,5)?^ (see Section 1.5.2).
Therefore the biochemical properties, cellular location and
their involvement in mitogenesis, transformation and differentiation
s
indicate that p21--- may function in a G^-like manner regulating
second messengers in signal transduction.
Research Aims
Despite extensive research, the mechanism of action of ras
is still unknown. It has been proposed that p21---- proteins
function in a G-protein-like manner mediating the effects of certain 
growth factors, by coupling their receptors to the stimulation of
F&S
PIC. To study the role of p21---- in regulating second messengers
as part of a signal transduction mechanism, NIH-3T3 fibroblasts, 
which have been transformed by constitutive expression of the 
c-Ha-ras-1, c-Ki-ras-2 or N-ras genes, were used. These cell lines 
are transformed by a several-fold over-expression of the normal ras 
proteins. Wild-type NIH-3T3 fibroblasts which express Ha-, Ki- or 
N-ras at very low levels were used as a control.
In chapter three the effect of over-expression of normal 
ras genes in NIH-3T3 fibroblasts upon inositol phospholipid 
hydrolysis was examined. The cell line H8/22, an inducible Ha-ras 
expressing clone of the NIH-3T3 cell line was also used to study the
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effects of short term transformation by the ras proto-oncogene. 
NIH-3T3 cells transformed by over-expression of ras genes 
demonstrated a reduced PGF -stimulated inositol phosphate
tvA
response and this was further investigated.
This led to an investigation of the role of inositol 
phospholipid turnover in the stimulation of cell proliferation 
(Chapter four).
In Chapter five PtdCho metabolism in NIH-3T3 cells 
transformed by over-expression of ras genes was studied.
The aim of this study was to provide additional ’clues' as 
to the exact function of the ras proto-oncogene product p21 and to 
determine its role in lipid signalling pathways.
CHAPTER 2 
MATERIALS AND METHODS
2. MATERIALS AND METHODS
2.1 Materials and cell lines
Cells:
Kindly donated by C.J. Marshall, 
Institute of Cancer Research, 
Chester Beatty Laboratories,
Fulham Road, London SW3 6JB
Kindly donated by D.W. Stacey, 
Roche Institute of Molecular 
Biology, Nutley, New Jersey 07110, 
U.S.A.
Kindly donated by K.D. Brown, 
A.F.R.C. Institute of Animal 
Physiology, Brabraham, Cambridge 
CB2 4AT, U.K.
Amersham International pic. Amersham. Buckinghamshire, England
3 -1
myo[ HJInositol (specific activity = 22.8Ci mmol )
3 —1
mvo[ H]Inositol 1-monophosphate (specific activity = ICi mmol )
3
myo[ Hjlnositol 1 ,4-bisphosphate (specific activity = 1 or 44Ci 
mmol
3
mvo[ HJInositol 1,4,5-trisphosphate (specific activity = 52Ci
mmol *
3
mvo[ Hllnositol 1,3,4,5-tetrakisphosphate (specific activity =
ICi mmol
3 -1[methyl- HlThymidine (specific activity = ICi mmol )
3 -1
[methyl- H]Choline Chloride (specific activity = 76Ci mmol )
3 —1
[ HJProstaglandin F (specific activity = 180Ci mmol )
NIH-3T3, EC816, EC806, EC807, 
H8/22, Ki858, Ki860, N866 
N872, T15
AmNIH-3T3
Swiss 3T3
BDH Chemical Company* Poole, England
Ammonium formate dimethylsulphoxide, EOTA (Ethylenediamine 
tetra-acetic acid), Hepes (N-2-hydroxyethylpiperazine-N*-2 ethane 
sulphonic acid), lithium chloride, orthophosphoric acid, potassium 
hydrogen phosphate, potassium dihydrogen phosphate, perchloric acid 
sodium hydroxide, sodium carbonate, trichloroacetic acid and 
universal indicator.
Biomedical Technologies Ltd.. England 
Epidermal Growth Factor 
Bioprocessing Ltd., Consett, England 
Platelet Derived Growth Factor 
Boehringer (UK) Ltd., Lewes, England 
ATP and Tris
Cambridge Research Biomedicals, Cambridge, England 
Bradykinin, bombesin and gastrin releasing peptide 
Formachem (Research International) Pic, Strathhaven, Scotland 
Boric acid, D-glucose and sodium hydrogen carbonate 
FSA Laboratory Supplies, Loughborough, England 
OptiPhase ’Hisafe* 3
Flow Laboratories, Rickmansworth, England 
0.2 micron filters 
Gibco, Paisley, Scotland
All cell culture medium including amino acids mixture (50x) and 
glutamine (lOOx)
Koch-Light Ltd.. Suffolk, England
Calcium chloride, magnesium sulphate, potassium chloride and sodium
potassium tartrate
Laserchrom, East Grinstead, England
Whatman Partisil 5 Wax column
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Hav and Baker. Dagenham. England
Formic acid, hydrochloric acid and sodium tetraborate
National Diagnostics. Aylesbury. England
Ecoscint
Riedel-DettaenAg Seelze-Hannover. Germany
Magnesium chloride and sodium dihydrogen carbonate
Whatman Ltd.. Maidstone. England
0.45 micron millipore filters
Pierce and Warriner. London, England
Micropor (Spectrapor 3) dialysis tubing
All other chemicals were obtained from Sigma Chemical 
Company, Poole, England
2.2 Cell lines and methods of cell culture
2.2.1 Cell lines
NIH-3T3 mouse fibroblasts, which have been transformed by 
constitutive expression of the c-Ha-ras-1. c-Ki-ras-2 or N-ras were 
used. These cell lines are transformed by a several fold over
expression of the normal ras proteins. Wild type NIH-3T3 cells
which express Ha-, Ki- and N-ras at very low levels were used as a
control.
Swiss mouse 3T3 fibroblasts and NIH-3T3 (AmNIH-3T3) cells 
obtained from America (gifted by Dennis W. Stacey, Roche Institute 
of Molecular Biology, Nutley, New Jersey 07110) were also used. 
Table 2.1 lists the cell lines used.
T15 and H8/22 cell lines, which are both clones of NIH-3T3 
cells were also used. The T15 cell line contains the normal human 
foetal N-ras proto-oncogene under the transcriptional control of a 
glucocorticoid-inducible promoter MMTV-LTR (murine mammary tumour 
virus long terminal repeat). The H8/22 cells contain the normal 
human foetal Ha-ras proto-oncogene under the control of the same
48.
Table 2.1 Cell lines
Cell type ras-Gene
NIH-3T3 
AmNIH-3T3 
Swiss 3T3 -
BC806
EC807
EC816
normal Ha-ras
H8/22+-
Ki858
Ki860 normal Ki-ras
N866
N872 normal N-ras
T15+
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glucocorticoid-inducible promoter. Using the steroid dexamethasone 
the expression of N-ras in the T15 cells or Ha-ras in the H8/22 
cells can be switched on and off and the cellular concentration of
I*SS
p21--- can be controlled. Cells grown in the absence of the
N^r&s —
inducer dexamethasone contain negligible human p21   (T15 )
Hft—TflS —
or p21------ (H8/22 ) and resemble wild-type NIH-3T3 cells in
morphology and growth characteristics. In cells grown in the
4 +
presence of 2uM (T15 ) or lOOnM (H8/22 ) dexamethasone there is
1TSS
a vast over production of the p21--- amounting to 1-2% of the
plasma membrane protein and the cells exhibit the transformed 
phenotype.
2.2.1.1 T15 cells
Dose-response curves for the effect of dexamethasone on
N—rES
p21 --- expression and on bombesin stimulated inositol phosphate
generation in T15 cells were performed by Wakelam et al. (1986).
Addition of increasing concentrations of dexamethasone to T15 cells
previously grown without this inducer (T15 ) resulted in a
concentration dependent increase in expression of the human N-ras
N-ras
proto-oncogene as determined by immunoprecipitable p21 ---
N-r ^ g
(Wakelam et al., 1986). Maximum expression of p21   and
bombesin-stimulated inositol phosphate generation was found in cells
grown in the presence of 1.5uM dexamethasone for 48h. Routinely
N—rss
2uM dexamethasone was used to induce p21   expression in T15
cells.
2.2.1.2 H8/22 cells
Figure 2.1 shows the dose-response curve for the effect of 
dexamethasone on PDGF-stimulated inositol phosphate generation in 
H8/22 cells. Maximum PDGF-stimulated inositol phosphate generation 
was found in cells grown in the presence of lOOnM dexamethasone for 
24h. In subsequent experiments lOOnM dexamethasone was used.
Figure 2.1 Dose response curve for the effect of dexamethasone on
PDGF-stimulated inositol phosphate generation in H8/22 
cells
3 -1
Cells were labelled with [ Hlinositol (luCi ml ) in
the presence of the stated concentration of dexamethasone for 24h.
PDGF (1.32ug ml *) stimulated inositol phosphate generation was
determined as described in Section 2.6, sample preparation, Method A
and the results are means + S.D. of one experiment where n=4.
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Figure 2.1
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C.J. Marshall (Institute of Cancer Research, Chester Beatty 
Laboratories, Fulham Road, London) confirmed that in this cell line 
addition of lOOnM dexamethasone for 24h to H8/22 cells previously 
grown without this inducer (H8/22) resulted in maximum expression of
p2lHa-ras
2.2.2 Cell Culture
All cells were grown as monolayers on plastic surfaces at 
37°C in a 5% (v/v) CO^, 95% humidified atmosphere in Dulbecco’s 
modified Eagle’s Medium (DMEM) containing donor newborn calf serum 
10% (v/v) for NIH-3T3, AmNIH-3T3 and Swiss 3T3 cells and 5% (v/v) 
for NIH-3T3 cells transformed by overexpression of the Ha-, Ki- and 
N-ras genes.
2.2.3 Cell passage
The ’spent’ medium from confluent flasks (approximately
6 2 
10 cells per 25cm flask) was removed by aspiration. Trypsin
solution (l-2ml) containing 0.1% trypsin (w/v), 0.025% EDTA (w/v)
and lOmM glucose in phosphate buffered saline (pH7.3) was added to
each flask, and left at 37°C for approximately 2-3 min.
Serum-containing medium (3ml) was added and the cells collected by
centrifugation at 800g in an MSE Centaur centrifuge for 5 min,
resuspended in DMEM containing serum and plated as required. An
Industrial D Coulter counter was used to determine the cell
concentration if necessary.
2.2.4 Maintenance of cell lines
Confluent cells were passaged as above and the cells 
resuspended in biofreeze vials at a density of 10^ cells ml  ^ in 
freezing medium (8% DMS0 (v/v), 20% calf serum (v/v) and 72% DMEM 
(v/v)). The vials were packed in cotton wool, placed in 
polystyrene boxes, frozen overnight at -80°C and then transferred 
to the vapour phase of a liquid nitrogen container for storage.
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When frozen cells were to be recovered, a vial was removed
from the liquid nitrogen container and placed into a 37°C water
bath for thawing. The cell suspension was aseptically transferred 
2
to 25cm flasks containing 4ml fresh serum-containing medium and
placed into the incubator at 37°C.
2.2.5 Preparation of inositol free calf serum
Donor newborn calf serum was dialysed to remove inositol,
3for use m  experiments where cells were labelled with [ H]inositol.
Calf serum was aliquoted into dialysis tubing in 50ml lots 
and dialysed against four changes of 500ml of a 1:20 (v/v) dilution 
of a 20x strength Earle’s salt solution (see Buffer composition 
section) in distilled, deionised water adjusted to pH7.4 with 1M 
sodium hydroxide. The dialysed calf serum, was filter sterilised 
using a 0.2 micron filter unit and stored frozen.
3
2.3 Hlthymidine incorporation
Cells were plated on to 24 well plates at a density of 
10^ cells per well. The medium was changed 24h later to one 
containing 0.5% (v/v) calf serum and the cells were left for three 
days to become quiescent. They were then washed in DMEM and
incubated in fresh DMEM, containing the appropriate additions
-1 3 -1
together with luCi ml [ H]thymidine, 0.4ng ml EGF, 0.4ug
ml ^ transferrin and 0.04ng ml ^ insulin. The medium was
removed 24h later and the monolayers were washed twice with Hanks
Buffered Saline. The monolayers were then washed four times with
lml of 5% (w/v) trichloroacetic acid and the cells solubilised in
lml of 0.3M sodium hydroxide. The solubilised cells were removed
to a scintillation vial containing 0.2ml of 1.5M hydrochloric acid
and the radioactivity determined by scintillation counting in 10ml
of ecoscint scintillation fluid.
2.4 Growth curves
4
Cells were plated on to 35mm dishes at a density of 10 
cells per dish, and the medium was changed 24h later to one 
containing the ligand being tested. If the cells were to be 
incubated serum free, the following additions were also made; 0.4ng 
ml * EGF, 0.4ug ml * transferrin and 0.04ng ml * insulin. At 
24h intervals, cell number was determined following trypsinisation, 
by counting in an Industrial D Coulter counter.
2.5 Separation of inositol phospholipids
2.5.1 Sample preparation
2
Two confluent 25cm flasks of NIH-3T3 and T15 cells were 
used for each time point. The cells were labelled for 0, 2, 8, 12, 
24 and 36h prior to the experiment with 5uCi ml * of
3
[ H]inositol in inositol and serum free DMEM. After the 
labelling period, the cells were washed twice with Hanks buffered 
saline, scraped and collected by centrifugation at 800g for 5 min. 
The cells were resuspended in 1.5ml Hank's buffered saline 
containing 1% (w/v) bovine serum albumin and lOmM glucose.
Triplicate 0.5ml aliquots were dispensed into plastic scintillation 
vials. The cells were killed with 500ul (20% w/v) ice-cold
trichloroacetic acid and samples kept on ice at all times after this 
stage.
(a) The samples were vortex-mixed and centrifuged at 2000g in 
an MSE Centaur 2 for 5 min. The supernatant was discarded 
and the pellet washed with lml of ice-cold 5% (w/v) 
trichloroacetic acid/lmM EDTA. The samples were 
centrifuged as above.
(b) The supernatant was discarded and the pellet washed with 
lml ice-cold distilled water. The samples were 
centrifuged as above.
The supernatant was discarded and lml of 
chloroform:methanol:hydrochloric acid (100:100:1, v/v/v) 
was added. The samples were vortex-mixed and left at room 
temperature for 20 min. The samples were then centrifuged 
and the supernatant removed to clean tubes.
0.33ml chloroform:methanol:hydrochloric acid (200:100:1, 
v/v/v) was added to the remaining pellet from step (c).
The tubes were vortex-mixed and the supernatant was added 
to the supernatant from the previous wash and combined. 
0.5ml chloroform and 0.37ml 0.1M hydrochloric acid were 
added to the combined supernatants. The samples were 
vortex-mixed, allowed to phase split and the upper phase 
discarded.
0.7ml of Folch's Synthetic Upper Phase was added to each of 
the samples and the tubes vortex-mixed and centrifuged.
The aqueous upper layer was discarded and the samples could 
be stored frozen at this stage under nitrogen.
Folch Synthetic Phase
The following were mixed in the ratios below (v/v/v): 
chloroform:methanol:0.1H hydrochloric acid, 10:5:3 
The two phases were stored separately at room temperature.
2.5.2 Separation of the polyphosphoinositides
(a) Hydrolysis of polyphosphoinositides to
Klycerophosphoinositol monophosphate (GroPtdlnsP) and 
Rlycerophosphoinositol bisphosphate (GroPtdlnsP^
The samples from step (g) above were dried down in a 
Hetovac centrifuge and the following were added: 0.5ml chloroform,
lOOul methanol, lOOul 1M sodium hydroxide in methanol. The samples 
were vortex-mixed and left for 15 min to allow deacylation to 
proceed. The following were then added: 0.5ml chloroform, 0.3ml
(d)
(e)
(f) 
<S>
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methanol, 0.3ml water and the samples were vortex-mixed centrifuged 
in a Hettich microfuge at 16000g for 5 min.
0.5ml of the upper phase of each sample was transferred to 
clean tubes and the samples neutralised by the addition of 190ul of 
0.1M boric acid. 150ul of 3M ammonium formate and 125ul of 0.1M 
sodium tetraborate were added to each sample and vortex-mixed.
Then, 1.5ml of distilled water was added and the samples mixed 
again. This procedure reduced the ionic strength of the samples to 
permit binding of the samples to the ion exchange chromatographic 
resin (see below). The samples could be stored frozen at this 
stage of the assay.
(b) Elution of GroPtdlnsP and GroPtdlnsP^ from Dowex formate
columns
The samples were loaded onto lml Dowex-1-formate columns 
and washed with 2x 17ml of 0.18H ammonium formate 5mM sodium 
tetraborate. Following this, GroPtdlnsP was eluted with 15ml of 
0.35M ammonium formate/0.1M formic acid and GroPtdlnsP^ was eluted 
with 20ml of 1M ammonium formate/0.1H formic acid. The amount of 
radioactivity in each sample was determined upon a known volume of 
each fraction by liquid scintillation counting.
2.6 Determination of inositol phosphate production
The generation of inositol phosphates was determined by two 
methods, both of which gave identical results. This methodology 
permitted the determination of accumulated inositol phosphates which 
has been shown to be the most reliable and easily applied measure of 
receptor stimulated inositol lipid hydrolysis.
Sample preparation. Method A
2
Cells were cultured m  25cm flasks and labelled by
incubation in inositol free DMEM containing dialysed calf serum and 
-1 3
luCi ml [ H)inositol for 24h. The monolayers were washed
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twice with Hank's buffered saline (37°C) and scraped with a teflon 
coated spatula into the same buffer containing lOmM glucose and 1% 
(w/v) bovine serum albumin (HBG). The cells were collected by 
centrifugation in an USE Centaur 2 centrifuge at 800g for 5 min, 
washed in the same buffer and resuspended in HBG containing lOmM 
lithium chloride. Following a 5 min incubation at 37°C, the cell 
suspension (containing approximately 2x10^ cells ml *) was 
dispensed into plastic insert vials containing agonist or buffer and 
incubated in a shaking water bath at 37°C. Incubations were 
terminated after the appropriate time by the addition of 
chloroform:methanol (1:2 v/v). The vials were vortex-mixed and 
left to extract for 20 min at room temperature.
Extraction of inositol phosphates
The accumulation of radiolabelled inositol phosphates was 
determined upon an aliquot of the upper aqueous phase by batch 
chromatography on Dowex 1 x 8-formate resins. 0.8ml of this phase 
was transferred to a clean vial and 2.2ml of distilled water were 
added. 0.25ml of Dowex was added to each tube, vortex-mixed and 
left until the Dowex had settled. The supernatant was removed and 
3ml 60mM ammonium formate/5mM sodium tetraborate added to the 
samples and the supernatant aspirated off when the Dowex had 
settled. This step was repeated once more and then the Dowex was 
washed four times with 3ml distilled water. Inositol phosphates 
were eluted from the Dowex with 3x 0.6ml of 1H ammonium formate/0.1M 
formic acid. Radioactivity in each sample was determined by 
scintillation counting in 12ml of ecoscint.
The effect of storage at 4 and -18°C on total
radiolabelled inositol phosphates in the upper aqueous phase was
checked, and they were found to remain stable for at least 14 days.
Extraction of inositol phospholipids. Method A
The radioactivity associated with the inositol
phospholipids was determined by scintillation counting of 250ul of
the lower chloroform phase following air drying.
Sample preparation. Method B
Cells were cultured on 24 well plates and grown to a
density of 10^ cells per well prior to incubation in inositol free
-1 3DMEM containing dialysed calf serum and luCi ml [ H]inositol 
for 24h. The monolayers were washed twice with Hank's buffered 
saline (37°C) and then incubated in HBG containing lOmM lithium 
chloride for 5 min prior to the addition of agonist or buffer to 
give a final volume of 150ul.
Following incubation for the appropriate time, at 37°C, 
incubations were terminated by rapid aspiration of the medium 
followed by the addition of lOOul of ice-cold 10% (w/v) perchloric 
acid. The cells were scraped, transferred to an Eppendorf tube and 
each well rinsed twice with 200ul of distilled water this being 
transferred to the same Eppendorf tube. The tubes were centrifuged 
for 4 min at 16000g in a Hettich microfuge at 4°C and 550ul of the 
supernatant from each sample was transferred to a separate tube 
containing 130ul of lOmM EDTA (pH7). The samples were neutralised 
by adding 360ul of a 1:1 (v/v) mixture of Freon and
tri-n-octylamine, followed by vigorous mixing of the separate phases 
on a vortex mixer (Sharpes and McCarl, 1982). After centrifugation 
for 1 min at 4000g in a Hettich microfuge the upper phase containing 
the radiolabelled inositol phosphates was removed for analysis as 
Method A.
Extraction of inositol phospholipids. Method B
Lipid extraction of the cell pellet by addition of 470ul of 
chloroform:methanol:hydrochloric acid (40:80:1, v/v/v). The
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samples were vortex-mixed and left to extract overnight at 4°C.
The phases were split by addition of 155ul chloroform and 155ul
distilled water and an air dried 250ul aliquot of the lower
chloroform phase was counted as Method A,
2.7 Separation of inositol phosphates
NIH-3T3 cells were plated on to 24 well plates at a cell 
4
density of 7.5x10 cells per well. The medium was changed 24h
later to inositol-free DMEM containing 2uCi ml * of
3 -1 -1
[ H]inositol, 0.4ng ml EGF, 0.4ug ml transferrin and
0.04ug ml * insulin. Following a 24h incubation period, the
monolayers were washed twice in Hank’s buffered saline and then
incubated at 37°C for 5 min in HBG and lOmM lithium chloride.
Cells were stimulated with 2.1uM PGF2c< *n containing lOmM
lithium chloride in a final volume of 50ul. Following incubation
o
for the appropriate time at 37 C incubations were terminated by 
the addition of 50ul ice-cold 10% (w/v) perchloric acid. The cells 
were scraped, transferred to an Eppendorf tube and each well rinsed 
three times with 75ul of distilled water, this being transferred to 
the same Eppendorf tube.
The tubes were centrifuged for 4 min at 16000g in a Hettich 
microfuge at 4°C and 275ul of the supernatant from each sample was 
transferred to a separate tube containing 65ul of lOmM EDTA (pH7). 
The samples were neutralised by adding 185ul of a 1:1 (v/v) mixture ' 
of Freon and tri-n-octylamine, followed by vigorous mixing of the 
separate phases on a vortex mixer. After centrifugation for 1 min 
at 4000g in a Hettich microfuge the upper phase containing the 
radiolabelled inositol phosphates was removed for analysis. If the 
samples were run on Dowex columns lml of 5mM sodium 
tetraborate/0.5mM EDTA was added.
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The radioactivity associated with the inositol 
phospholipids was determined by scintillation counting of 250ul of 
the lower phase following air drying.
Separation of inositol phosphates from cell extracts were 
carried out by two methods:
2.7.1 Separation of inositol phosphates using Dowex-formate resin
Samples were applied to lml Dowex-formate columns and the 
3
following [ H]labelled compounds eluted as follows:
i) Inositol was eluted with 12ml of distilled water
ii) Inositol and glycerophosphoinositol were eluted with 12ml
of 60mM ammonium formate/5mM sodium tetraborate 
iii) Inositol monophosphates were eluted with 18ml of 0.2M
ammonium formate/0.1M formic acid 
iv) Inositol bisphosphates were eluted with 18ml of 0.4M
ammonium formate/0.1M formic acid 
v) Inositol trisphosphates were eluted with 15ml of 0.8M
ammonium formate/0.1M formic acid.
The amount of radioactivity in each sample was determined 
by liquid scintillation counting.
3
The elution profile of I H]-labelled inositol phosphate 
standards from a Dowex-formate column is shown in Figure 2.2.
2.7.2 -Separation of inositol phosphates usinR HPLC
HPLC analysis was performed using a Whatman Partisil 5 Wax 
column employing a non-linear step gradient from 1-35% (v/v) 1M 
diammonium phosphate adjusted to pH3.7 with orthophosphoric acid 
(solution B). Samples were loaded onto the column and eluted at a
3
Figure 2.2 Resolution of t HI inositol phosphate standards by 
Dowex anion exchange chromatography 
The figure shows the elution of tritiated inositol 
1-monophosphate standards from Dowex formate columns using 18ml of 
0.2M ammonium formate/0.1M formic acid applied in lml aliquots. 
Tritiated inositol 1,4-bisphosphate was eluted using 18ml of 0.4M 
ammonium formate/0.1M formic acid and tritiated inositol
1.4.5-trisphosphate was eluted using 15ml of 0.8M ammonium 
formate/0.1M formic acid applied in lml aliquots. Known amounts of 
each standard were added to acid extracts of unlabelled cells.
This figure indicates that there is clear resolution of inositol
1-monophosphate, inositol 1 ,4-bisphosphate and inositol
3
1.4.5-trisphosphate. Recoveries of [ H]~labelled standards were 
greater than 95%. Results are from a single experiment typical of 
three.
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flow rate of lml min ^ as follows:-
0 - 1 0  min 1% B
10 - 11 min linear gradient to 8% B
11 - 21 min 8% B
21 - 22 min linear gradient to 17% B
22 - 32 min 17% B
32 - 34 min linear gradient to 35% B
After each run, the column was eluted with 35% B for an 
additional 3 min and then eluent was returned linearly to 1% B over 
2 min. 1% B was run through the column for a further 10 min before 
the next sample was injected.
All column solutions were filtered through 0.45 micron 
Whatman filters prior to use. Fractions of 0.25ml were collected 
at 15 sec intervals. The radioactivity in each sample was 
determined by liquid scintillation counting. The identity of
3
fractions was determined by running standard [ HJ-labelled samples
of Ins(l)P, Ins(l,4)P2 , Ins(l,4,5)P3 , Ins(l,3,4)P3 (gifted by
R.F. Irvine, Department of Biochemistry, AFRC Institute of Animal
Physiology, Brabraham, Cambridge CB2 4AT) and Ins(l,3,4,5)P^.
3
The elution profile of [ H3—labelled inositol phosphate standards 
from this column is shown in Figure 2.3. Recoveries of the 
inositol phosphates were greater than 95%.
3
2.7.3 Preparation of [ H]—labelled inositol 1,3,4,5- 
tetrakisphosphate standard for HPLC
pHl-labelled Ins(l,3,4,5)P^ was prepared by incubating
3
[ H]Ins(l,4 ,5 )P2 with the lOOOOOg supernatant of homogenised 
bovine adrenal cortex. The incubation buffer consisted of 0.25M 
sucrose, 20mM MgCL^, lOmM ATP and 50mM Tris (pH9.0). At pH9 the 
Ins(l,4,5)P^ kinase retains its activity while the phosphatases 
are inactive, resulting in an almost 100% conversion of
3
Figure 2.3 Separation of [ HIinositol phosphate standards by
HPLC
3
The figure shows the separation of [ H]inositol phosphate 
standards by HPLC using a diammonium phosphate gradient as 
previously described. The data was obtained from the resolution of
3
[ H]inositol phosphate standards eluted from a Partisil 5 Wax 
column using the gradient described and peaks of inositol
1-monophosphate (A), inositol 1 ,4-bisphosphate (B), inositol 
1,3,4-trisphosphate (C), inositol 1,4,5-trisphosphate (D) and 
inositol 1,3,4,5-tetrakisphosphate (E) are indicated. The dotted 
line indicates the elution gradient used. Results are from a 
single experiment typical of three.
time 
(m
in)
62.
d.p.m .
ro 01
_l
0 ro 01UJ 0 01 0 cn 0
0 0 0 0 0 0
0 0 0 0 0 0
o
o
01
ro
o
ro
cn
co
co
roo coo oo o
% 1M diammonium phosphate
63.
Ins(l,4,5)P3 to Ins(l,3,4,5)P^. The [3H]Ins(l,4,5)P3 was
stored in an ethanol:water solution, 9:1 and lOOul (lOOuCi) was
3
blown to dryness under nitrogen. The [ H]Ins(l,4,5)P3 was 
reconstituted in 480ul of incubation buffer and incubated for 45 min 
at 37°C with 20ul of the lOOOOOg supernatant of adrenal cortex.
The incubation was terminated by the addition of 200ul of 10% 
perchloric acid, and left on ice for 10 min. The sample was 
centrifuged at lOOOOg in a Hettich microfuge for 5 min and 650ul of 
the supernatant was transferred to a separate Eppendorf tube. The 
samples were neutralised by adding 424ul of a 1:1 (v/v) mixture of 
Freon and tri-n-octylamine, followed by vigorous mixing of the 
separate phases on a vortex mixer. After centrifugation for 1 min 
at 4000g in a Hettich microfuge, the upper phase containing the 
radiolabelled inositol phosphates was removed. The resulting 
Ins(l,3,4,5)P^ and the Ins(l,4,5)P3 were separated on a Dowex 
anion exchange column as follows:
i) Ins(l,4,5)P3 was eluted with 25ml of 0.8M ammonium 
formate/0 .1M formic acid
ii) Ins(l,3,4,5)P^ was eluted with 10ml of 1.2M ammonium 
formate/0.1M formic acid.
2.8 Determination of water soluble choline metabolites
2.8.1 Sample preparation
Cells were plated on to 24 well plates at a density of
4
5x10 cells per well. After 24h the medium was changed to DMEM 
containing 2% (v/v) donor calf serum and luCi ml ^ [methyl
3
H]choline chloride. Experiments were performed 48h later on the
cells which were then confluent and quiescent. After removal of 
the labelling medium the cells were washed in DMEM and incubated in 
fresh DMEM containing 1% BSA (w/v) for lh. The monolayers were 
washed with 0.5ml Hank’s buffered saline (37°C) for 5 min and then
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incubated in HBG for 10 min. The HBG was aspirated and the cells 
incubated in HBG containing agonist or buffer to give a final volume 
of 150ul.
Following incubation for the appropriate time at 37°C, 
incubations were terminated by the addition of 500ul ice-cold 
methanol, except in those experiments in which intracellular choline 
levels were examined where incubation medium was aspirated 
immediately prior to addition of methanol. The plates were placed
on ice for 10 min and the contents of each well scraped, transferred 
to an Eppendorf tube and each well rinsed with 150ul distilled water 
and 250ul of methanol this being transferred to the same Eppendorf 
tube. Then 375ul of chloroform was added, the samples vortex-mixed 
and left to extract for lh. The phases were split by addition of 
375ul chloroform and 375ul distilled water. After centrifugation 
for 1 min at 14000g in a Hettich microfuge the upper aqueous 
methanolic phase containing the radiolabelled water soluble choline 
containing metabolites was removed for analysis.
The radioactivity associated with the choline containing 
phospholipids was determined by scintillation counting of 250ul of 
the lower chloroform phase following air drying.
2.8.2 Extraction of choline metabolites
Choline metabolites were separated on Dowex 50H+ columns 
as described by Cook & Wakelam (1989). The methanolic aqueous 
phase of samples were diluted to 4ml with distilled water and 
applied to lml Dowex 50-W-H columns and the following
3
[ H]-labelled compounds eluted as follows:
i) Glycerophosphocholine was eluted with 5ml of distilled water
ii) Cholinephosphate was eluted with 15ml of distilled water
iii) Choline was eluted with 20ml of 1M hydrochloric acid.
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The amount of radioactivity in each sample was determined 
by liquid scintillation counting of aliquots of the collected 
samples.
Figure 2.4 shows the elution profile obtained when 
3 14 3
[ HJGroPCho, [ C]ChoP and [ H]Cho, in the presence of a
non-radioactive aqueous methanolic phase of a cell extract, were
separated on a lml Dowex 50-W-H* column. The recovery of each
metabolite and cross-contamination of the samples were calculated.
These results are shown in Table 2.2 and demonstrate greater than
93% recovery of each standard. Table 2.2 also shows that there was
3 3
essentially no cross-contamination of [ H]Cho with [ HJGroPCho
14 3
or [ CjChoP. A small (6%) cross-over between [ HlGroPCho and
14
[ C] ChoP was detected, but this was not of a significant 
magnitude to affect the results.
2.9 Prostaglandin binding studies
Confluent and quiescent cultures of cells on 24 well plates 
(approximately 1.25 x 10"* cells per well) were washed twice with 
DMEM and incubated for lh in DMEM containing 1% (w/v) BSA at 
37°C. The monolayers were washed with Hank's buffered saline 
supplemented with 0.2% (w/v) BSA, lOmM Hepes and O.OlmM indomethacin 
(pH7.3) and incubated for 15 min at 4°C in ligand-free binding 
medium. The binding medium consisted of Hank's buffered saline 
supplemented with 0.05% (w/v) BSA, lOmM Hepes, O.OlmM indomethacin, 
cell culture grade amino acids (1:99 (v/v) dilution of GIBCO lOOx 
physiological amino acid mixture and 2mM bacitracin (pH7.3). This
medium was then replaced with fresh binding medium containing the
3 .stated concentration of [ H) PGF__ . After a 2h incubation on /
2c* /
ice the monolayers were rapidly washed four times with ice-cold/ 
Hank's buffered saline containing 0.1% (w/v) BSA, lOmM Hepes and
O.OlmM indomethacin (pH7.3). Washed cells were then solubilised in
3
Figure 2.4 Resolution of [ Hlglvcerophosphocholine
14 3
i. C lcholinephosphate and [ Hlcholine standards by
Dowex cation exchange chromatography
3
The figure shows the elution of [ H]GroPCho from a
Dowex-H form column using 9ml of distilled water applied m  lml 
14aliquots. [ C]ChoP was eluted using 15ml of distilled water and
3
[ H]Cho was eluted using 20ml of 1M hydrochloric acid applied in 
lml aliquots. Known amounts of each standard were added to a 
non-radioactive aqueous methanolic phase of a cell extract.
Results are means + S.D. of one experiment typical of 8 others. 
This figure shows that there is clear resolution of 
glycerophosphocholine, cholinephosphate and choline.
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Table 2.2 Analysis of recoveries of and cross contamination
3
between [ HlCho labelled metabolites separated on 
Dowex columns
Fraction
Cho
ChoP
GroPCHo
Recovery
96.0
94.4
93.3
% Contamination with 
Cho ChoP GroPCHo
0 0
3.1 - 2.2
0 5.9
Known amounts of I^HlGroPCho, I^C]ChoP and [^H]Cho 
were added to a non-radioactive aqueous methanolic phase of a cell 
extract and separated on Dowex columns. Recoveries and cross over 
were determined by dual label liquid scintillation counting. The 
results are means calculated from 4 separate experiments where 
standard errors did not exceed 6%.
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0.5M sodium hydroxide containing 2% (w/v) sodium carbonate and 1% 
(w/v) Na Dod SO,,
Following neutralisation with 1M hydrochloric acid the 
total cell-associated radioactivity was determined by liquid 
scintillation counting. Non-specific binding was determined in the 
presence of ImM unlabelled PGF2<X anc* was aPProximately 37%.
Cell number was determined on parallel wells incubated as above, 
except in the absence of ligand, following trypsinisation, by 
counting in an Industrial D Coulter counter.
2.10 Determination of choline kinase activity
Choline phosphate (ChoP) can be generated in cells either 
by hydrolysis of phosphatidylcholine or during its biosynthesis.
The phosphorylation of choline by choline kinase is the first 
committed step in the biosynthetic pathway and has been shown to be 
stimulated in quiescent NIH-3T3 fibroblasts by serum and insulin 
(Warden & Friedkin, 1985). Choline kinase activity was determined 
in control and Ha-, Ki- and N-ras transformed NIH-3T3 cells.
2.10.1 Assay for choline kinase activity
Confluent cultures were washed three times with Hank’s 
buffered saline (37°C), scraped and collected by centrifugation at 
800g for 5 min. The cells were permeabilised by resuspension in 
lOmM Tris HCl (pH8.5), containing 0.05% (v/v) digitonin at 4°C.
The cells were then centrifuged at lOOOOg in a Hettich microfuge at 
4°C for 5 min and the supernatant removed to a clean Eppendorf 
tube. Choline kinase activity was assayed in the supernatants by a 
modification of the method of Macara (1989). The assay buffer 
contained lOOmM Tris HCl (pH8.5), lOmM MgCl^, lOmM Na^ ATP, and 
0.25mM [^H] choline chloride (1.25uCi ml ^).
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2.10.2 Separation of the reaction products by ion exchange 
chromatography
Samples were diluted to 4ml with distilled water and
3
applied to lml Dowex-hydrogen form columns, [ H]-labelled 
compounds eluted as follows:
i) Cholinephosphate was eluted with 16ml of distilled water
ii) Choline was eluted with 20ml of 1M hydrochloric acid.
The amount of radioactivity in each sample was determined 
by liquid scintillation counting of aliquots of the collected 
samples.
2.11 Protein Determination
The method is based on that of Lowry et al. (1951). The 
stock solutions were:
A. 2% (w/v) sodium carbonate in 0.1M sodium hydroxide
B. 1% (w/v) copper sulphate
C. 2% (w/v) sodium potassium tartrate.
Just before use the reagents are mixed in the following v/v 
ratio: A:B:C, 100:1:1. Protein standards were prepared using Img 
ml * bovine serum albumin fraction V and a standard curve was 
constructed for a maximum of 30ug protein per sample. 2,5,10ul of 
the unknown samples were assayed in triplicate. lml of the A:B:C 
solution above was added to each sample, mixed and left to stand for 
10 min. lOOul of Folin-Ciocalteau reagent, diluted 1:4 with water 
was added to each sample. The samples were mixed and left for 30 
min. The absorbance of the samples were determined 
spectrophotometrically at 750nM in an LKB Ultrospec II 
spectrophotometer.
2.12 Buffer composition
2.12.1 Earle* s Salt (x20)
2.33M sodium chloride 
107mM potassium chloride 
33.2mM magnesium sulphate 
23.33mM sodium dihydrogen phosphate 
H O m M  glucose
The pH of the buffer was adjusted to 7.3 with 1M sodium 
hydroxide.
2.12.2 Hank*s buffered saline
1.26mM calcium chloride 
0.5mM magnesium chloride 
0,9mM magnesium sulphate 
5.37mM potassium chloride 
137mM sodium chloride 
4.2mM sodium hydrogen carbonate 
0.35mM sodium dihydrogen phosphate 
The pH of the buffer was 7.3 when freshly made.
2.12.3 Phosphate buffered saline (PBS)
146mM sodium chloride 
5.36mM potassium chloride 
9.6mM disodium hydrogen phosphate 
1.46mM potassium dihydrogen phosphate.
The pH of the buffer was adjusted to 7.3.
All buffers were made using distilled water and stored at
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2.13 Preparation of Dowex 1 x 8-200 fonnate form
Dowex 1 x 8-200 chloride form was (obtained from Sigma 
Chemical Company) treated as follows to obtain Dowex formate for use 
in anion exchange chromatography of inositol phosphates.
A known packed volume of Dowex was washed with distilled 
water, left to settle and the unsettled Dowex discarded. This 
process was repeated twice. The Dowex was transferred to a 
scintered glass funnel and washed with approximately 20 volumes of 
2M sodium hydroxide. The Dowex was then washed with lOx its volume
of water followed by approximately 5 volumes of 1M formic acid.
Finally, the Dowex was washed with 50 volumes of water until the pH 
of the Dowex slurry was constant at approximately pH5.5.
2.14 Preparation of Dowex 50-W-H*
Dowex 50-W-H* was (obtained from Sigma Chemical Company) 
treated as follows to obtain Dowex for use in cation exchange 
chromatography of water soluble choline metabolites.
A known packed volume of Dowex was washed with distilled 
water, left to settle and the unsettled Dowex discarded. This 
process was repeated twice. The Dowex was then washed three times 
in 3 volumes of 1M hydrochloric acid. Finally the Dowex was washed 
four times in 3 volumes of distilled water or until the pH was 
constant at approximately pH5.5
2.15 Preparation of Dowex columns
Columns were prepared by adding 1ml of Dowex to a glass 
wool plugged pasteur pipette.
CHAPTER 3
DESENSITIZATION OF PROSTAGLANDIN -STIMULATED INOSITOL 
PHOSPHATE GENERATION IN NIH-3T3 FIBROBLASTS TRANSFORMED
BY OVER-EXPRESSION OF NORMAL RAS GENES
72.
3.1 INTRODUCTION
F&S
The function of p21--- in cell proliferation and
transformation is not known. Ras proteins bind guanine
nucleotides, express an intrinsic GTPase activity and have been 
suggested to function as G-proteins, coupling the receptors for 
certain growth factors to the stimulation of PIC (Barbacid, 1987).
Evidence for this proposition came from the finding that in
the T15 cell line induction of a steroid-hormone regulated ras
construction, causing over-expression of the N-ras gene, resulted in
the apparent amplification of the coupling of the bombesin receptor
to PIC (Wakelam et al., 1986; Lloyd et al., 1989). In addition
Chiarugi et al. (1986) demonstrated that transformation of Balb-3T3
fibroblasts with the EJ/T24-Ha-ras oncogene increased the
responsiveness of PIC to muscarinic stimulation. An increase in
the turnover of inositol phospholipids was detected by Fleishman et
al. (1986) in both NRK and NIH-3T3 cells transformed by three
different ras genes. In NIH-3T3 cells transformed by activated,
point-mutated N- or Ha-ras genes, the agonist independent
stimulation of PIC was found to be increased (Wakelam et al.., 1987;
Hancock et al^., 1988). These activating mutations result in a
r s s
reduction in the GTPase activity of the p21--- protein.
Other studies have failed to demonstrate consistent 
stimulatory effects of ras on PIC. Benjamin et al. (1987) found 
that NIH-3T3 cells expressing high levels of the EJ-Ha-ras oncogene 
show markedly reduced PDGF-stimulated PIC activity, as determined by 
Insd.A.SJP^ generation suggesting that the EJ-Ha-ras uncouples 
the PDGF receptor from the Ptdlns(4,S^^-specific phospholipase
C. This work has been confirmed by Parries et al. (1987) who also 
found markedly reduced PDGF-stimulated inositol phosphate generation 
as a consequence of the expression of EJ-Ha-ras.
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Since it is unclear what, if any, general effect upon 
inositol phospholipid metabolism occurs following transformation of 
cells by ras, basal and agonist-induced total inositol phosphate 
generation was examined in a range of transformations of NIH-3T3 
cells induced by the over-expression of normal Ha-, Ki- or N-ras 
genes. These experiments were performed in the presence of LiCl 
(lOmM) to prevent metabolism of the generated inositol phosphates 
beyond inositol monophosphate. This methodology permitted the 
determination of accumulated inositol phosphates and has been shown 
to be the most reliable and easily applicable measure of receptor 
stimulated inositol phospholipid hydrolysis.
3.2 RESULTS
3
3.2.1 Characterisation of [ Hlinositol labellins of lipids in 
NIH-3T3 and N-ras transformed NIH-3T3 cells
3
To determine the characteristics of [ H]inositol 
labelling of lipids in NIH-3T3 and N-ras transformed NIH-3T3 cells 
and to investigate the possibility of different turnover rates of 
inositol phospholipids in these cells, NIH-3T3 and T15+ cells were
3
labelled with [ H]inositol for increasing times. The 
radioactivity associated with the lipid fraction from 
chloroform/methanol extracted cells was determined as described in 
Section 2.5. After 36h the T15* cells were found to have
3
incorporated 2.9 times the amount of total [ H]inositol into their
lipids compared to NIH-3T3 control cells.
3
Figure 3.1 illustrates the [ H]inositol labelling of 
GroPtdlnsP and GroPtdlnsP^ in NIH-3T3 and T15* cells. The 
results in Figure 3.1b show that T15* cells demonstrated
3
significantly higher incorporation of [ H]inositol into GroPtdlnsP 
and GroPtdlnsP^ than control cells (Fig.3.la). As the data has 
been normalised for the amount of protein assayed, the increased
3
Figure 3.1 X. Hi inositol labelling of inositol lipids in NIH-3T3
and T15* cells 
3
The [ H]inositol labelled phospholipids were deacylated 
to glycerophosphoinositol (GroPtdlns), glycerophosphoinositol 
monophosphate (GroPtdlnsP) and glycerophosphoinositol bisphosphate 
(GroPtdlnsP^) which were separated on Dowex-formate columns as 
described in Section 2.5. The data is from one experiment and is 
expressed as mean dpm/mg protein + S.D., n=3. Only results for 
GroPtdlnsP and GroPtdlnsP^ are shown.
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Figure 3.1a
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labelling of l"*H] GroPtdlnsP and [^HjGroPtdlnsP^ (also 
3
[ H)GroPtdIns, results not shown) were not due to differences in
3
cell number. The peak levels of ( H]GroPtdInsP and
3
[ HjGroPtdlnsP^ in NIH-3T3 cells appeared after 8h. There was
3 3
then a decrease in [ HlGroPtdlnsP and [ HjGroPtdlnsP^
3
levels. The incorporation of [ H]inositol into GroPtdlnsP and 
GroPtdlnsP^ in NIH-3T3 cells maintained a steady level after 12h,
3
whilst the incorporation of [ H)inositol into GroPtdlnsP and 
GroPtdlnsP^ continued to increase in T15+ cells. This 
increased labelling of inositol phospholipids in T15* cells as 
compared to NIH-3T3 cells (Fig.3.la-lb) suggests a role for 
PtdIns(4 ,5 )P2 hydrolysis in cell proliferation and transformation.
3.2.2 Growth factor stimulated generation of inositol phosphates 
The time course of PGF^^-stimulated inositol phosphate 
generation is shown in Figure 3.2. PGF^-stimulated inositol 
phosphate generation increased linearly with time to a maximum at 30 
min. The response then plateaued till 60 min. Unless otherwise 
stated, when measuring ligand stimulated total inositol phosphate 
generation the cells were stimulated for 30 min.
To determine if there were changes in stimulated inositol 
phosphate generation in cells transformed by over-expression of 
normal Ha-, Ki- or N-ras genes, a range of agonists were screened. 
Bradykinin, calf serum and PDGF stimulated significant inositol 
phosphate generation in all the cell lines examined. Figure 3.3 
shows the effect of saturating concentrations of bradykinin, calf 
serum and PDGF on stimulated inositol phosphate generation in 
[**H]inositol-labelled NIH-3T3 cells and Ha-, Ki- and N-ras 
transformed cells.
In cells expressing high levels of the normal Ha-, Ki- or 
N-ras proto-oncogene, there was a marked increase compared with the
Figure 3.2 The time course of P G F ^ . -stimulated inositol
phosphate generation in NIH-3T3 cells
3 -1
Cells were labelled with [ H]inositol (luCiml ) and
24h later cells were stimulated with PGF^^ for the times stated.
Inositol phosphate generation was determined as described in Section
2.6 - sample preparation method A - and the results are means + S.D.
of one experiment typical of 3 others.
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Figure 3.2
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Figure 3,3 Growth factor stimulation of inositol phosphate 
generation in control and Ha-, Ki- and N-ras
transformed NIH-3T3 cells
3 -1
Cells were labelled with [ H]inositol (luCiml ) for
24h and after a 30 min stimulation, inositol phosphate generation
was determined as described in Section 2.6 - sample preparation
method A. The results are means + S.D., n=4 in each case and the
data is from one experiment which gave qualitatively the same
results as three others.
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NIH-3T3 cells, in inositol phosphate generation in response to 
stimulation by bradykinin, calf serum and PDGF.
Addition of bradykinin to Ha-, Ki- or N-ras transformed 
cells gave a 4.3-, 5.1- and 1.6-fold stimulation respectively, 
compared with the control cells. Addition of calf serum to Ha-,
Ki- or N-ras transformed cells resulted in a fold increase of 2.4, 
2.7 and 2.6 respectively, while addition of PDGF to Ha- or N-ras 
transformed cells gave 2.7- and 2.6-fold stimulation compared with 
control cells. Therefore stimulated inositol phosphate generation 
in ras transformed cells is amplified compared to NIH-3T3-control 
cells.
3.2.3 Basal rates of production of inositol phosphates
3
The higher [ H]inositol labelling of inositol 
phospholipids in T15+ cells as compared to NIH-3T3 cells (Fig.3.1) 
and the increased agonist stimulated inositol phosphate response 
(Fig.3.3) could be due to increased basal rates of turnover (i.e. in 
the basal activity of PIC) in the ras transformed cells. If the 
production of inositol phosphates is measured in the absence of 
agonist then a basal level of inositol phosphate generation can be 
determined. Table 3.1 shows there were only small differences in 
basal rates of production of inositol phosphates, between NIH-3T3 
cells and the ras transformed NIH-3T3 cell lines examined, 
demonstrating that an increase in inositol phospholipid hydrolysis 
was only apparent during receptor activation.
3.2.4 Stimulation of inositol phosphate Reneration by
PGF in control, Ha-- Ki- or N-ras transformed cells
Stimulation of confluent NIH-3T3 cells with PGF (2.1uM)
2 C\
induced a 1 2-fold increase in the generation of inositol phosphates 
within 30 min as compared to unstimulated controls (Table 3.2). It 
is demonstrated in Chapter 4 that this generation of inositol
79.
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Table 3.2 The stimulation of inositol phosphate generation by 
PGFgrv in control. Ha-. Ki- and N-ras transformed 
NIH-3T3 cells
Cell Line ras-Gene Inositol phosphate generation
(% increase over untreated control)
NIH-3T3 1250 + 78
N866 263 ± 27
N872 normal N-ras 263 ± 49
T15 + 380 ± 73
EC806 normal Ha-ras 355 ± 34
EC807 261 ± 34
EC816 413 ± 56
H8/22+ 322 ± 22
Ki858 normal Ki-ras 181 ± 24
Ki860 219 + 10
3 -1
Cells were labelled with [ H]inositol (luCi ml ) for
24h and after a 30 min stimulation with PGF (2.1uM) inositol
4  0\
phosphate generation was determined as described in Section 2.6. 
Results are expressed as means + S.E.M., pooled from several 
experiments with n=6-51.
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phosphates was a consequence of agonist stimulated Ptdlns(4f5)P^ 
breakdown. However, when NIH-3T3 cells which had been transformed 
by a several fold over-expression of the normal Ha-, Ki- or N-ras 
genes were stimulated with PGF^^ (2.luM), only a 2-4 fold increase 
in inositol phosphate generation was observed (Table 3.2). There 
thus appears to be a ras induced desensitization to P G F ^  in the 
transformed cells.
The NIH-3T3 clone H8/22, in which the expression of the 
human Ha-ras proto-oncogene can be switched on by culturing in the 
presence of dexamethasone was used to demonstrate that the markedly 
reduced P G F ^  -stimulated inositol phospholipid turnover in ras
transformed cells is directly related to the expression of p21---
and is not a transformation effect. Addition of increasing 
concentrations of dexamethasone to H8/22 cells previously grown 
without this inducer (H8/22 ) resulted in a
concentration-dependent increase in expression of the human Ha-ras
Ha-ras
proto-oncogene as demonstrated by immuno-precipitable p21 ---
(C.J. Marshall, personal communication).
H8/22 cells were cultured for increasing lengths of time in 
the presence of dexamethasone (lOOnM; see Fig.2.1, Section 2.2.1.2) 
and basal and PDGF (1.32ugml "S stimulated inositol phosphate 
generation determined. Figure 3.4a shows that significant inositol 
phosphate generation occurred 8h after dexamethasone treatment in 
response to PDGF. A decrease in the stimulated levels of inositol 
phosphates was observed after 12h of dexamethasone treatment, but 
the levels of stimulated inositol phosphates then increased after 
this time with a maximum response observed after 48h of a 1608% 
increase over basal. These results indicated that stimulated 
inositol phosphate generation in H8/22* cells occurred prior to 
morphological changes. Figure 3.4a demonstrates that the
Figure 3.4 Time course for the effect of dexamethasone on PDGF 
and PGF2 ^  -stimulated inositol phosphate generation 
in H8/22 cells
3 -1
Cells were labelled with [ H]inositol (luCiml ) for
48h and cultured in the presence of dexamethasone (lOOnM) for the
times stated. PDGF (1.32ug ml *) or PGF__, (2.1uM) stimulated
inositol phosphate generation was determined as described in Section
2.6 - sample preparation method A. Results are means + S.D. of one
experiment where n=4.
Problems were encountered in repeating these experiments as
it was difficult to obtain a very pure PDGF preparation.
Therefore, bradykinin (3,2uM) was used as a ligand in an experiment
and results demonstrated very similar trends. At time zero with no
dexamethasone treatment bradykinin stimulated a significant inositol
phosphate response of 41% increase over basal. The levels of
stimulated inositol phosphates then increased with a maximum
response at 48h after dexamethasone treatment of 224% increase over
basal. In this experiment the decrease in the magnitude of the
PGF^^ stimulated response with increasing time of dexamethasone
treatment was demonstrated to be very similar to that shown in
Figure 3.4b.
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Figure 3.4a
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progressive elevation of p21^a “,aa concentration was paralleled by
a comparable increase in the magnitude by which PDGF stimulated
inositol phosphate generation, implying that increased efficiency of
coupling of the PDGF receptor to inositol phosphate production is
Ha-ras
related to the concentration of p21 ---.
However, when cells treated with dexamethasone, as above, 
were stimulated with PGF^^ (2 .luM), the progressive elevation of 
p21^a concentration was paralleled by a comparable decrease in 
the magnitude of the inositol phosphate response (Fig.3.4b). With
no dexamethasone treatment stimulated an inositol phosphate
response of 1127% increase over basal. However, after 48h of 
dexamethasone treatment PGF n  only stimulated a response of 272% 
increase over basal.
The reduction in the stimulation of inositol phosphate 
generation in ras transformed cells was observed at all PGF2o( 
concentrations tested. Figure 3.5a-5b illustrates the
dose-dependence of -stimulated inositol phosphate generation
as a percentage increase over unstimulated controls. For all the 
cell lines tested half-maximal stimulation occurred at a 
concentration of 0.18uM, while a saturating response was observed at 
approximately 2uM. At this concentration there was a dramatic
difference in the magnitude of the PGF0~ -stimulated inositol
ZCA
phosphate response in the NIH-3T3 cells (12 fold) compared with the
Ha-, Ki- or N-ras transformed cells (1.8 to 3.4 fold). A summary
of the values obtained for the cell lines tested is shown in
Table 3.3. No change in the EC_. value for PGF__ as detected
° 50 2<*
between the cell lines, E C ^  = 0.18uM, indicating that 
over-expression of the ras genes in NIH-3T3 cells affected the 
response to PGF with no associated change in receptor affinity.
Figure 3.5 Dose-dependence of PGF2C/Vt inositol
phosphate generation in normal and ras transformed 
NIH-3T3 cells
3 -1
Cells were labelled with [ H]inositol (luCiml ) for
24h and stimulated for 30 min with various concentrations of PGF_
2 C\
in the presence of lOmM LiCl. Inositol phosphate generation was 
determined as described in Section 2.6. Results are expressed as 
means + S.D., pooled from several experiments.
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Figure 3.5a
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Table 3.3 Summary of EC5Q values of PGFgpr -stimulated 
inositol phosphate generation
Cell line ras-Gene ECgQ CxlO^M) No. of expt.
NIH-3T3 0.178 + 0.030 11
EC816 0.083 ± 0.001 2
EC806 Ha-ras 0.105 ± 0.040 2
EC807 0.083 ± 0.002 2
Ki858 Ki-ras 0.188 + 0.050 4
Ki860 0.186 ± 0.020 4
N866 N-ras 0.187 + 0.020 3
N872 0.175 + 0.030 3
3 -1
Cells were labelled with [ H)inositol (luCi ml ) for
24h and stimulated for 30 min with various concentrations of PGF.
in the presence of lOmM LiCl. Inositol phosphate generation was
determined as described in Section 2.6. Results are pooled from
the stated number of experiments and are expressed as means + S.D.
86.
3.2.5 Characterisation of receptors on control and
ras-transformed cells
Binding studies were performed in order to determine if the 
reduced stimulation in inositol phosphate generation in response to 
PGF^<^ in the ras-transformed cells was due to a reduction in 
receptor number,
When intact, quiescent NIH-3T3 cells were incubated with 
[“*H]PGF (2.5uM) at 4°C, cell-associated radioactivity
Z(J\
increased steadily reaching a maximum value at 2h (Fig.3.6 ).
3
Figure 3.7 shows that the specific binding of [ H]PGF to 
intact quiescent NIH-3T3 cells as a function of radiolabelled ligand 
concentration was clearly saturable. Scatchard analysis of the 
binding data (Fig.3.7, insert) demonstrates that NIH-3T3 cells 
possess a single class of cell-surface receptor of Kd = 0.44 x 
10 with approximately 400,000 receptors per cell. Binding 
experiments performed upon the ras transformed cells demonstrated 
that, with the exception of T15 cells, there was no significant 
difference in either the number of PGF^^ receptors per cell or in 
their Kd values (Table 3.4). The increase in receptor number in 
the T15 cell line may be due to non-specific effects of the inducer 
dexamethasone as these cells are grown continuously in the presence 
of dexamethasone. Glucocorticoids can have a variety of effects 
upon cells. It is possible that dexamethasone may have caused an 
inhibition of PGF^^synthesis and thus a consequent reduction in 
agonist induced down-regulation of receptor number as has been 
observed for mouse fibrosarcoma cells (Tashjian et jQ., 1975).
The H8/22 cell line did not show significantly greater
PGF n receptor numbers. However, 20-fold less dexamethasone is
2\\
s
used to induce expression of p21   in this cell line.
3
Figure 3.6 Time dependence of the binding of [ H 3PGF^to 
intact quiescent NIH-3T3 cells
The figure shows the time dependence of the binding of
3 o
[ H]PGF9 to intact quiescent NIH-3T3 cells at 4 C, determined
as described in Section 2.9.
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Figure 3.6
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3
Figure 3.7 Binding characteristics of [ HlPGF^. ^ to NIH-3T3 
cells
The figure shows the concentration dependence of the
3 o
binding of [ HlPGF^^ to intact quiescent NIH-3T3 cells at 4 C
determined as described in Section 2.9.
Inset: Scatchard plot of the same data: bound (B), radiolabelled
ligand is expressed in fmol per 1 0^ cells; the 
concentration of PGF in the medium (F) is in fmol.
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Figure 3.7
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Table 3.4 PGFp^  receptors on normal and ras transformed NIH-3T3 
cells
Cell line ras-Gene Kd(xlO“6M) Receptor number No.of Expt
NIH-3T3 0.44 ± 0.06 392000 ± 63500 12
EC806 Ha-ras 0.46 ± 0.04 268000 ± 74000 2
EC807 0.32 311000 ± 3500 1
EC816 0.50 ± 0.05 392000 ± 69000 2
H8/22+ 1 0.21 502000 ± 69000 2
Ki858 Ki-ras 0.37 ±  0.04 456028 ± 27000 2
Ki860 0.65 400000 ± 6000 1
N866 N-ras 0.80 ± 0.72 625000 ± 201000 2
N872 1 0.84 ± 0.67 538000 ± 78000 2
T15+ 0.44 ± 0.18 1731000 ± 67000 2
Binding studies were performed as described in Section 
2.9. Results are pooled from the stated number of experiments and 
are expressed as means + S.D.
90.
Binding experiments performed upon NIH-3T3 cells cultured in the 
presence of dexamethasone (2uM) for 72h demonstrate that 
dexamethasone had no significant effect either on the number of 
PGF^^ receptors (426272 + 4736, n=2) or in the Kd values of the 
receptors (Kd = 0.426 + 0.05, n=2).
Thus the desensitization of PGF0 -stimulated inositol 
phosphate generation in ras transformed cells is not due to any 
reduction in receptor number or change in affinity or dissociation 
constant.
3.2.6 The effect of indomethacin on inositol phosphate generation
Homologous desensitization can be induced in cells as a 
consequence of increased autocrine secretion. In order to 
determine if there was increased synthesis of PGF^^in the ras 
transformed cells, which could lead to an agonist-induced 
desensitization of the inositol phosphate response, control and ras 
transformed cells were cultured in the presence of the 
cyclo-oxygenase inhibitor indomethacin (O.lmM) for 72h. Cells were 
stimulated with PGForv and inositol phosphate generation 
determined. Indomethacin treatment had no effect upon the 
responsiveness of the cells to a subsequent stimulation with PGF^^ 
(Table 3.5).
The time course of PGF. stimulated inositol
2(X
phosphate generation in NIH-3T3 cells incubated in the presence or 
absence of indomethancin is shown in Figure 3.8. There was a 
linear increase in P G F - s t i m u l a t e d  inositol phosphates, a 
maximum stimulation of 16-18 fold of control at 30 min, with the 
response being desensitized at 40 min. Indomethacin did not affect 
the rate of PGF^^ stimulated inositol phosphate generation.
91 .
Table 3.5 PGFg^  -stimulated inositol phosphate generation in
control and ras transformed NIH-3T3 cells grown in the 
presence or absence of indomethacin
Cell line ras-Gene Inositol phosphates
(% increase over untreated control)
cells Rrown in cells Rrown in
absence of presence of
indomethacin indomethacin
NIH-3T3 2169 + 83 2165 + 107
BC807 Ha-ras 362 + 48 378 + 72
Ki860 Ki-ras 244 + 33 240 + 25
N872 N-ras 364 ± 28 312 ± 24
Cells were cultured in the presence or absence of O.lmM
3 -1
indomethacin for 72h and labelled with [ H]inositol (luCi ml )
for the last 24h. PGF2o( stimulated inositol phosphate
generation was determined as described in Section 2.6. Results are
means + S.D. where n=4 and are pooled from three separate
experiments.
Figure 3,8 Time course for the effect of indomethacin on
P G F ^  -stimulated inositol phosphate generation in 
NIH-3T3 cells
3 -1
Cells were labelled with [ H]inositol <luCi ml ) for
24h. Cells stimulated with PGF0 (2.1uM) in the presence of
indomethacin (O.luM) were also pre-incubated for 10 min in the
presence of indomethacin. Inositol phosphate generation was
determined as described in Section 2.6 - sample preparation Method
A. Results are means + S.D., where n=4 of one experiment, which
gave qualitatively the same results as three others.
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Figure 3.8
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Figure 3.9 illustrates growth curves of NIH-3T3 cells 
cultured in the presence or absence of indomethacin (O.luM) and 
demonstrates that indomethacin had no effect on cell proliferation.
It is therefore unlikely that the reduced response to 
PGF is due to the agonist itself (i.e. not homologous 
desensitization), but must occur via some other mechanism.
3.2.7 Effect of cell culture density upon the responsiveness of
NIH-3T3 cells to PGF...
20\
It was noted that NIH-3T3 cells cultured to different cell 
densities gave differing responses to PGF2o< ' Table 3.6 shows 
that as the number of cells in a culture dish is increased and 
consequently the number of actively dividing cells is diminished, 
the magnitude of the stimulation of inositol phosphate generation by 
PGF^^ is increased. This increase in response is not due to the 
number of cells per incubation since when cells scraped from the 
same culture dishes were diluted in incubation medium, there was no 
effect upon the magnitude of the PGF9 stimulated inositol 
phosphate generation (Table 3.7). Table 3.7 also demonstrates that 
the magnitude by which bradykinin stimulated the generation of 
inositol phosphates was unchanged following cell dilution. When 
there are 25,000 or less cells per incubation, the bradykinin and 
PGF^^ stimulated inositol phosphate responses were lower.
However, at this low cell density the measurement of inositol 
phosphates is unreliable, being at the limit of accurate detection 
particularly in control samples.
P G F ^  receptor number was determined at different cell 
densities. Problems were encountered when binding experiments were 
performed on NIH-3T3 cells cultured at low cell density, since low 
levels of cell-associated radioactivity meant accurate measurements 
of receptor number could not be determined. However, estimates
Figure 3.9 The effect of indomethacin on the growth of NIH-3T3 
cells
Cells were cultured in the presence ( ♦  pres, indomethacin) 
or absence ( □ abs.indomethacin) of indomethacin (O.luH). Cell 
numbers were determined by Coulter counting as described in Section 
2.4. Results are means + S.D. of 4 counts of duplicate plates and 
are from one experiment.
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Table 3.7 The effect of cell number dilution upon Bradykinin and 
PGF2 <x -stimulated inositol phosphate generation in 
NIH-3T3 cells
Cell number Dilution dpm % increase over
per incubation Factor in control untreated control
Bradykinin PGFgc*
2 0 0 , 0 0 0 1 619 19 356 12 1775 63
1 0 0 , 0 0 0 1.2 316 + 17 348 ± 21 1771 + 32
50,000 1.4 173 ± 8 351 ± 3 1805 + 68
25,000 1.8 107 ± 8 263 ± 7 1218 ± 11
12,500 1.16 67 ± 5 189 ±_ 38 969 ± 70
3 -1
Cells labelled with [ H]inositol (luCiml ) for 24h
3
were scraped from four 25cm flasks and diluted as described in
the table. Bradykinin (3.2uM) and PGF_^ (2.luM)-stimulated
2 C\
inositol phosphate generation was determined as described in Section 
2.6 - sample preparation method A. Results are means ± S.D. of one 
experiment where n=4.
97.
made from the results obtained indicated that there was no 
difference in receptor number expressed in cells cultured at 
different densities.
3.2.8 The effect of the presence of serum growth factors during
3
X Hi inositol labelling on subsequent growth factor 
stimulation of inositol phosphates 
Removal of growth factor containing serum from 
proliferating NIH-3T3 cells, but not from their transformed 
derivatives, causes a cessation of proliferation. NIH-3T3 cells 
and a Ha-ras transformed NIH-3T3 cell line (EC807) were cultured 
either serum free in medium supplemented with insulin (lngml *), 
transferrin (lOng ml and EGF (lOpgml *) or in medium
containing 10% calf serum. NIH-3T3 cells cultured serum free and 
subsequently stimulated with PGF2o( s^owe(  ^ an inositol phosphate 
response, 60% greater than that observed in cells cultured in the 
presence of 10% calf serum {Table 3.8). However, no such change in 
response was observed in ras-transformed cells cultured in the 
absence of serum (Table 3.8).
3.2.9 The effect of TPA pre-treatment upon PGF_ -stimulated4i0\
inositol phosphate generation and concentration of PKC 
Desensitization of glucagon stimulated adenylate cyclase 
has been shown to be a PKC mediated process (Murphy et al., 1987).
In order to determine if such a mechanism could be involved in the 
desensitization observed here, control and ras transformed NIH-3T3 
cells were cultured in the presence of TPA (lOOnM) for 12, 24 and 
48h and with the non PKC activating ^-phorbol (lOOnM) for 24h 
(Table 3.9). The inhibitory effect of TPA on PGF0 .-stimulated 
inositol phosphate generation was greater with a 12h pre-treatment 
compared with a 24 or 48h TPA pre-treatment for both control and ras 
transformed cells. A 12h TPA pre-treatment resulted in the
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stimulation of inositol phosphate generation being reduced by 54, 89 
and 90% in the NIH-3T3, EC807 (Ha-ras) and N866 (N-ras) cell lines, 
respectively (Table 3.9). A 24h TPA pre-treatment resulted in the 
stimulation of inositol phosphate generation being reduced by 42, 73 
and 84%, while a 48h TPA pre-treatment resulted in a reduction of 
39, 77 and 83% in the NIH-3T3, EC807 and N866 cell lines, 
respectively. The non PKC activating y0-phorbol had no inhibitory 
effect on -stimulated inositol phosphate generation.
3
The method of [ HlPDBu binding was used to estimate the
amount of PKC present in control and ras transformed cells prior to
and following treatment with TPA (lOOnM). To assess total binding,
cells on 24 well plates were incubated for 15 min at 37°C in the
3
presence of lOOnM [ H]PDBu. Non-specific binding was determined
in the presence of lOuM unlabelled PDBu and was 29 + 10%. In
control, Ha-ras (EC807) and N-ras (N8 6 6 ) transformed cells the
amount of PDBu bound was 284 + 75, 465 + 3 and 451 + 30fmol PDBu
bound/mg protein, respectively (results are means + S.D. where n=3
and are from one experiment). Following a 24h TPA pre-treatment
the amount of PDBu bound in control Ha- and N-ras transformed cells
was 2 2 + 1 3 ,  99 + 12 and 76 + 4fmol PDBu bound/mg protein. Thus,
following a 24h TPA pre-treatment PKC concentrations were reduced;
the amount of PKC was estimated to be 7, 21 and 17% of levels in non
TPA pre-treated NIH-3T3, Ha- and N-ras transformed cells,
respectively. In this experiment PKC concentrations were 1.6-fold
greater in the ras transformed cells compared to control cells. In
two other experiments PKC concentrations were estimated to be 3-fold
greater in the Ha-ras (EC807) and N-ras (N8 6 6 ) transformed cells
compared to control cells.
The amount of PKC determined following a 24th TPA pre-treatment may be under 
estimated as it is difficult to remove all traces of TPA from the cells; any residual TPA 
may compete with [3H]PDBu in the binding assay.
101 .
3.3 Discussion
F&S
Evidence indicating that p21--- may be involved in a
signal transduction mechanism has existed for some time. It has
1T&S
been suggested that p21--- controls the activity of PIC, which
catalyses the hydrolysis of Ptdlns(4,5)P^ (Fleishman et al..
1986; Preiss et al., 1986; Wolfman & Macara, 1987). This 
hypothesis is based on the fact that transformation and 
proliferation accompany rapid metabolism of Ptdlns(4,5)?^
(Berridge, 1984; Macara, 1985) and that a G-protein appears to 
control PIC activity (Cockcroft & Gomperts, 1985). Bombesin 
stimulation of Ptdlns(4,5)P^ hydrolysis was shown to be amplified 
in NIH-3T3 cells over-expressing the N-ras proto-oncogene (Wakelam 
et al., 1986; Wakelam, 1988). An amplification of muscarinic 
stimulation of Ptdlns(4,5)P^ hydrolysis in Balb/c 3T3 cells 
transformed by EJ-Ha-ras has also been reported (Chiarugi et al., 
1986). Parries et al. (1987) demonstrated that while NIH-3T3 cells 
did not respond to bradykinin, NIH-3T3 cells transformed by Ha-, Ki- 
or N-ras expressed bradykinin stimulated PIC activity. In the same 
study, however, NIH-3T3 cells transformed by v-Ha-ras exhibited a 
loss of PDGF-stimulated Ptdlns(4,5)P^ hydrolysis. Seuwen et al. 
(1988) reported a desensitization of the inositol phospholipid 
signalling pathway in CCL39 fibroblasts transformed by activated Ha- 
or Ki-ras genes.
Cells transformed by ras proliferate more rapidly and 
demonstrate greater turnover of their inositol phospholipids than 
control cells (Fig.3.1). This indicates that there may be a role 
for increased inositol phospholipid turnover in cell proliferation
3
and transformation. The incorporation of [ H)inositol into 
PtdIns(4)P and Ptdlns(4,5)?^ in NIH-3T3 cells reaches a steady 
state level after 12h, whilst the rate of incorporation of
102.
3 # 4. ,
[ Hlinositol continues to increase m  T15 cells (Fig.3.1).
This may be due to the inhibition of mechanisms in the ras
transformed cells that normally desensitize inositol phospholipid
turnover in normal cells. It was considered possible that the
increased inositol phospholipid turnover in the T15+ cells could
be due to an increase in basal turnover. However, basal rates of
inositol phosphate production are not increased in ras transformed
cells (Table 3.1).
In cells expressing high levels of the normal Ha-, Ki- or
N-ras proto-oncogene, there is a marked increase, compared with the
control cells, in inositol phosphates generated in response to
stimulation by bradykinin, calf-serum and PDGF (Fig.3.3). It is
possible that there could be a change in receptor number as a result
of transformation by ras, but this is unlikely as Wakelam et al.
(1986) demonstrated that there is no change of bombesin receptor
binding characteristics as a consequence of ras transformation.
However, Downward et al. (1988) demonstrated that in Rat-1
fibroblasts over-expressing normal and transforming Ha-, Ki- and
N-ras genes the amplified bradykinin stimulated inositol phosphate
response might be due to receptor up-regulation since bradykinin
receptor numbers were found be 40-fold higher in the cells
over-expressing p21--- compared to control cells.
The results presented in this chapter demonstrate that in
cells expressing high levels of the normal Ha-, Ki- or N-ras
proto-oncogenes, the stimulation by PGF_ , of inositol phosphate
2<a
generation is reduced (Table 3.2). In NIH-3T3 cells stimulation by
PGF„_, results in a 1 2-fold increase in the level of inositol 
2 c^
phosphates. However, in Ha-, Ki- or N-ras transformed cells 
PGF only stimulated a 2-4-fold increase increase (Table 3.2).
There thus appears to be a ras induced desensitization of PGF ^
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stimulated inositol phospholipid turnover in the ras transformed 
cells. The NIH-3T3 clone H8/22 was used to demonstrate that the
markedly reduced PGF -stimulated inositol phospholipid turnover
2C\
in ras transformed cells is directly related to the expression of
lTfiS
p21--- and is not a transformation effect. The data in Figure
3.4 shows that p21 --- induced amplification of PDGF-stimulated
inositol phosphate generation occurred approximately 8h after 
dexamethasone treatment of H8/22 cells.
Results obtained 
N-ras
by Davies (1989) in a similar experiment showed that p21 ---
induced amplification of bombesin-stimulated inositol phosphate 
generation was detected approximately 6h after dexamethasone 
treatment of T15 cells.
These data strongly suggest that the ras-induced amplification of
inositol phosphate production is not associated with the transformed
state, but is an early event in cell proliferation and
N**rsis
transformation and is directly a consequence of p21 ---
expression. However, when H8/22- cells treated with dexamethasone, 
as above, were stimulated with P G F ^  , the progressive elevation 
of p21**a concentration was paralleled by a comparable decrease 
in the magnitude of the inositol phosphate response (Fig.3.4).
This ras induced desensitization of PGF^^ -stimulated inositol
104.
phospholipid turnover is not due to any changes in receptor number, 
or change in EC^q or Kd (Table 3.3 and 3.4) and thus would appear
to be due to a reduced coupling of the agonist receptor complex to
PIC. It is unlikely to be due to any reduction in PIC since there
is no change in the basal rate of inositol phosphate generation in
cells transformed by an over-expression of normal ras genes (Table 
3.1). The site of the desensitization may thus be at either the
level of coupling between the receptor to G-protein, or between the
4" N—F8S
G-protein and PIC. In T15 cells which over-express p21 ---,
an amplification in both bombesin (Wakelam et al., 1986; Lloyd et
al., 1989) and fluoroaluminate (Wakelam, 1989) stimulated
Ptdlns(4,5)P„ hydrolysis was detected. However, PGFow £ Z C\
-stimulated inositol phosphate generation is also desensitized in
T15+ cells (Table 3.2) with no change in affinity or dissociation
constant, or a decrease in receptor number (Tables 3.3, 3.4).
Therefore, at least part of the desensitization mechanism must be at
the level of receptor to G-protein coupling.
In control NIH-3T3 cells desensitization of the PGFrtw
-stimulated inositol phosphate response occurred at 30 min
(Fig.3.2). Desensitization of agonist-stimulated Ptdlns(4,5)?^
hydrolysis is very important as it acts as an inhibitory mechanism
to switch off or modulate Ins(l,4,5)P^ production, thus
2+
effectively protecting the cell from Ca -evoked damage during a 
sustained activation of Ca^*-mobilising receptors.
Desensitization of an agonists second messenger response 
can be induced both by exposure to the agonist, that is 
homologously, or following exposure to an alternative agonist that 
is heterologously. It appears that the desensitization of the 
PGF^^-stimulated inositol phosphate response in the ras 
transformed cells is induced heterologously, since inhibition of
105.
PGF _ synthesis by treatment of the cells with indomethacin does
20\
not amplify the stimulation of inositol phosphate generation in
response to PGF__, . In ras transformed cells there is increased 2c\
secretion of a variety of autocrine growth factors (Bowen-Pope et 
al,« 1984), e.g. PDGF, which are able to stimulate PtdIns(4 ,5 )P2 
hydrolysis perhaps leading to the persistent activation of PKC.
Huang and Ives (1987) demonstrated that exposure of vascular smooth 
muscle cells for 10 min to phorbol esters caused an 82% inhibition 
of thrombin stimulated Ins(l,4,5)P^ generation. This effect is 
due to PKC activity since no inhibition was observed in PKC depleted 
cells. Exposure of the cells to phorbol esters for 30 min did not 
alter the binding affinity or maximum binding of thrombin. Other 
examples of phorbol ester mediated inhibition of PtdIns(4,5)P^ 
hydrolysis in the absence of an effect on agonist binding include 
work by Brown et al.. (1987) and Pfeilschifter et al. (1989). Brown 
et al. (1987) demonstrated that pre-treatment of Swiss 3T3 cells for 
15 min with TPA caused a reduction in the bombesin-stimulated 
inositol phosphate response. Pre-treatment of Swiss 3T3 cells for 
48h with TPA had the effect of greatly decreasing the inhibitory 
effect of a subsequent 15 min pre-treatment with TPA on the 
bombesin-stimulated inositol phosphate response (Brown et al..,'
(1987). Pfeilschifter et al. (1989) demonstrated that 
pre-treatment of vascular smooth-muscle cells for 10 min with TPA 
decreased the angiotensin II-induced Ins(l,4,5)P generation. 
Pre-treatment of these cells for 24h with TPA lead to an enhanced 
basal, as well as angiotensin II-stimulated, generation of 
Ins(l,4,5)P^. Treatment of DDT^MF-2 smooth muscle cells with 
bradykinin or phorbol esters lead to the desensitization of 
(X^-adrenergic receptor-stimulated Ptdlns(4,5)P^ hydrolysis and 
has been shown to be a consequence of receptor phosphorylation
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(Leeb-Lundberg et al., 1985). These observations suggest that 
phosphorylation of receptors by PKC exerts a negative feedback 
control on agonist-stimulated inositol phospholipid turnover and 
that PKC is an important factor in limiting the production of 
Ins(l,4,5)P^ in stimulated cells. Consistent with this 
possibility is the fact that the PGF^^ -stimulated inositol 
phosphate response is reduced following exposure to TPA in both 
NIH-3T3 and ras transformed cells (Table 3.9). Long term TPA 
pre-treatment of NIH-3T3 cells lead to a reduction in the PGF_ 
-stimulated inositol phosphate response, whilst long term TPA 
pre-treatment of Swiss 3T3 cells (Brown et aJL_., 1987) and vascular 
smooth muscle cells (Pfeilschifter et al., 1989) lead to an enhanced 
bombesin and angiotensin II-stimulated Ptdlns(4,5)?^ hydrolysis, 
respectively. The different results obtain are most likely due to 
the fact that PKC can be almost completely down-regulated in Swiss 
3T3 cells and vascular smooth muscle cells, whilst in NIH-3T3 cells 
after a 24h TPA pre-treatment at least 7-21% of the PKC remains, as 
determined by PDBu binding. Cells transformed by Ha- or N-ras« 
pretreated for 24h with TPA, had greater amounts of PKC remaining 
compared with control cells and this is reflected in that there is 
greater inhibition of the PGF_ -stimulated inositol phosphate 
response in ras transformed cells. In non TPA treated cells the 
amount of PKC in Ha- and N-ras transformed cells was estimated to be 
at least 1.6-fold greater than control-NIH-3T3 cells and this may be 
a contributory factor in the desensitization of the PGF_
-stimulated inositol phosphate response in ras transformed cells. 
This percentage inhibition of the PGF^^-stimulated inositol 
phosphate response in long term TPA pre-treated control and ras 
transformed cells is surprising. It might have been expected that 
with only 7-21% of the PKC remaining that the inhibitory effect
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would be less marked. Possibly the remaining PKC is adequate to 
induce the desensitization or perhaps only isoforms of PKC not 
involved in the desensitization of the inositol phospholipid 
signalling pathway were down-regulated. Kariya and Taki (1987) 
demonstrated that in rabbit aortic smooth muscle cells there exists 
types of PKC resistant to down-regulation after prolonged treatment 
with phorbol esters.
Direct demonstration that the inhibition of PGF_
4
-stimulated Ptdlns(4,5)P2 hydrolysis in long term TPA treated 
cells and the desensitization of the PGF . -stimulated inositol
4 C\
phosphate response in ras transformed cells is a result of PKC 
catalysed phosphorylation of the P G F ^  receptors awaits the 
purification of the receptor or the generation of specific 
antibodies.
Cells transformed by a range of ras genes have elevated
levels of DAG (Preiss et al., 1986; Kamata et al.. , 1987: Lacal et
al., 1987a, 1987b; Wolfman & Macara, 1987). Lacal et al. (1987b)
Hd^rds
have demonstrated that microinjection of p21 — ~ into Xenopus
oocytes increases DAG levels. Increases in DAG concentrations may
lead to increases in PKC activity which has been shown to be
essential for ras induced mitogenesis (Lacal et al., 1987c). The
stimulation of mitogenesis in a range of normal fibroblast cell
lines by growth factors has also been shown to be accompanied by an
increase in DAG levels and in PKC activity (Habenicht et al., 1981;
Cook et al., 1990).
If the desensitization of PGF0 , -stimulated inositol
2o<
phospholipid hydrolysis is a consequence of increased PKC activity 
then one would expect to observe desensitization in both the 
transformed cells and in rapidly proliferating, non-contact 
inhibited NIH-3T3 cells as is indeed demonstrated in Tables 3.2 and
3.6.
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Removal of growth factor containing serum from NIH-3T3 
cells causes a cessation of proliferation and thus a reduction in 
PKC activity and consequently a reduction in the observed 
desensitization (Table 3.8). However, the removal of serum from 
the ras transformed cells does not result in resensitization.
Since ras transformed cells are known to secrete a range of 
autocrine growth factors, including TGF^ and PDGF-like molecules 
(Owen & Ostrowski, 1987), it is not possible to remove from the 
culture medium factors which are able to stimulate a range of 
signalling pathways including PtdIns(4 ,5 )P2 hydrolysis. PKC 
activity will, therefore, continue to be stimulated in ras 
transformed cells even in the absence of serum, whereas in the 
control NIH-3T3 cells in the absence of serum, the PKC activity will 
be lower. It is, therefore, possible that the desensitization of 
PGF^^-stimulated inositol phosphate generation in both the ras 
transformed and in the proliferating NIH-3T3 cells is due to 
increased PKC activity. This suggestion is supported by the 
finding that when normal and ras transformed NIH-3T3 cells are 
cultured in the presence of the PKC activator TPA for 48h their
responsiveness to PGF is significantly reduced as compared to
Z C\
untreated control cells (Table 3.9).
The experiments presented in this chapter also suggest an 
explanation for the observed variability of effects of transfecting 
ras genes into fibroblast cells upon inositol phospholipid 
metabolism. Since such cells are continuously proliferating and do 
not exhibit 'density dependent regulation', they do not quiesce. 
Therefore any amplified agonist stimulated inositol phosphate 
response may be desensitized' and not be apparent.
CHAPTER 4
ACTIVATION OF INOSITOL PHOSPHOLIPID HYDROLYSIS BY 
PROSTAGLANDIN F WITHOUT ANY STIMULATION OF 
PROLIFERATION IN QUIESCENT NIH-3T3 FIBROBLASTS
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4.1 INTRODUCTION
The stimulation of the proliferation of fibroblast cells in
culture has been demonstrated to be achieved by a range of growth
factors which are capable of activating the inositol phospholipid
signal transduction pathway (Berridge, 1987b). Agonist stimulated
Ptdlns(4,5 )P2 hydrolysis generates two second messenger molecules,
DAG and Ins(1,4,5)P^ which activate PkC and stimulate the release 
2+
of Ca from intracellular stores respectively (Downes & Michell, 
1985). A rise in intracellular free calcium concentration has been 
demonstrated to be one of the earliest detectable events following 
the stimulation of mitosis in fibroblast cells (Hesketh et al..
1985) and the activation of PkC leads to the phosphorylation of a
* * * •(- f
range of cellular proteins, but m  particular the Na /H
antiporter, resulting in increased cytoplasmic pH (Hesketh et al.,
1985). Evidence has been obtained which suggests that Na+-H*
exchange is linked to DNA synthesis (L’Allemain et aJ., 1984;
Pouyssegur et al., 1984). Alkalinisation of the cytosol appears to
be obligatory for mitosis and it has been shown that growth factor
stimulation of Swiss 3T3 and A431 cells results in increased
intracellular pH (Schuldiner & Rozengurt, 1982). It has not yet
been determined, however, whether the raised pH values associated
with exponentially growing cells is a regulatory signal or if it is
a consequence of cell proliferation.
PGF is an agonist which has been demonstrated to be a 
2
growth factor for, and to stimulate the hydrolysis of 
Ptdlns(4,5)P^ in Swiss 3T3 fibroblast cells (MacPhee et al..
1984). PGF^^ stimulated inositol phosphate generation in NIH-3T3 
fibroblasts and the involvement of inositol phospholipid turnover in 
the regulation of proliferation has been investigated.
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4.2 RESULTS
4.2.1 Time-dependent PGF^^  -stimulated inositol phosphate
generation in NIH-3T3 cells
Although total inositol phosphate generation is a reliable 
measure of receptor stimulated Ptdlns(4,5)P^ hydrolysis, it is 
possible that it could also occur as a consequence of Ptdlns 
hydrolysis (Hajerus et al., 1988). As Ins(l,4,5)P^ is the second 
messenger, it was important to obtain conclusive evidence that it is 
generated following stimulation with PGF2 o('
Cell extracts were prepared from control and PGF^ ^
(2.1uM) stimulated NIH-3T3 cells in the presence of lOmM LiCl and 
applied to Dowex formate columns to separate the inositol 
phosphates. Stimulation with 2.1uM P G F ^  induced significant 
generation of inositol monophosphate (IP) within 10 seconds. This 
then increased in a linear manner and after 120 seconds it had 
reached 189% of control (Fig. 4.1a). Significant increases in 
inositol bisphosphate (IP^) were observed by 10 seconds 
(approximately 48% increase). IP^ continued to increase reaching 
434% of control after 120 seconds (Fig. 4.1b). Figure 4.1c 
demonstrates that stimulation with PGF (2.1uM) induced the
Z vA
generation of inositol trisphosphate (IP^) within 5 seconds 
(approximately 68% increase). At 20 seconds values were 
approximately 377% of control. The levels declined at 30 seconds, 
but increased again to 440% at 60 seconds and at 120 seconds to 369% 
of control.
There are two isomeric forms of IP^ known to be produced 
on receptor stimulation, Ins(l,4,5)P^ and Ins(l,3,4)P^ (Irvine 
et al♦ (1984b), which cannot be separated by Dowex anion exchange 
chromatography. Therefore the analysis of inositol phosphates was 
extended by separation upon a parti si 1 5 WAX HPLC column. This
FiRure 4.1 Time-dependent PGF  -stimulated inositol phosphate
ZvA
Reneration in NIH-3T3 cells. Separation by Dowex 
anion exchanRe chromatoRraphy
3
[ H]inositol labelled cells were stimulated with PGF
Z 0 \
(2.1uH) for the times stated in the presence of lOmM LiCl. The 
inositol phosphates were separated on Dowex-formate 1x8-200 resin 
columns as described in Section 2.7a. Results are presented as the 
mean percentage of the radioactivity associated with the 
unstimulated control, n=6 in each case and the data is pooled from 
two separate experiments. The control d.p.m. values were: Figure
4.1a inositol monophosphate = 547 + 1; Figure 4.1b inositol 
bisphosphate = 198 + 1; Figure 4.1c inositol trisphosphate = 140 + 
6 .
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HPLC method also had the advantage of being able to isolate the 
higher inositol phosphates, for example inositol penta- or 
hexa-kisphosphates. Figure 4.2 shows the time-course of 
PGF -stimulated inositol phosphate generation as determined by
4 VA
HPLC. Stimulation with 2.1uM PGF induced the generation of
Ins(l,4 ,5 )P2 (Fig,4.2c) and Ins(l,3,4,5)P^ (Fig.4.2e) within 5
seconds, though the magnitude of the increase in Ins(l,3,4,5)P^
generation at 5 seconds (approximately 40% increase) was less than
that for Ins(l,4,5)P^ (approximately 150% increase). The
stimulation of Ins(l,4 ,5 )P2 generation was always observed to be
biphasic, as is demonstrated in Figure 4.2c. Peak accumulation of
Ins(l,4 ,5 )P2 » in the particular experiment demonstrated, was
observed at 15 seconds when values were approximately 400% of
control. The levels then declined returning to basal by 30
seconds. In some experiments the magnitude of the increase in
Ins(l,4,5)P^ was greater, reaching over 600% of the control
value. A 10 second delay was observed before accumulation of
Ins(l,3,4)P^ was detected (Fig.4.2d). Accumulation of this
isomer was then rapid and after 60 seconds the level was 500% of the
basal; after 60 seconds the rate of generation appeared to
decline. Data obtained by Dowex chromatography (Fig.4.1c) shows
that after 30 seconds IP„ levels increased and at 120 seconds were
3
369% of control. The analysis of IP^ isomers by HPLC strongly 
suggests that the increases in IP^ levels after 30 seconds is most 
likely due to increases in Ins(l,3,4)P^ and not Ins(l,4,5)P^*
Peak accumulation of Ins(l,3,4,5)P^ was detected following a 10 
second stimulation but in contrast to Ins(l,4 ,5 )P2 » the level 
appeared to remain elevated; at 120 seconds levels were 160% of 
control. Rapid accumulation of inositol mono- and bis-phosphates 
was also detected. At 120 seconds IP and IP^ levels were 145% 
and 485% of the control values, respectively. Small changes were
Figure 4.2 Time-dependent PGF^^ -stimulated inositol phosphate 
generation in NIH-3T3 cells. Separation upon a 
partisi1 5 WAX HPLC column
3
[ H]inositol labelled cells were stimulated with PGF_
4
(2.1uM) for the times stated in the presence of lOmM LiCl. The
inositol phosphates were separated by HPLC as described in Section
2.7b. Results are presented as the mean percentage of the
radioactivity associated with the unstimulated control, n=3 in each
case and the data is from a single experiment typical of three.
The control d.p.m. values were: Figure 4.2a inositol monophosphate
= 198,976 ± 6,023; Figure 4.2b inositol bisphosphate = 7,807 +
463; Figure 4.2c Ins(l,4,5)P^ = 1,523 + 97; Figure 4.2d
Ins(l,3,4,)P3 = 2,159 + 403; Figure 4.2e Ins(l,3,4,5)P4 = 3,409
+ 54; Figure 4.2f putative InsP,. = 15,981 + 1,297; Figure 4.2g
putative InsP = 2,711 + 288.
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also observed in the putative inositol penta- or hexa-kisphosphate 
fractions with the increases being significant after 10 seconds at 
about 120% and 130% of the control values respectively (Figs. 4,2f,g) 
The HPLC data from IP, IP^ and Ins(l,4 ,5 )P2 
time-courses correlates with the data obtained by Dowex 
chromatography (see Fig.4.1) and indicates that P G F ^  stimulates 
Ins(l,4,5)P^ production in NIH-3T3 cells as a result of PIC 
catalysed hydrolysis of Ptdlns(4,5)P^.
4.2.2 Inositol phospholipid hydrolysis and proliferation
Stimulation of NIH-3T3 cells with calf serum (4%) induced a 
4-fold increase in total inositol phosphates, whilst in the same 
experiment a maximal dose of PGF_^ induced a 1 0-fold increase 
(Table 4.1). However, when the two stimulants were added together 
to the cells a 2 1-fold increase in inositol phosphate generation was 
detected (Table 4.1). This synergistic accumulation of inositol 
phosphates would be thought to be reflected in an equally 
synergistic effect upon mitosis.
Table 4.2 shows the effect of PGF_ . upon calf serum
3
stimulated [ Hlthymidine incorporation into quiescent NIH-3T3
3
cells. [ H]thymidine incorporation experiments were carried out 
to measure increases in the DNA content of the cells, this being a
measure of mitogenesis. PGF , at a concentration that gave a
Z0\
maximal effect upon PtdlnsMjSJP^ hydrolysis, had no effect upon
3
calf serum stimulated [ Hjthymidme incorporation into 
serum-starved cells (Table 4.2). This lack of effect was observed
3
at all calf serum concentrations tested. Since [ H]thymidine 
incorporation into DNA is dependent upon uptake of the base into the 
cells it was considered possible that in these cells the 
prostaglandin was inhibiting thymidine uptake whilst at the same 
time stimulating DNA synthesis. Therefore, mitosis was also
115.
Table 4.1 Calf serum and PGF^ . -stimulated inositol
*°\
phosphate generation in NIH-3T3 cells
Stimulant
Calf serum 4% (v/v)
PGF (2.luM)
Calf serum 4% (v/v) and 
PGF (2.luM)
3 -1Cells were labelled with [ H]inositol (luCi ml ) for
24h and stimulated for 30 min in the presence of lOmM LiCl.
Inositol phosphate generation was determined as described in Section
2.6. Results are presented as means ± S.D. pooled from two typical
experiments and n=8 in each case.
Inositol phosphate Reneration 
(% increase over untreated control) 
426 ± 62
1015 ± 76
2163 +- 113
116.
Table 4.2 Effect of PGF_ upon calf serum stimulated
2 On
3
£ Hlthvmidine incorporation into growth arrested
NIH-3T3 cells
Additions
None
PGF
1 H] thymidine 
(dpm) 
11594 ± 454
12337 + 1140
Fold increase
1.06
0.5% calf serum 
0.5% calf serum 4- PGF
2 *
15101 ± 540
14763 4- 1459 0.98
1%  calf serum 
1% calf serum 4- PGF2
19104 ± 4588
18764 4- 2518 0.98
5% calf serum 
5% calf serum 4- PGF
2 *
18535 + 1174
18879 4- 2394 1.02
10%  calf serum 
10% calf serum + PGF
19136 ± 2435
18851 4- 1999 0.98
Quiescent NIH-3T3 cells were washed with DMEM and incubated
-1 3 -1
for 24h in DMEM containing luCiml [ H]thymidme, 0.04ngml
insulin, 0.4ugml * transferrin, 0.4ngml * EGF and the additions
stated in the table. Acid insoluble radioactivity was determined
as described in Section 2.3. Results are expressed as means ±
S.D., where n=4 and are from one experiment typical of three
others. The P G F ^  concentration was 2.1uM, calf serum
concentrations are stated on a volume basis. Fold increase refers
to effect of PGF„ . upon stimulation by calf serum.
117.
measured by determining cell number by Coulter counting, this being 
an absolute quantification of proliferation. Figure 4.3 
illustrates growth curves for NIH-3T3 cells. Cells were plated in 
35mm dishes and 24h later the medium was changed to one containing
calf serum (10%) or calf serum (10%) and PGF (2.1uM).
2 o(
Additions of PGF^^^.luM) were made every 12h. Figure 4.3 
demonstrates that PGF2 c< was having no upon calf serum
stimulated cell proliferation. The fall in cell number after 168h 
is probably due to cell death as cells become over confluent.
Table 4.3 shows the effect of growth factors on
3
incorporation of ( Hlthymidine into growth arrested NIH-3T3 
cells. In addition to having no potentiating effect upon calf 
serum stimulated mitosis, PGF induced no DNA synthesis in
£  Os.
quiescent NIH-3T3 cells in the presence of EGF, insulin and 
transferrin (Table 4.3). EGF (O.lugml *), insulin (lngml *),
3
bombesin (2.5uM) and bradykinm (3.2uM) potentiated [ Hlthymidine 
incorporation by 1.83-, 2.90-, 1.09- and 2.31 fold, respectively 
(Table 4.3).
Contrary to the results presented in this chapter, PGF„ , 
has been reported to be a potent mitogen for NIH-3T3 cells (Yu et 
al., 1988). Consequently, NIH-3T3 cells were obtained from this 
group (subsequently referred to as AmNIH-3T3 cells). Table 4.4 
demonstrates that in this cell line is indeed a potent
3
mitogen stimulating a 2.3 fold increase in [ Hlthymidine 
incorporation. Calf serum stimulated a similar fold increase in
3
I Hlthymidine incorporation in both NIH-3T3 and AmNIH-3T3 cells
8.1 and 6.1 respectively. Figure 4.4 illustrates growth curves for
AmNIH-3T3 cells cultured in the presence of calf serum (10%) or calf
serum (10%) and PGF„ (2.1uM) and demonstrates that PGF„^
I 2 ^
potentiated calf serum stimulated cell growth to a saturation
Figure 4.3 NIH-3T3 growth curves
Cell numbers were determined by Coulter counting as 
described in Section 2.4. Six counts were made of duplicate plates 
and results are expressed as means + S.D. from a single experiment 
typical of two others. □  cells grown in DMEM + 10% (v/v) calf 
serum, ♦  cells grown in DMEM + 10% (v/v) calf serum +■ 2.1uM 
PGF^^ (cells supplemented with P G F ^  (2.1uM) every 12h).
118.
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Table 4.3 Effect of growth factors on incorporation of 
3
Hlthymidine into growth arrested NIH-3T3 cells
Additions
Serum free 
Calf serum 10% (v/v) 
EGF (O.lugml-1) 
Insulin (lngml *) 
Bombesin (2.5uM)
+ Insulin (lngml *) 
Bombesin (2.5uM) 
Bradykinin (3.2uM)
dpm[ Hlthymidine 
incorporated 
2061 ± 163
12366 ± 1646 
3771 + 261
5976 ± 364
5698 ± 291
2246 ± 197
4760 ± 306
2040 + 153
Fold increase 
over control
6.00
1.83
2.90
2.78
1.09
2.31
0.99
Quiescent NIH-3T3 cells were washed in DMEM and incubated
3 -1
for 24h in DMEM containing lOuM [ Hlthymidine (O.luCimol ),
0.04ngml * insulin, 0.4ngml * transferrin, 0.4pgml * EGF and
the additions stated in the table. Acid insoluble radioactivity
was determined as described in Section 2.3. Results are expressed
as means + S.D. where n=4 and are from one experiment typical of two
others.
120.
3
Table 4.4 Stimulation of [ Hlthymidine incorporation in
NIH-3T3 and AmNIH-3T3 cells
Additions
3
dpm[ Hlthymidine Fold increase
incorporated over control
NIH-3T3 cells
serum free control 1629 ± 173 -
calf serum 10% (v/v) 13228 ± 210 8.1
PGF_rt (2.luM) 
2 G\
1617 + 103 1.0
serum free control + LiCl(lOmM) 1447 + 40 -
LiCl (lOmM) + calf serum
10% (v/v) 13286 + 324 9.1
PGF2(X (2.luM) + LiCl(lOmM) 1734 ± 174 1.2
AmNIH-3T3 cells
serum free control 1808 + 191 -
calf serum 10% (v/v) 11054 + 449 6.1
PGF (2.luM) 4214 + 210 2.3
serum free control + LiCl(lOmM) 
LiCl (lOmM) +- calf serum
2033 + 45 -
10%  (v/v) 15419 + 414 7.6
PGF„_ (2.ImM) + LiCl(lOmM) 3728 ± 183 1.8
Quiescent cells were washed in DMEM and incubated for 24h
-1 3 -1
in DMEM containing luCiml [ Hlthymidine, 0.04ngml insulin,
0.4ugml ^ transferrin, 0.4ngml * EGF and the additions stated in
the table. Acid insoluble radioactivity was determined as
described in Section 2.3. Results are expressed as means + S.D.
where n=3-4 and are from one experiment typical of two others.
Figure 4.4 AmNIH-3T3 growth curves
Cell numbers were determined by Coulter counting as
described in Section 2.4. Results are means + S.D. of six counts
of triplicate plates and are from one experiment typical of two. d
cells grown in DMEM + 10% (v/v) calf serum, ♦ cells grown in DMEM
10% (v/v) calf serum and 2.1uM P G F ^  (cells supplemented with
PGF (2.1uM) every 12h).
£ 0\
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density 160% of controls. The fall in cell number after 192h is 
probably due to cell death as cells become over confluent.
Table 4.4 also demonstrates that the inclusion of lOmM LiCl
3
only had a minor effect upon PGF^^ stimulated [ Hlthymidine
incorporation in both cell lines. Additionally, the different
mitogenic effects of PGF on the two cell lines were still
Z 0\
observed when the ion was included.
MacPhee et al. (1984) have reported that the prostaglandin 
acts as a mitogen for Swiss 3T3 cells. Table 4.5 shows the effect
3
of °n ^ncorPora^ on I Hlthymidine into growth arrested
NIH-3T3 cells and demonstrates that PGF stimulates
Z
3
[ Hlthymidine incorporation in Swiss 3T3 cells in a dose dependent
manner, giving a maximal 2.4-fold increase compared to a 1.3-fold
increase in response to calf serum.
Figure 4.5 illustrates growth curves for Swiss 3T3 cells
cultured in the presence of calf serum (10%) or calf serum (10%) and
PGF (2.1uM) and demonstrates that PGF _ is a mitogen for 
Z 0 \. Z ^
these cells potentiating calf serum stimulated cell growth to a
saturation density 140% of controls.
Since it has been demonstrated that PGF„ stimulated DNA
2c*
synthesis in Swiss 3T3 and AmNIH-3T3 cells, but not in NIH-3T3 cells 
a comparison of the stimulation of inositol phosphate generation in 
the cell types was made. In agreement with Saski (1985) the 
prostaglandin was found to induce a 2-3 fold increase in inositol 
phosphate generation in Swiss 3T3 cells, a value much lower than 
that found in NIH-3T3 cells. However, Table 4.6 shows that 
induced essentially equivalent increases in inositol
2<X
phosphate generation in the two NIH-3T3 lines (12.5-fold). Further
analysis of the PGF -stimulated inositol phosphate response in
ZO\
the AmNIH-3T3 cells revealed no major differences to that in NIH-3T3 
cells (discussed further in Section 4.2.3).
123.
3
Table 4.5 Stimulation of [ Hlthymidine incorporation in Swiss
3T3 cells
Additions
serum free control
10% calf serum
8.41 x 10 10M PGF
8.41 x 10 H PGF
8.41 x 10~8M PGF
20\
2c*
8.41 x 10 ?M PGF
2<X
8.41 x 10 M PGF
dpm[ Hlthymidine 
incorporated 
3257 ± 599
4142 + 647
6329 ± 1734 
5000 + 981
7658 ± 613
7992 ± 185
7095 + 400
Fold increase 
over control
1.3
1.9 
1.5
2.3
2.4 
2.2
Quiescent Swiss 3T3 cells were washed in DMEM and incubated
- 1 3  . -1
for 24h in DMEM containing luCiml [ Hlthymidine, 0.04ngml
insulin, 0.4ngml  ^ transferrin, 0.4pgml  ^ EGF and the additions
state in the table. Acid insoluble radioactivity was determined as
described in Section 2.3. Results are expressed as means + S.D.
where n=4 and are from one experiment typical of two others.
Figure 4.5 Swiss 3T3 growth curves
Cell numbers were determined by Coulter counting as
described in Section 2.4. Results are means + S.D. of 4 counts of
duplicate plates and are from one experiment similar to one
other. □  cells grown in DMEM +■ 10% (v/v) calf serum, ♦  cells
grown in DMEM +• 10% (v/v) calf serum and 2.1uM PGF^^ (cells
supplemented with PGF (2.1uM) every 12h.
ZC\
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Table 4.6 Comparison of stimulated inositol phosphate generation 
between NIH-3T3 and AmNIH-3T3 cells
Inositol phosphates <% increase over untreated control)
Ligand NIH-3T3 AmNIH-3T3
Bombesin (2.5uM) 9 + 3  193 + 27
PDGF (1.32ugml_1) 4 3 + 7  2 8 + 1 0
Bradykinin (3.2uM) 104 + 9  3 1 + 3
PGF <2.1uM) 1250 + 78 1261 + 147
c
Calf serum (4% v/v) 254 + 33 259 + 9
3 -1
Cells were labelled with [ H]inositol (luCiml ) for
24h and stimulated for 30 min in the presence of lOmM LiCl, with the
stated agonists. Inositol phosphate generation was determined as
described in Section 2.6. Results are means + S.E.M., pooled from
three separated experiments where n=4 in each case.
126.
Figure 4.6a (NIH-3T3) and Figure 4.6b (AmNIH-3T3) 
illustrate the dose-dependence of PGF2<x -s^^mu^a^e^ inositol 
phosphate generation as a percentage over unstimulated controls.
The for inositol phosphate generation for both NIH-3T3 and
AmNIH-3T3 cells was essentially the same, 0.18uM and O.lluM 
respectively, with a saturating response being observed at 
approximately 2uM.
4.2.3 Time-dependent PGF^^ stimulated inositol phosphate
generation in AmNIH-3T3 cells. Separation upon a partisil 
5 WAX HPLC column
Analysis of the P G F ^  -stimulated changes in individual 
inositol phosphates in the AmNIH-3T3 cells (Fig,4.7) demonstrated a 
very similar pattern to that observed in NIH-3T3 cells (Fig.4.2). 
Stimulation with PGF^^ (2.1uM) induced the generation of 
Ins(l,4 ,5 )P2 (Fig.4.7c) and Ins(1,3,4,5)P^ (Fig.4.7e) within 5 
seconds, though the magnitude of the increase in Ins(l,3,4,5)P^ 
generation at 5 seconds (approximately 195% increase) was less than 
that for Ins(l,4 ,5 )P2 (approximately 225% increase). As in the 
NIH-3T3 cells stimulation of Ins(l,4,5)P^ generation was observed 
to be biphasic in the AmNIH-3T3 cells. Peak accumulation of 
Ins(l,4,5)P^ was observed at 20 seconds when values were 
approximately 375% of control. The levels then declined to 200% of 
basal at 120 seconds. In the NIH-3T3 cells, at 30 seconds 
Ins(l,4,5)P^ levels had declined to basal. Peak accumulation of 
Ins(l,3,4,5)P^ was detected following a 20 second stimulation (10 
seconds later than that observed in NIH-3T3 cells) but unlike 
Ins(l,4,5)P^, the level appeared to remain elevated and at 120 
seconds was 300% of that of basal. A 10-15 second delay was 
observed before accumulation of Ins(l,3,4)P^ was detected 
(Fig.4.7d), accumulation of this isomer was then rapid and after 120
Figure 4.6 Dose-dependence of P G F ^  -stimulated inositol
phosphate generation in NIH-3T3 and AmNIH-3T3 cells
3 -1
Cells were labelled with I H]inositol (luCi ml ) for
24h and stimulated for 30 min with various concentrations of PGF^
in the presence of lOmM LiCl. Results are expressed as means ±
S.D. Results for NIH-3T3 cells are pooled from 3 experiments,
while results for AmNIH-3T3 cells are from a single experiment
typical of three.
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Figure 4.6a
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FiRure 4.7 Time-dependent PGF„_ -stimulated inositol phosphate
Z CA
Reneration in AmNIH-3T3 cells. Separation upon a 
parti si 1 5 WAX HPLC column
3
[ H]inositol labelled cells were stimulated with PGF^^
(2.1um) for the times stated in the presence of lOmM LiCl. The
inositol phosphates were separated by HPLC as described in Section
2.7b. Results are presented as the mean percentage of the
radioactivity associated with the unstimulated control, n=3 in each
case and the data is from a single experiment typical of three.
The control d.p.m. values were : Figure 4.7a inositol monophosphate
= 78595 + 3089; Figure 4.7b inositol bisphosphate = 4570 + 383;
Figure 4.7c Ins (1,4,5)P^ = 958 + 55; Figure 4.7d Ins (1,3,4)P^
= 1886 ± 306; Figure 4.7e Ins (1,3,4,5)P^ = 1005 + 143; Figure
4.7f putative Ins Pc = 8300 + 473; putative Ins P. = 1910 + 721.
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seconds reached 800% of the basal. Rapid accumulation of inositol 
mono- and bis-phosphates was also detected. At 120 seconds IP and 
IP^ levels were 125% and 580% of the control values, respectively 
(Figs.4.7a-7b). Changes were observed in the putative inositol 
penta- or hexa-kisphosphate fractions. Levels of 
penta-kisphosphate declined to 25% below levels at 10 seconds and 
returned to basal levels again at 20 seconds. However, levels fell 
to 20% below basal at 120 seconds (Fig.4.7f). Hexa-kisphosphate 
levels declined to 35% below basal at 15 seconds, then increased at 
20 seconds where levels were 115% of the control value.
4.2.4 Characterisation of PGF^_^ receptors on AmNIH-3T3 cells 
In order to determine if there were differences in the
3
binding characteristics of [ H]PGF__ to AmNIH-3T3 cells,20^
binding studies were performed. Scatchard analysis of PGF^^ 
binding data generated a Kd of 0.56uM with approximately 500,000 
receptors per cell (Fig.4.8 ).
Almost identical values for the NIH-3T3 cells (Chapter 3, 
Section 3.2.5) have been obtained.
Whilst no differences in PGF^^-stimulated inositol 
phosphate generation was detected between the two cell lines, the 
AmNIH-3T3 cells were found to respond to a greater extent to 
bombesin (193% over untreated controls) compared to NIH-3T3 cells 
(9% over unstimulated controls). Bradykinin stimulated inositol 
phosphate generation to a greater extent in NIH-3T3 cells, 104% over 
unstimulated controls compared to 31% in AmNIH-3T3 cells (Table 4.6).
3
Figure 4.8 Scatchard analysis of the binding of [ H]PGF0 to
AmNIH-3T3 cells
Binding was performed and assessed as described in Section
2.9. Bound P G F ^  (B) is expressed in fmol per 10^ cells; the
concentration of PGFrt in the medium (F) is in fmol.2<x
B
/F
1 30.
Figure 4.8
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4.3 Discussion
PGF_ is clearly shown in this study to stimulate the 
2 c*
hydrolysis of Ptdlns(4,5)?^ generating Ins(l,4,5)P^ in both the
clones of NIH-3T3 cells examined (Figs. 4.1, 4.2 and 4.7). This
work indicates that on stimulation with PGF_ , , Ins(l,4,5)P„ is
2 3
the initial inositol phosphate generated. The other inositol
phosphates found in the PGF2o( stimulated cells can be produced
directly or indirectly, from Ins(l,4,5)?^ by the actions of
kinases or phosphomonoesterase activity (Hawkins et al., 1986).
Their accumulation to much higher levels can be accounted for by
their much slower rates of metabolism (Irvine et al., 1985).
Ins(l,4 ,5 )P2 is metabolised in two ways: by specific removal of
its 5-phosphate to give Ins(l,4)P^ (Downes et al., 1982) or by
3~kinase action to give Ins(l,3,4,5)P (Batty et al., 1985;
Hawkins et a d , 1986), which in turn is dephosphorylated to
Ins(l,3,4)P^ (Hawkins et al., 1986). The stimulation of
Ins(l,4,5)P^ generation was biphasic, which may imply a secondary
phase of PtdIns(4 ,5 )P2 breakdown (Figs. 4.2 and 4.7). The
significance and mechanism of this second phase of Ins(l,4,5)P^
generation was uncertain. The initial rate of generation of
I n s d ,3,4,5)P^ was slower than that for Ins (1,4,5)?^* but
Ins(l,3,4,5)P^ levels reached steady state much more rapidly. In
contrast, Ins(l,3,4)P^, IP^ and IP levels rose throughout the
120 second period of stimulation with an initial short time lag of
5-10 seconds for Ins(l,3,4)P^. Ins(l,3,4)P^ is degraded
relatively slowly, so by 120 seconds, its levels greatly exceed
those of Ins(l,4,5)P^. The delayed accumulation of
Ins(l,3,4)P in response to PGF is consistent with this 
3  ^0\
compound being a metabolite of Ins(l,4,5)P^ and
I n s d ,3,4,5)P^. Figures 4.2f-2g and 4.7f-7g show two labelled
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compounds that eluted after Ins(l,3,4,5)P^ on HPLC that have 
similar chromatographic properties to inositol penta- or 
hexa-kisphosphate (Heslop et al., 1985). As standards were not 
available, their identification is putative. Only in two 
experiments were fractions collected for these peaks. Therefore, 
insufficient data is available to determine whether these peaks are 
significantly influenced by PGF^^ stimulation.
The possibility that IP and IP^ are generated in 
PGF -stimulated cells as a consequence of Ptdlns or Ptdlns(4)P
* 'A
hydrolysis can be ruled out. This is due to the fact that the 
initial rate of generation of IP and IP^ was slower than that for 
Ins(l,4,5)P^. If these inositol phosphates were generated as a 
consequence of Ptdlns and PtdIns(4)P hydrolysis then their 
production would occur much more rapidly. Thus, the inositol 
phosphates generated in response to P G F ^  stimulation of both 
clones of NIH-3T3 cells are a consequence of Ins(l,4 ,5 )P2 
generation. This demonstrates that the assay for total inositol 
phosphates in control and stimulated cells is an accurate estimate 
of Ptdlns(4,5 )P2 hydrolysis.
Ins(l,4,5)P^ has been shown to release Ca^+ from 
intracellular stores in many different cells (Berridge & Irvine, 
1984). Lloyd et a^. (1989) have shown that stimulation of NIH-3T3 
cells with a maximal PGF concentration results in an increase 
in intracellular free Ca^*. The effects of the prostaglandin 
upon inositol phospholipid metabolism are thus similar to those 
observed in response to a range of other agonists such as bradykinin 
and vasopressin in a variety of cell types (see Berridge, 1987a).
The stimulation of inositol phosphate generation was 
dose-dependent with half-maximal stimulation at 0.18uM and a 
saturating response observed at 2uM (Fig.4.6 ). This is
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close to the Kd observed for PGF_ receptor binding (Chapter 3,c C\
Section 3.2.5). It is also similar to that reported by MacPhee et 
al. (1984) for the stimulation of inositol phospholipid metabolism 
in Swiss 3T3 cells. In bovine corpora lutea, Powell et al. (1975) 
reported a single class of PGF receptor of Kd 0.5-luM, this
2C\
being similar to that obtained for NIH-3T3 cells.
Whilst stimulation of NIH-3T3 cells with PGF„_ induced
2o(
Ptdlns(4,5)P^ breakdown, it was without effect upon the
stimulation of DNA synthesis in this clone of NIH-3T3 cells (Tables
4.2, 4.3, 4.4, Fig.4.3). This result was surprising since it has
been reported that the prostaglandin is a potent growth factor for
both NIH-3T3 (Yu et al., 1988) and Swiss 3T3 cells (Herschman et
al., 1978; MacPhee et al., 1984). PGF was unable to induce
DNA synthesis even in the presence of insulin, EGF and transferrin
(Tables 4.2, 4.3, 4.4); NIH-3T3 cells demonstrated an absolute
requirement for low concentrations of these growth factors since
they can not survive a 24h period in serum-free medium. Jimenez de
Asua et ajL. (1985) demonstrated that insulin enhances the
stimulatory effect of PGF2 <* ^  increasing the rate of entry into
S phase, whilst EGF and PGF2 <^  ^ave a synergistic effect on
stimulation of DNA synthesis in Swiss 3T3 cells. The results in
this chapter confirm that the prostaglandin is indeed a growth
factor for Swiss 3T3 cells (Table 4.5, Fig.4.5) and for the clone of
NIH-3T3 cells used by Yu et al. (1988) (Table 4.4, Fig.4.4). No
major differences were observed in the stimulation of inositol
phosphates generation by PGF0 . between the two clones of NIH-3T3
cells (Table 4.6, Fig.4.7), nor were any differences detected in
EC,.^, Kd or PGF„_ receptor number (Figs.4.6 , 4.8). It is 
50 2<a
clear, however, from the results shown in Table 4.6, that there are 
differences in responsiveness to other defined agonists, most
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noticably to bombesin. However, this may reflect a different
receptor number and deserves further study. Significantly, there
is no difference in the response to calf serum (Table 4.6) which is
equally effective in stimulating the proliferation of both cell
types (Figs.4.3, 4.4). The stimulation of inositol phosphate
accumulation by PGF_ in Swiss 3T3 cells is less marked (3-4
fold) than in the two clones of NIH-3T3 cells, but it is clearly a
growth factor for this cell type (Table 4.5).
Calf serum stimulated DNA synthesis in all three cell types
(Tables, 4.2, 4.3, 4.4, 4.5, Figs. 4.3, 4.4, 4.5) and also induces
inositol phosphate generation. This induction of DNA synthesis is
dose-dependent, but is not potentiated in the NIH-3T3 cells by any
concentration of PGF_ (Table 4.2). This lack of potentiation is
2<a
despite a synergistic effect upon inositol phosphate generation 
(Table 4.1). The mechanism underlying the synergistic stimulation 
of inositol phosphates induced by PGF and calf serum is 
unknown. However, Paris et al. (1988) demonstrated that tyrosine 
kinase activating growth factors potentiate thrombin-induced 
Ptdlns(4,5)P^ hydrolysis in hamster fibroblasts and suggest that 
such growth factors enhance the coupling between G-protein and PIC, 
possibly through the phosphorylation of one of the two proteins.
Calf serum contains tyrosine kinase activating growth factors and it 
is possible that such mitogens could bring about such an enhanced 
coupling between G-protein and PIC resulting in the synergistic 
inositol phosphate generation observed when NIH-3T3 cells are 
stimulated by both calf serum and PGF . NIH-3T3 cells
demonstrate the same rank order for the effectiveness of calf serum, 
PDGF and bombesin in stimulating inositol phosphates and
3
I H]thymidine incorporation, yet PGF which stimulated a
ZO\
1 2-fold increase in inositol phosphate generation does not stimulate 
3
[ H]thymidine incorporation.
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The results in this chapter, therefore, place a question 
upon the role of inositol phosphate metabolism in growth 
factor-stimulated cell proliferation. Tones et al. (1988) have 
demonstrated no requirement for inositol phospholipid breakdown in 
serum-stimulated mitogenesis in CH0-K1 cells. Taylor et al. (1988) 
have found that the proliferation of Swiss 3T3 cells can be 
inhibited by the addition of pertussis toxin with no inhibition of 
the stimulation of inositol phosphate generation. These studies 
and the experiments reported in this chapter suggest that, whilst 
mitogens can activate the breakdown of inositol phospholipids, it is 
either, not obligatory for the onset of mitosis, or in itself not a 
complete signal. Consequently, some additional signal must be 
being generated in the AmNIH-3T3 and Swiss 3T3 cells, but not in the 
NIH-3T3 cells, in response to P G F ^  , either in early G^ or at a 
later stage in the cell cycle, which is required for the onset of 
DNA synthesis and mitosis. The identity of this signal, is however 
unclear.
CHAPTER 5
THE EFFECT OF OVER-EXPRESSION OF NORMAL ras GENES IN NIH-3T3 
FIBROBLASTS UPON PHOSPHATIDYLCHOLINE METABOLISM
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5.1 Introduction
Many growth factors stimulate the receptor activated 
hydrolysis of Ptdlns(4,5)?^ generating the two second messengers 
Ins(l,4,5)P^ and DAG. It has been proposed that this is the key 
to the mechanism whereby agonists, such as bombesin, stimulate cell 
proliferation (Berridge, 1987b). However, the results presented in 
Chapter 4 indicate that in some cell lines, breakdown of inositol 
phospholipids is either, not obligatory for the onset of mitosis, or 
in itself not a complete signal.
Mitogenesis only occurs if there is persistent activation 
of PKC which requires a maintained increase in cellular DAG 
levels. Agonist stimulated PtdIns(4,5)P^ hydrolysis is a 
transient process which is rapidly desensitized (see e.g. Brown et 
al., 1987), whilst the cellular level of DAG has been demonstrated 
to remain elevated in the absence of significant amplified 
Ptdlns(4,5 )P2 hydrolysis (Cook et al., 1990). Lacal et al.
(1987a) demonstrated a reproducible increase in DAG levels in Ha-ras 
transformed NIH-3T3 cells, in the absence of a reproducible increase 
in inositol phosphates. These observations suggest that DAG might 
be generated from the metabolism of phospholipids other than 
PtdIns(4,5)P^. In Swiss 3T3 cells it has been demonstrated that 
there is sustained PtdCho breakdown even when the inositol phosphate 
response is desensitized (Cook & Wakelam, 1989). Many agonists 
that stimulate inositol phospholipid metabolism have now been shown 
to activate the hydrolysis of PtdCho in various cell types (see 
Pelech & Vance, 1989).
PtdCho hydrolysis catalysed by a PtdCho specific 
phospholipase C was proposed (Slivka et al. , 1988), since in studies 
demonstrating enhanced DAG production (from PtdCho), ChoP generation 
was also detected. However, many of these studies did not examine
137.
the individual water soluble metabolites generated following PtdCho 
hydrolysis and with the demonstration that phosphatidic acid 
accumulates prior to DAG in hepatocytes stimulated with vasopressin 
(Bocckino et al., 1987), the involvement of phospholipase C must be 
reassessed.
DAG can also arise from the sequential actions of 
phospholipase D (PLD) and phosphatidic acid-phosphohydrolyase.
Cabot et al. (1988) demonstrated that in REF52 cells stimulation 
with vasopressin results in the catabolism of PtdCho to phosphatidic 
acid and Cho, while Cook and Wakelam (1989) have shown that in Swiss 
3T3 cells stimulation with bombesin leads to the rapid generation of 
Cho, prior to ChoP, suggesting that agonist-stimulated PtdCho 
breakdown is a PLD catalysed process. It has been suggested that 
both phospholipase C and PLD activation can be either a direct 
agonist-receptor stimulated event or secondary to the activity of 
PKC.
The following study was carried out in order to determine 
whether PtdCho breakdown is a phospholipase C or PLD catalysed 
process and to investigate the effect of over-expression of normal 
Ha-, Ki- or N-ras genes in NIH-3T3 cells upon both stimulated and 
basal PtdCho metabolism.
5.2 Results
3
5.2.1 Characterisation of [ HlCho-labellins of lipids in
NIH-3T3 cells
To determine the optimum labelling period it was necessary 
3
to characterise the I H]Cho-labelling of lipids in NIH-3T3
3
cells. NIH-3T3 cells were labelled with [ Hjcholine chloride for 
increasing times. Cells were then stimulated with (2.1uM)
3
or TPA (lOOnM; 24 and 48h time points only) and [ H]Cho,
3 3
[ H]ChoP and [ H]GroPCho were separated as described in Section
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2.8 (Fig.5.1a-lc). The amount of radioactivity associated with the
lipid fraction from chloroform/methanol treated cells was also
3
determined (Fig.5.Id). Maximum incorporation of [ H)Cho into Cho 
containing lipids occurred at 30h. Levels then dropped slightly to
3
72h (Fig.5.Id). Maximum levels of [ HJGroPCho also occurred at 
30h and levels plateaued to 72h (Fig.5.la). No PGF ^  or TPA
3
stimulated increases in the levels of [ HjGroPCho were observed.
3
Maximum incorporation of [ H]Cho into ChoP occurred at 12h and
levels decreased steadily to 72h (Fig.5.lb). No PGF0_ or TPA
3
stimulated increases in the levels of [ H]ChoP were observed.
3
Maximum levels of I H]Cho were observed at 30h, while
maximum PGF0_ and TPA stimulated levels were observed at 24h.
2 o(
3
Both unstimulated and stimulated [ H]Cho levels remained elevated 
for the duration of the time course. In subsequent experiments
3
cells were labelled with [ H)Cho for 30h.
3
5.2.2 PGF? -stimulated increases m  cell associated [ H ]Cho-
ZC\
labelled metabolites in NIH-3T3 and Ha-ras transformed 
NIH-3T3 cells
3
Stimulation of [ H]Cho-labelled NIH-3T3 cells and Ha-ras
(EC807) transformed NIH-3T3 cells with PGF_ (2.1uM) caused the
2c(
generation of both intracellular and total Cho (Table 5.1). In
cells expressing high levels of the normal Ha-ras proto-oncogene,
there is a significant increase, compared to control-NIH-3T3 cells,
in Cho generation. No stimulated changes in the levels of 
3 3
[ HjGroPCho and [ H)ChoP were noted in either cell types. As
3
the levels of stimulated intracellular and total [ H]Cho were very
3
similar, in subsequent experiments only total [ H]Cho metabolites 
were analysed.
o
Figure 5.1 Characterisation of [JHlCho labelling of lipids m  
NIH-3T3 cells
3
Cells were labelled with [ Hlcholme chloride 
(luCiml-^) for the times stated and stimulated with
PGF (2.1uM) and TPA (lOOnM; 24 and 48h time points only) and
Z 0\
3 3 3[ H]Cho, [ H]ChoP and [ H]GroPCho were separated as described 
in Section 2.8. The results are means + S.D. of one experiment 
similar to one other.
d.
p.
m
. 
d.
p.
m
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5.2.3 Analysis of growth factor stimulated generation of
3
HICho-labelled metabolites from control and Ha-ras 
transformed NIH-3T3 cells
To determine what effect over-expression of normal ras 
genes have on growth factor stimulated PtdCho breakdown, 
[^H]Cho-labelled NIH-3T3 cells and Ha-ras (EC807) transformed 
NIH-3T3 cells were stimulated with saturating concentrations of 
bombesin, PDGF, bradykinin, calf serum and PGF9 (Table 5,2).
No stimulated changes in the levels of GroPCho or ChoP were noted in 
either cell type. Bombesin and PDGF did not stimulate increases in 
the levels of Cho, while calf serum stimulated similar increases in 
Cho in both cell lines (NIH-3T3=23 + 17% above basal; EC807=34 + 8%  
above basal; P=0.125). Bradykinin stimulated increases in Cho 
levels in Ha-ras transformed cells only (21 + 8% above basal).
PGF9„ -stimulated a significant increase in Cho generation in both
t 'A
cell lines, but in the Ha-ras transformed cells, stimulated Cho 
levels are 2-fold greater (54 + 11% above basal) compared to control 
cells (28 + 6% above basal). This would suggest that in Ha-ras 
transformed cells there is greater PGF^^-stimulated PLD activity.
5.2.4 PGF -stimulated Cho generation in control and Ha-ras
2C\
transformed NIH-3T3 cells
To examine the PGF^^-stimulated PLD activity in control
and Ha-ras (EC807) transformed cells the dose-dependence of
PGF^q^-stimulated Cho generation as a percentage increase of
unstimulated controls was determined (Fig.5.2). For both control
and Ha-ras transformed NIH-3T3 cells half-maximal stimulation
(EC,-q ) occurs at a concentration of approximately 0.17uM. A
saturating response is observed at approximately 2uM; at this
concentration PGF0_ -stimulated Cho generation is almost 2-fold 
20\
greater in the Ha-ras transformed cells (EC807= 56 + 7% above basal)
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Table 5.2 Growth factor stimulation of GroPCho, ChoP and Cho in 
control and Ha-ras (EC807) transformed NIH-3T3 cells
Cell Type Ligand % of untreated control
GroPCho ChoP Cho
NIH-3T3 Bombesin (2.5uM) 100 + 4 106 + 3 97 + 7
PDGF(1.32ugml_1) 97 + 4 104 + 7 104 + 9
Bradykinin (3.2uM) 103 ± 4 100 + 8 102 ± 9
Calf serum (4%) 99 ± 4 100 8 123 ± 17
PGF20^(2.1uM) 101 ± 5 107 5 128 ± 6
EC807 Bombesin (2.5uM) 99 Hr 10 100 + 7 110 ± 7
(Ha-ras) PDGF (1.32ugml-1) 100 + 6 101 + 4 109 ± 9
Bradykinin (3.2uM) 106 8 100 + 6 121 ± 8
Calf serum (4%) 103 + 3 100 ± 7 134 ± 8
PGF_(2.1uM) 111 + 8 104 + 5 154 + 11
3
Cells were labelled with [ Hjcholine chloride
-1
(luCiml ) for 30h and after a 20 min stimulation the accumulation 
of GroPCho, ChoP and Cho were determined as described in Section 
2.8. Results are expressed as means + S.D., pooled from 3 to 6 
experiments.
Figure 5.2 Dose dependence of P G F ^  -stimulated Cho generation
in control and Ha-ras (EC807) transformed NIH-3T3 cells
3
Cells were labelled with [ Hlcholine chloride 
(luCiml *) for 30h and stimulated for 30 min with various
3
concentrations of PGF ^  . [ H]Cho generation was determined as
2 On
described in Section 2.8. Results are expressed as means + S.E.M., 
pooled from four separate experiments.
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compared to control cells (NIH-3T3= 30 + 7% above basal). No
stimulated increases in the levels of GroPCho or ChoP were observed
at any of the PGF„W concentrations tested.
2C\
The time course of PGF -stimulated changes in Cho
£ C\
levels in control and Ha-ras transformed cells is illustrated in 
Figure 5.3. In NIH-3T3 cells PGF (2.1uM) stimulated the
£ U\
generation of Cho, which was significant at 1 min <20% above basal)
and thereafter paralleled the basal increase in Cho resulting in
levels of 28% above basal at 30 min (Fig.5.3a). In Ha-ras
transformed cells, small increases in Cho generation were noted at 1
min. However, significant increases in Cho levels were only
observed after 2 min (5% above basal) and increased to 55% above
basal at 30 min, this being almost 2-fold greater than the
PGF„ -stimulated increases observed in control cells. A similar 
2 o(
time lag of 2 min in PGF -stimulated Cho generation was always
i C\
observed in Ha-ras transformed cells. No significant.changes in
the radioactivity associated with GroPCho or ChoP were observed in
response to PGF (2.1uM) in either cell type.
£ (*
5.2.5 TPA-stimulated Cho generation in control and Ha-ras 
transformed NIH-3T3 cells
In NIH-3T3 cells significant TPA (lOOnM)-stimulated 
increases in Cho generation were only observed after 5 min (7% above 
basal). Thereafter levels increased to 73% above basal at lh 
(Fig.5.4a). A time lag of 2 min in TPA-stimulated Cho generation 
was always observed in control cells. In Ha-ras transformed cells 
a significant increase (17% above basal) in Cho generation was 
observed after a 1 min stimulation with TPA (lOOnM) and levels 
continued to rise for the 60 min duration of the time course to 79% 
above basal. This being similar to the stimulated levels in 
control cells. No significant change in the radioactivity
Figure 5,3 Time-course of PGF2^  -stimulated changes in Cho 
levels in control and Ha-ras (EC807) transformed 
NIH-3T3 cells
3
Cells were labelled with [ Hlcholine chloride 
(luCiml1) for 30h and after stimulation with PGF (2.1uM) for 
the times stated, the levels of Cho were determined as described in 
Section 2.8. Results are expressed as means + S.D., n=8 in each 
case, pooled from two separate experiments which gave qualitatively 
the same results as three others. Results have been normalised 
using d.p.m. values of untreated controls. Figure 5.3a: NIH-3T3 
cells - basal rate of Cho turnover was 0.036 + 0.009% min 
Figure 5.3b EC807 cells - basal rate of Cho turnover was OX>45 ± 
0.016% min “S  rate = d.p.m. Cho produced per min x 100/d.p.m. in 
choline containing lipids.
d.
p.
m
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Figure 5.3a
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FiRure 5.4 Time-course of TPA-stimulated changes in Cho levels in
control and Ha-ras (EC807) transformed NIH-3T3 cells
3
Cells were labelled with [ Hlcholine chloride 
(luCiml *) for 30h and after stimulation with TPA (lOOnM) for the 
times stated, the levels of Cho were determined as described in 
Section 2.8. Results are expressed as means + S.E.M., n=10 in each 
case, pooled from three separate experiments which gave 
qualitatively the same results as two others. Results have been 
normalised using d.p.m. values of untreated controls. Figure 
5.4a: NIH-3T3 cells - basal rate of Cho turnover was 0.035 + 0.003%
min ^ , Figure 5.4b EC807 cells - basal rate of Cho turnover was 
0.0700 + 0.006% min "S rate = d.p.m. Cho produced per min x 
1 0 0 /d.p.m. in choline containing lipids.
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associated with GroPCho or ChoP was observed in response to TPA in 
either cell type. The non C-kinase activating ^-phorbol was 
without effect upon GroPCho, ChoP or Cho levels (results not shown).
5.2.6 Basal levels and basal rates of production of GroPCho. ChoP 
and Cho in control and Ha-. Ki- or N-ras transformed 
NIH-3T3 cells
A comparison of the basal levels of GroPCho, ChoP and Cho 
in control and Ha-, Ki- or N-ras transformed NIH-3T3 cells is
summarised in Table 5.3. Values stated are d.p.m. in cell
associated GroPCho, ChoP and Cho divided by d.p.m. in choline 
containing lipids. The ratio EC807:NIH-3T3 describes EC807 values
divided by NIH-3T3 values and is one example of a comparison of ras
transformed cell values, with control cell values.
The results show that the basal levels of GroPCho are 
reduced in ras transformed cells; for example, the levels of 
GroPCho in Ha-ras transformed cells are 41% of those in control 
cells. Basal levels of Cho were similar in all cell types
tested. However, the basal levels of ChoP were always found to be
greater in the ras transformed cells and the fold increase ranged 
from 1.38 to 3.25 (Table 5.3).
The basal rate of GroPCho turnover was 2.10-fold greater in 
Ha-ras transformed cells compared to control cells (EC807= 0.057 + 
0.03% min NIH-3T3= 0.027% ± 0.01% min [n=5-6]; rate =
d.p.m. GroPCho produced per min x 100/d.p.m. in choline containing 
lipids). The basal rate of Cho turnover was greater in Ha-ras 
transformed cells (range 1.3- to 2.68-fold greater) compared to 
control cells (EC807= 0.053 ± 0.01% min”1 ; NIH-3T3= 0.028 ± 0.01% 
min n=7-9), while the level of ChoP appears to be in steady 
state in both cell types.
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Table 5.3 Basal levels of GroPCho« ChoP and Cho in control
and Ha-, Ki- or N-ras transformed NIH-3T3 cells
Cell type Udpm in Cho metabolite/dpm in lipids)xlOO] No. of
GroPCho ChoP Cho Expts.
NIH-3T3 9.42 ± 1.07 13.73 + 1.39 5.20 ± 0.55 18
EC807(Ha-ras) 3.86 ± 0.49 28.69 + 2.36 4.82 ± 0.72 18
Ki860(Ki-ras) 2.11 39.40 6.41 1
N872(N-ras) 1.46 28.30 6.89 1
ratio
EC807:NIH-3T3 0.41 ± 0.05 2.09 ± 0.15 0.93 ± 0.05
Cells
3
were labelled with [ Hlcholine chloride
(luCiml *) for 30h and basal levels of GroPCho, ChoP and Cho were 
determined as described in Section 2.8. Results are pooled from 
the stated number of experiments and are expressed as means ±
S.E.M. Ratio describes EC807 (cells transformed by overexpressed 
Ha-ras) values divided by NIH-3T3 values. GroPCho ratio 
EC807:NIH-3T3 ranged from 0.19 to 0.75; ChoP ratio EC807:NIH-3T3 
ranged from 1.38 to 3.25; Cho ratio EC807:NIH-3T3 ranged from 0.56 
to 1.44.
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5.2.7 Cho kinase activity in control and Ha-. Ki- or N-ras 
transformed NIH-3T3 cells
Lacal et al. (1987a) reported that the cellular
concentration of ChoP was significantly elevated in v-Ha-ras
transformed NIH-3T3 cells, 1.42- to 2.47-fold greater than control
cells. This being similar to the 2.09-fold increase in ChoP levels
observed in this study (Table 5.3). It was suggested that the ChoP
arises from constitutive hydrolysis of PtdCho by phospholipase C, an
activity that would account for the reported elevated DAG levels
found in ras transformed cells (Lacal et al. 1987a). Macara (1989)
however, has suggested that it is possible that the increased ChoP
arises through the induction of Cho kinase activity. Therefore,
experiments to determine Cho kinase activity in control and ras
transformed NIH-3T3 cytosol extracts were performed. In order to
measure Cho kinase activity in these cells, the conversion of 
3 3
[ H]Cho to [ H]ChoP in the presence of a known amount of the
3
cytosolic extract was measured. The amount of [ H]ChoP generated
3
in these samples was quantified by separating the [ H]-labelled
ChoP by Dowex anion exchange chromatography. Phosphorylation was
linear with time for at least 40 min (Fig.5.5a) and with protein
concentration up to 20ug (Fig.5.5b).
Initial experiments to determine the Michaelis Menton
constant (K ) for control and Ha-ras transformed NIH-3T3 cells Cho 
m ---
3
kinase were performed using [ H]Cho at a specific activity of 
lCimmol”*. The results in Figure 5.6 show the velocity of the
reaction for Cho kinase in a control and Ha-ras transformed NIH-3T3
cytosolic preparation. The V x calculated from this data was 
1.24 (NIH-3T3 cell; Fig.5.6a) and 2.83nmoles ChoP min *mg protein 
(EC807 cells; Fig.5.6b). The half maximal substrate concentration 
determined from these plots for control and Ha-ras transformed cells
Figure 5.5 Effect of time and protein concentration on Cho kinase 
activity in NIH-3T3 cells 
Cho kinase activity was assayed as described in Section
2.10. Results are means ± S.D. of one experiment where n=3. The 
experiment was repeated once and gave very similar results. Figure 
5.5a - effect of time on Cho kinase activity in NIH-3T3 cells;
Figure 5.5b - effect of protein concentration on Cho kinase activity 
in NIH-3T3 cells.
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Figure 5.6 Substrate requirement of Cho kinase specific activity 
from control and Ha-ras transformed NIH-3T3 cytosolic 
preparation
The kinetics of the NIH-3T3 (Fig.5.6 a and 6c) and EC807 
(Fig.5.6b and 6d) Cho kinase was determined as described in Section
2.10. The results are from one experiment performed on triplicate 
samples and Figure 5.6a and 6b are plots of velocity (V) of the 
enzyme reaction in nmol ChoP min *mg * protein versus substrate 
concentration in uM(S). Results are means + S.D., n=3 in each case 
and the data are from one experiment which is representative of
three others. Figure 5.6c and 6d are the same data plotted as V
V , .
versus /[S]. Mean values of four similar experiments
were: NIH-3T3 cells - 18.21 ±  4.67uM; EC807 cells - 18.85 ± 1.60uM.
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was approximately 14.15 and 13.96uM Cho respectively. From these
plots the control and Ha-ras transformed NIH-3T3 Cho kinase appears
to display Michaelis-Menton kinetics. Figure 5.6c and 5.6d are the
Badie-Hofstee plots of the data in Figure 5.6a and 5.6b
respectively. From these graphs the values obtained for
control and Ha-ras transformed NIH-3T3 cells were 20.15 and 19.32uM
respectively: the V values obtained were 1.5 and 3.39nmoles
r * max
ChoP min *mg ^protein, respectively.
The specific activities of Cho kinase in the cell extracts
from Ha-, Ki- and N-ras transformed NIH-3T3 cells were significantly
higher, 2.29, 2.02 and 2.07-fold greater respectively, than those of
control cells (Table 5.4). These differences could be attributed
to the fact that on reaching confluency NIH-3T3 cells quiesce
whereas ras transformed cells continue in active growth.
Comparison of measurements of Cho kinase activity in cultures which
were 100% confluent and 50% confluent (in exponential growth) were
made. Cells in logarthimic growth gave similar V and K
max m
values to those cells which were confluent (Table 5.5).
5.2.8 Comparison of stimulated and basal PtdCho metabolism in 
NIH-3T3 and AmNIH-3T3 cells
In Chapter 4 it was demonstrated that P G F - i n d u c e d  
mitosis in AmNIH-3T3 cells, but not in NIH-3T3 cells, while inducing 
inositol phosphate generation in both cell types. It was of 
interest, therefore, to determine if differences in PtdCho 
metabolism existed between these cell types, hence comparisons of 
stimulated and basal PtdCho metabolism were made. Saturating 
concentrations of bombesin, PDGF, bradykinin, and calf serum did not 
stimulate changes in the levels of GroPCho or ChoP in either cell 
type (Table 5.6). Saturating concentrations of PGF„rt did not 
stimulate changes in the levels of GroPCho in NIH-3T3 cells or ChoP
153.
Table 5.4 Cho kinase activity in control and Ha-. Ki- and
N-ras transformed NIH-3T3 cells
Cell type Mean specific activity Enhancement No. of
(nmoles/mi n/mg protein) ratio Expts.
NIH-3T3 0.861 +0.14 8
EC807(Ha-ras) 1 . 9 7 8 + 0 . 3 0  2.29 8
Ki 860 (Ki-rajs) 1.740 + 0.28 2.02 2
N872(N-ras) 1.780 + 0.24 2.07 2
Cho kinase was assayed as described in Section 2.10.
Results are expressed as means + S.D., pooled from the stated number 
of experiments. Enhancement ratio described values from cells 
transformed by Ha-ras (EC807); Ki-ras (Ki860); N-ras (N872) 
divided by NIH-3T3 values. The specific activity of Cho kinase 
from extracts of NIH-3T3 and EC807 cells ranged from 0.432 to 1.586 
and 1.128 to 3 .390nmoles/min/mg protein respectively.
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Table 5.5 Measurements of Cho kinase activity in cultures of
control and Ha-ras transformed NIH-3T3 cells which were 
100% confluent and 50% confluent
Cell type V K (uM)
max m
(nmoles/min/mg protein)
NIH-3T3 
100% confluent
NIH-3T3 
50% confluent
EC807(Ha-ras) 
100% confluent
EC807(Ha-ras) 
50% confluent
0.814 ± 0.21 
0.973 + 0.31 
2.324 ± 0.53 
2.462 + 0.47
15.21 + 2.63 
16.93 + 3.47 
16.11 ± 3.07 
17.45 + 1.74
Cho kinase activity was assayed as described in Section
2.10. Results are means + S.D., pooled from 3 experiments.
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Table 5.6 Growth factor stimulation of GroPCho, ChoP and Cho in 
NIH-3T3 and AmNIH-3T3 cells
Cell Type Ligand % of untreated control 
GroPCho ChoP Cho
NIH-3T3 Bombesin (2.5uM) 100 + 4 106 jh 3 97 7
PDGF(1.32ugml_1) 97 + 4 104 +_ 7 104 9
Bradykinin (3.2uM) 103 + 4 100 + 8 102 + 9
Calf serum (4%) 99 + 4 100 8 123 ± 17
PGF2c^ (2.1uM) 101 + 5 107 + 5 128 ± 6
AmNIH-3T3 Bombesin (2.5uM) 101 7 108 7 96 + 17
PDGF (1.32ugml“1) 94 + 8 103 20 95 ± 7
Bradykinin (3.2uM) 95 + 7 107 + 11 99 ± 8
Calf serum (4%) 100 ± 6 108 8 131 ± 5
PGF . (2.luM) 119 ± 9 105 + 13 130 10
- 1.
Cells were labelled with [ H]choline chloride 
(luCiml J') for 30h and after a 20 min stimulation the accumulation 
of GroPCho, ChoP and Cho were determined as described in Section 
2.8. Results are expressed as means + S.D., pooled from 4 to 6 
experiments.
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levels in either cell type. However, PGF^ -stimulated 
significant increases in GroPCho levels (approximately 19% above 
basal) in AmNIH-3T3 cells. Bombesin, PDGF and bradykinin did not 
stimulate changes in the levels of Cho, while calf serum and 
PGF- -stimulated significant increases in Cho levels
& W
(approximately 30% above basal) in both NIH-3T3 and AmNIH-3T3 cell 
types.
A comparison of the basal levels of GroPCho, ChoP and Cho 
in NIH-3T3 and AmNIH-3T3 cells is summarised in Table 5.7. Values 
stated are d.p.m. in cell associated GroPCho, ChoP and Cho divided 
by d.p.m. in Cho containing lipids. The ratio AmNIH-3T3:NIH-3T3 
describes AmNIH-3T3 values divided by NIH-3T3 values. No 
significant differences in the levels of GroPCho, ChoP or Cho were 
noted between the cell types (Table 5.7).
The specific activity of Cho kinase from AmNIH-3T3 cell 
extracts was similar (0.935 ± 0.12nmoles ChoP/min/mg protein; n=2) 
to that obtained from NIH-3T3 cell extracts (0.861 + 0.14nmoles 
ChoP/min/mg protein; n=8 ).
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Table 5.7 Basal levels of GroPCho, ChoP and Cho in NIH-3T3 and 
AmNIH-3T3 cells
{dpm in Cho metabolite/dpm in lipids) x 100] 
Cell type GroPCho ChoP Cho
NIH-3T3 6.94 ± 1.32 7.97 ± 1.15 3.63 + 1.28
AmNIH-3T3 7.08 ± 0.7 8.55 + 1.27 3.94 ± 1.34
AmNIH-3T3:NIH-3T3 1.09 + 0.18 1.07 + 0.08 1.14 + 0.23
3
Cells were labelled with [ HJcholine chloride 
(luCiml ^) for 30h and basal levels of GroPCho, ChoP and Cho were 
determined as described in Section 2.8. Results are pooled from 
four experiments and are expressed as means ± S.D. Ratio describes 
AmNIH-3T3 values divided by NIH-3T3 values.
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5.3 Discussion
As pgf2o( induced PtdIns(4.5)P2 hydrolysis in both 
NIH-3T3 and AmNIH-3T3 cells and was a mitogen in AmNIH-3T3 cells, 
but not in NIH-3T3 cells, it was of interest to determine if 
differences in basal and/or agonist-stimulated PtdCho metabolism 
existed between the two clones of NIH-3T3 cells. No differences in 
growth factor stimulated Cho responses were detected between the two 
clones. However, in AmNIH-3T3 cells, but not in NIH-3T3 cells,
PGF0^ -stimulated an increase in GroPCho levels. This may imply
£ 0\
a difference between the cells in agonist-stimulated phospholipase 
A^ activity. This was the only difference noted between the two 
NIH-3T3 clones as basal levels of GroPCho, ChoP and Cho were similar 
and deserves further study. Cho kinase activity was also very 
similar in both clones.
Exactly which intracellular signalling system(s) ras 
interacts with is not clear. Stimulation of DNA synthesis by ras 
requires functional PKC activity (Lacal et al., 1987c; Morris et 
al., 1989) and mitogenesis only occurs if there is persistent 
activation of PKC, thus requiring a maintained increase in cellular 
DAG levels. Cells transformed by ras oncogenes have elevated 
levels of DAG (Preiss, 1986; Lacal et al_., 1987a, 1987b; Wolfman & 
Macara, 1987; Fleishman et al., 1986). However, in all cell types 
examined, agonist-stimulated Ptdlns(4,5)P2 hydrolysis is a 
transient process which is rapidly desensitized (e.g. Brown et al., 
1987). Therefore, DAG must be generated from the metabolism of 
phospholipids other than Ptdlns(4,5)P2 . It has been suggested 
that PtdCho breakdown could be a potential source of DAG and many 
agonists that stimulate Ptdlns (4,5)P2 hydrolysis have now been 
shown to also activate the hydrolysis of PtdCho in various cell 
types (see Pelech & Vance, 1989).
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The data presented in this chapter suggests that
stimulation of PKC either directly (e.g. by TPA) or indirectly, via
activation of PtdIns(4,5)P2 hydrolysis (e.g. by PGP2cx and
serum), may stimulate breakdown of PtdCho by PLD. The results in
Table 5.2 demonstrate that calf serum and PGF_^, induced
2(X
hydrolysis of PtdCho and the formation of Cho in both control and 
Ha-ras transformed NIH-3T3 cells, while bradykinin induced Cho 
generation only in Ha-ras transformed cells. In the Ha-ras 
transformed cells P G F ^  -stimulated Cho levels were 2-fold greater 
than control cells suggesting that in the transformed cells there is 
greater PGF- -stimulated PLD activity (Table 5.2). No
* C\
stimulated changes in the levels of GroPCho of ChoP were observed in 
either control or Ha-ras transformed cells, indicating that none of 
the growth factors tested stimulated phospholipase A2 or 
PtdCho-phospholipase C activity (Table 5.2). The stimulation of
Cho generation by PGF was dose-dependent, with half maximal
i. 0\
stimulation at 0.18uM and a saturating response observed at 2uM 
(Fig.5.2). This was observed for both the control and the Ha-ras 
transformed cells. This EC^^ is close to the Kd observed for 
PGF receptor binding (Chapter 3, Section 3.2.5) and the EC -
2 ^  DU
for PGF2o^  “Stimulated Ptdlns(4,5)P2 hydrolysis (Chapter 3,
Section 3.2.4).
Agonist-stimulated PLD activity in HL60 cells has been 
suggested by time-course experiments showing rapid formation of 
phosphatidic acid with slower formation of DAG (Pai et al., 1988) 
and by the finding of phosphatidic acid formation even in the 
presence of a DAG kinase inhibitor (Mahadevappa, 1988). 
Receptor-regulated PLD activity has also been proposed to account 
for PtdCho hydrolysis in vasopressin-stimulated hepatocytes 
(Bocckino et al., 1987) and REF-52 cells (Cabot et al., 1988).
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Results obtained by Cook and Wakelam (1989) strongly suggest that in 
Swiss 3T3 cells bombesin stimulated PtdCho breakdown by the 
activation of a receptor linked PLD on the basis that Cho is 
elevated between 10 and 30 seconds whilst ChoP levels only rise 
after 2 min.
Examination of P G F ^  -stimulated PLD activity by 
time-course experiments demonstrated that, in NIH-3T3 cells, Cho 
generation was significant at 1 min while in Ha-ras transformed 
cells a time lag of 2 min in PGF^^ -stimulated Cho generation was 
observed (Fig. 5.2). Compared to bombesin-stimulated Cho 
generation in Swiss 3T3 cells (Cook & Wakelam, 1989),
PGF^^ -stimulated Cho generation in NIH-3T3 cells is slightly 
delayed, as Cho generation is not significantly elevated until 0.5 
to 1 min. Although PGF -stimulated breakdown of PtdCho isZO\
likely to be via activation of a receptor linked PLD other
possibilities cannot be ruled out. For example, the possibility
exists that PLD activity is being stimulated by the increase in
intracellular free calcium concentration in response to PGF^^
-stimulated Ins(l,4,5)P^ generation. Lloyd et al. (1989) have
shown that PGF_ stimulates a similar Ca^+ response in both 
i. C\
control (T15~) and N-ras transformed NIH-3T3 cells (T15+). If 
an increase in intracellular Ca^+ concentration was responsible 
for activating PLD activity, then it would be expected that the 
fold-stimulation of Cho generation would be similar in both control 
and Ha-ras transformed cells and this is clearly not the case.
PGF- -stimulated increases in Cho generation are observed at 30
C N A
min indicating that the signal stimulated by P G F ^  is long
lived. As PGF- -stimulated Ptdlns(4,5)P- hydrolysis is 
2o( 2
desensitized at 30 min (Chapter 3, Fig.3.2) then the increase in 
intracellular free calcium concentration in response to
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PGF -stimulated Ins(l,4,5)P generation would be unlikely to
2 o
account for increases in Cho generation observed at 30 min.
Indeed, Taki and Kanfer (1979) have suggested that PLD is active
24-
even in the absence of Ca . The time lag of 2 min in 
P G F ^  -stimulated Cho generation observed in Ha-ras transformed 
cells is difficult to explain. It may, however, be due to the fact 
that the basal rate of Cho production is at least 1.3-fold greater 
than that observed in control cells, which may mask an early 
stimulated increase.
Stimulation of PtdCho hydrolysis by TPA has been described 
in a number of systems (see Pelech & Vance, 1989) and has been 
tentatively proposed to be involved in providing a second phase of 
increased DAG levels, through the mediation of PKC (Muir & Murray, 
1987; Cook et al., 1990). In NIH-3T3 cells TPA-stimulated 
increases in Cho generation were only observed after 5 min 
(Fig.5.4). A time lag of at least 2 min in TPA-stimulated Cho 
generation was always observed in control cells. In Ha-ras 
transformed cells a significant increase in Cho generation was 
observed after 1 min stimulation with TPA. At lh TPA-stimulated 
similar fold increases in Cho generation (1.75-fold) in both control 
and Ha-ras transformed cells. These results strongly suggest that 
PLD activity is mediated by increased PKC activity and this is 
supported by work by Cabot et al. (1989) who demonstrated that in 
REF52 cells staurosporine, a PKC inhibitor and down-regulation of 
PKC were dually effective in suppressing TPA-induced PLD catalysed 
hydrolysis of PtdCho. However, Cook and Wakelam (1989) found that 
whilst down-regulation of PKC in Swiss 3T3 cells caused an 
inhibition of both bombesin and TPA-stimulated Cho generation, 
staurosporine only partially inhibited the responses to both the 
agonist and phorbol ester in normal cells. The time-lag in
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TPA-stimulated Cho generation in control cells is difficult to 
account for. Liscovitch et fQ. (1987) also demonstrated an 
apparent lag period of 2.5-5 min in TPA (lOOnM) stimulated Cho 
generation in NG108-15 cells. Upon TPA treatment PKC is known to 
re-distribute from one cell compartment to another. It is possible 
that the translocation of PKC from the cytoplasm to the membrane 
requires a period of time and this may contribute to the lag period 
after the addition of TPA before an increase in PtdCho metabolism is 
observed. The ras transformed cells are always in active growth 
and do not quiesce when confluent. Therefore, PKC is always 
activated and may be already in a membrane-bound state. Indeed in 
T15+ and N866 cells, the proportion of membrane-bound PKC is 
3-fold higher than in control, non-transformed cells (Davies, S.A. & 
Wakelam, M.J.O., unpublished data). Thus when the cells are 
stimulated with TPA, since PKC activity is already stimulated, TPA 
acts to amplify the response and changes in Cho levels are 
significant within 1 min.
Consequently, activation of PKC in NIH-3T3 cells may lead 
to both the desensitization of Ptdlns(4,5)P£ hydrolysis and to the 
stimulation of PtdCho breakdown, thus potentiating its own
24-
activation whilst reducing the increase m  intracellular free Ca 
concentration. Therefore, it is possible that the stimulation of 
PtdCho breakdown in response to PGF^^ is activated by the 
increase in PKC activity as a consequence of prior Ptdlns(4,5)P^ 
hydrolysis rather than being a direct receptor activated event. 
Stimulation of NIH-3T3 cells with maximal concentrations of either 
PGF _ or TPA causes the loss of only about 5% of the label from
/U\
the total PtdCho fraction. This is in agreement with the findings 
of Cook and Wakelam (1989) using bombesin and TPA-stimulated 
Swiss-3T3 cells and also Liscovitch et al., (1987) using
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TPA-stimulated NG108-15 cells and is probably due to the relatively 
small generation of Cho as compared to the large size of the 
cellular PtdCho pool.
The data presented in this chapter demonstrates that in 
ras-transformed cells PtdCho turnover is increased both by PLD and
phospholipase A^ pathways. The results show that in ras
transformed cells basal levels of GroPCho are reduced (Table 5.3), 
but that the rate of GroPCho production is 2.1-fold greater in 
Ha-ras transformed cells compared to control cells. This would 
imply that in ras-transformed cells there is greatly increased 
phospholipase A^ activity. This may be of importance as
hydrolysis of PtdCho by phospholipase A^ can produce arachidonic
acid, an immediate precursor of eicosanoids. Bar-Sagi and 
Feramisco (1986) have also suggested that phospholipase A^ 
activity may be activated when cells are microinjected with
T*dS
p21---. However, Price et a^. (1989) have demonstrated that
induction of DNA synthesis by oncogenic ras was unaffected by 
inhibitors of prostaglandin synthesis, indicating that conversion of 
the released arachidonic acid to various prostaglandins is not 
required for stimulation of DNA synthesis by ras. No difference 
was found in the basal levels of Cho between normal and 
ras-transformed cells, but the basal rate of Cho production was 1.3 
to 2.68-fold greater in the ras-transformed cells. This suggests 
that there is increased basal PLD activity in ras transformed 
cells. This increased PLD activity may result from increased PKC
activity as ras-transformed cells are always in active growth.
Therefore, PKC is always activated. It is also possible that the 
increased autocrine production of several growth factors e.g. PDGF, 
observed in ras-transformed cells may also amplify PKC activity and
hence PLD activity. Basal levels of ChoP were always found to be
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greater in the ras-transformed cells compared to control cells and 
the fold increase ranged from 1.38 to 3.25 (Table 5.3). The basal 
level of ChoP appears to be in steady state in both control and 
Ha-ras transformed cells. This would imply that the rate of 
production of ChoP equals its conversion to CDP-choline by CTP: 
phosphocholine cytidyltransferase.
Lacal et al. (1987a) demonstrated similar increases in ChoP
levels in v-Ha-ras transformed NIH-3T3 cells. They suggested that
ChoP arises from constitutive hydrolysis of PtdCho by
PtdCho-phospholipase C, an activity that would account for the
reported elevated DAG levels found in rjis-transformed cells.
Preiss et al. (1986) and Lacal et al. (1987a) have shown that levels
of DAG are elevated in ras^-transformed cells, but this does not seem
to be derived from increased PtdIns(4 ,5 )P2 hydrolysis (Wolfman &
Hacara, 1987; Morris et aJL., 1989). Macara (1989) suggested that
the increased levels of ChoP in the ras-transformed cells arises
through the induction of Cho kinase activity. Indeed the results
in Table 5.4 demonstrate that the specific activity of Cho kinase in
extracts of the ras-transformed cells is at least 2-fold greater
than in control cells. This fold increase being similar to the
fold increase observed in ChoP levels in the ras-transformed cells
compared to control cells (Table 5.3). Cho kinase activity
measured in both control and Ha-ras transformed cells in exponential
growth gave similar V and K values to cells which were
max m
confluent (Table 5.5). Therefore, differences in basal levels of 
ChoP and Cho kinase activity are not simply due to the increased 
rate of proliferation of ras-transformed cells. Transformation of 
NIH-3T3 cells by ras appears to induce Cho kinase activity and it is 
this induction, rather than increasing PtdCho-phospholipase C 
activity that accounts for the elevation of basal levels of ChoP in
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ras-transformed cells. Indeed Price et al. (1989) demonstrate that
scrape loading Vall2p21--- into Swiss3T3 cells elevates ChoP
levels. This increase occurs 10 to 20 min after scrape loading and 
continues for at least 60 min. They also demonstrate that this 
ras-dependent increase in ChoP is abolished in PKC down-regulated 
cells. This suggests that Cho kinase activity is dependent upon 
PKC activity and as PKC is always activated in ras-transformed cells 
it would account for the increased ChoP levels in ras-transformed 
cells compared to control cells.
CHAPTER 6
DISCUSSION
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6.1 Discussion
The aim of the work described in this thesis was to 
investigate the effects of over-expression of normal ras proteins 
upon lipid signalling pathways in cultured NIH-3T3 fibroblasts.
E*&S
The results in Chapter 3 indicate that over-expression of p21---
in NIH-3T3 cells is associated with increased cell proliferation and
transformation (Fig.3.1). Very high levels of normal cellular 
r d sp21--- are required to be expressed in order to induce
transformation. For example McKay et al. (1986) demonstrated that
in the T15 cell line a 20-50-fold over-expression of normal 
N—ras
p21 --- was required. To achieve similar effects with
V"*rfls
p21 --- or a mutated cellular ras oncogene, a lower concentration
of the gene product is required i.e. concentrations comparable with
those in untransformed cells (see McKay et al., 1986). Feramisco
Ha—ras
et al, (1984) demonstrated that mutated p21 ---, when injected
into quiescent fibroblasts, caused rapid increases in DNA synthesis
and mitosis and had a profound effect on cell morphology, whereas
H a 1 r a s
normal cellular p21   injected at the same concentration had
little or no observable effect.
The biochemical properties of ras proteins, plasma membrane
binding, GDP/GTP binding and GTP hydrolysis are central to their
biological function. The proteins are biochemically and
biologically active only when in a GTP-bound state; GDP bound forms
are inactive (Trahey & McCormick, 1987). GAP stimulates the GTPase
activity and thus the conversion of p21-GTP to p21-GDP. However,
r&s
GAP has no effect on the GTPase activity of oncogenic p21---
proteins and as a result, these proteins remain in their active,
GTP-bound state. This may partly explain why a lower concentration 
r & s
of mutant p21---- is required for the stimulation of cell
proliferation and transformation than normal p21--- . Mulcahey et
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al. (1985) demonstrated that microinjection of neutralising 
r ft s
anti-p21  antibodies into quiescent fibroblasts, blocked
proliferation induced by the addition of growth factors. This data
together with some sequence homology to other proteins strengthens
r as
the possibility that p21--- can act in a G-protein-like manner in
signal transduction pathways which result in cell proliferation and
transformation. It is still not clear, however, which processes
ras
are being regulated and therefore with which molecules p21---
interacts.
ras
The results in Chapter 3 have suggested that p21— ~ can
function at a post-receptor level to enhance growth factor
stimulated inositol phosphate generation. In Chapter 3 it was
demonstrated that in cells expressing high levels of the normal Ha-,
Ki- or N-ras proto-oncogene, there was a marked increase in inositol
phosphate generation in response to stimulation with certain growth
factors compared to the control NIH-3T3 cells. This increase is
likely to be due to the enhanced production of Ins(l,4,5)P^ and
its metabolites, since Lloyd et aJ. (1989) demonstrated that, in the
T15 cell line, the induction of the N-ras proto-oncogene caused an
amplification of bombesin-stimulated Ins(l,4,5)P^ generation and
intracellular Ca^+ release. The effect is due specifically to
N-ras
the expression of P21 --- and can be correlated to the amount of
cellular p21N (Wakelam et al., 1987).
Several lines of evidence support the proposal that
r a s
P21--- is coupled to PtdIns(4 ,5 )P2 hydrolysis. Fleishman et
al. (1986) have shown that NIH-3T3 and NRK cells transformed by Ha-,
Ki- and N-ras genes demonstrate an increase in the steady state
levels of inositol phosphates and DAG compared to non-transformed
cells. Lacal et al_. (1987b) demonstrated that microinjection of 
Ha-ras
transforming p21   into Xenopus oocytes resulted in increased
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generation of inositol phosphates and DAG. Hancock ejt al.. (1988)
demonstrated that NIH-3T3 cells constitutively expressing and COS-1
cells transiently expressing oncogenically activated Ha- or Ki-ras
genes display a significantly enhanced basal rate of inositol
phospholipid turnover. These results suggested that the ras
proto-oncogenes control the activity of PIC which hydrolyses
Ptdlns(4,5 )P2 to form Ins(l,4,5)P^ and DAG and the presence of
an activated mutated ras oncogene would result in a constitutively
activated PIC. In support of this hypothesis Chiarugi ejb al.
(1986) demonstrated that transformation of Balb-3T3 fibroblasts with
the EJ/T24-Ha-ras oncogene increased the responsiveness of PIC to
muscarinic stimulation. In addition, Wakelam et al. (1986)
demonstrated that, in the T15 cell line, induction of a
steroid-hormone regulated ras construct, causing over-expression of
the N-ras gene, resulted in an increase in the apparent coupling of
rfl s
the bombesin receptor to PIC. However, this effect of p21---
expression may be confined to certain cell lines and Xenopus oocytes 
as contradictory evidence has been presented.
Some workers have reported a loss of response to growth 
factors in cells transfected and transformed by ras. Seuwen et al.
(1988) observed a desensitization of the inositol phospholipid 
response in CCL39 fibroblasts transformed by mutant Ha- and Ki-ras 
in response to serum or thrombin. However, this desensitization is 
apparently at the receptor level, since the response to ALF^ 
persisted. The desensitization appeared not to be specific to ras 
expression as a similar effect was observed in polyoma 
virus-transformed CCL39 cells. Parries et al. (1987) demonstrated 
that transformation of NIH-3T3 cells by viral Ha- or Ki-ras caused 
the desensitization of the PDGF-stimulated inositol phosphate 
response with no effect on receptor number. Benjamin et al. (1988)
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observed a similar desensitization and have demonstrated that EJ-ras 
transformed NIH-3T3 cells have decreased PDGF-stimulated 
Ins(l,4,5)P^ and Ca^+ levels compared to control cells.
In Chapter 4 differences in the agonist-stimulated 
mitogenic and second messenger responses between two clones of 
NIH-3T3 cells were observed. This may have a bearing upon the 
contradictory observations made on the effects of transfection of 
apparently the same cell type with the same ras gene upon inositol 
phospholipid metabolism (Wakelam et sQ., 1986; Seuwen et al.,
1988; Downward et al., 1988). Some of the conflicting results may 
arise from the use of different ras proto-oncogenes and oncogenes 
and different growth conditions. Wakelam (1988) reported that the 
amplified bombesin-stimulated inositol phosphate response in N-ras 
transformed NIH-3T3 cells is only observed at low cell densities. 
These cells when cultured at high cell density, demonstrate an 
inhibition of the amplification; these inhibitory effects are 
probably caused by the increased secretion of autocrines.
The results presented in Chapter 3 further demonstrate that 
in cells expressing high levels of the normal Ha-,Ki- and N-ras 
proto-oncogene, the stimulation by inositol phosphate
generation is reduced. This effect is not due to any reduction in 
receptor number, or change in E C ^  or Kd and thus would appear to 
be due to a reduced coupling of the agonist receptor complex to 
PIC. The desensitization of P G F ^  induced inositol phospholipid 
turnover is associated with proliferative state, as the 
desensitization is observed in both the transformed cells and in 
rapidly proliferating, non-contact inhibited NIH-3T3 cells (Tables
3.2 & 3.6). Since the desensitization can be mimicked by treatment 
of the control cells with TPA, it is possible that the increased 
autocrine production of growth factors in the ras-transformed cells
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could lead to increased PKC activity causing phosphorylation of 
PGF_ receptors. Indeed Leeb-Lundberg et al. (1985)
Z vS
demonstrated that bradykinin or phorbol ester treatment of DDR^
MF-2 cells caused a desensitization of cx^-adrenergic
receptor-stimulated Ptdlns(4,5)P^ hydrolysis; an effect shown to
be a consequence of receptor phosphorylation. Although
phosphorylation of the PGF0 receptors appears to be the most
likely explanation for the ras induced desensitization of the
P G F ^  -stimulated inositol phosphate response, direct
demonstration of PKC catalysed phosphorylation of the PGF__
2 c\
receptor awaits the purification of the receptor or the generation 
of specific antibodies. PKC catalysed phosphorylation of receptors
may play a crucial role in a negative feedback regulation of the
2 + .
Ca mobilising pathway. Indeed in Chapter 3 it is shown that
PGF_ .-stimulated Ptdlns(4,5)P„ hydrolysis is desensitized 
2 o\ 2
following a 30 min exposure to the agonist in control-NIH-3T3 cells.
In many cell types examined agonist-stimulated 
Ptdlns(4,5)P^ hydrolysis has been demonstrated to be a transient 
process which is rapidly desensitized (e.g. Brown et al., 1987).
Cook et al. (1990) demonstrated that in bombesin-stimulated Swiss 
3T3 cells the levels of DAG remained elevated for at least 60 min 
whilst the Ins(l,4,5)P^ concentration had returned to basal levels 
within 1 min. Consequently, the sustained elevation of DAG would 
appear to be generated from the metabolism of phospholipids other 
than Ptdlns(4,5)P^. It has been demonstrated that many agonists 
can stimulate the hydrolysis of PtdCho in addition to 
Ptdlns(4,5)P^ (see Pelech & Vance, 1989). The results presented 
in Chapter 5 demonstrate that P G F ^ ^ , a potent mitogen in some 
cells which has been shown to stimulate the hydrolysis of 
Ptdlns(4,5)?2 generating Ins(l,4,5)P^ (Chapter 4), is also
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capable of stimulating the hydrolysis of PtdCho, apparently by a 
PLD-catalysed mechanism. TPA has also been demonstrated to 
stimulate the hydrolysis of PtdCho. Therefore it is likely that 
PKC either directly or indirectly activates PLD. . Experiments with 
TPA suggest that PLD activation is secondary to inositol 
phospholipid hydrolysis. Cook and Wakelam (1989) have demonstrated 
that the E C ^  for TPA-stimulated Cho generation in Swiss 3T3 cells 
is very similar to that for the stimulation of purified brain 
C-kinase activity (Castagna et al., 1982). Also the EC^^ for Cho 
generation was identical to the for the inhibition of
bombesin stimulated inositol phosphate production in Swiss 3T3 cells 
(Brown et al^., 1987). The ability of TPA to stimulate PtdCho 
hydrolysis implies that a small, transient burst in Ptdlns(4,5)?^ 
hydrolysis in response to an agonist might be sufficient to initiate 
PtdCho catabolism, resulting in the generation of lipid activators 
of PKC; PtdCho turnover might then provide for a sustained 
activation of PKC even when Ptdlns(4,5)P^ hydrolysis is 
desensitized. Consequently, activation of PKC in NIH-3T3 cells may 
lead both to the desensitization of PtdIns(4 ,5 )P2 hydrolysis and 
to the breakdown of PtdCho, thus potentiating its own activation, 
whilst reducing the increase in intracellular free Ca^+ 
concentration. Thus, it is possible that the stimulation of PtdCho
breakdown in response to PGF_ is activated by the increase in
ZC\
PKC activity as a consequence of Ptdlns(4,5)P^ hydrolysis rather 
than being a direct receptor activated event. This hypothesis 
could explain the results of Griendling et al. (1986). These 
authors demonstrated that in rat aortic vascular smooth muscle 
cells, angiotensin II caused a biphasic generation of DAG, peaking 
both at 15 secs and at 5 min. Only the first peak was accompanied 
by an accumulation of Ins(l,4,5)P^ and a marked decrease in
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Ptdlns(4f5)P2 ; these rapid effects were blocked by a PKC 
activating phorbol ester, while the sustained DAG formation remained 
unchanged. Thus differences in the time-course of Ins(l,4,5)P^ 
and DAG generation could be explained by the above described 
activation of Ptdlns(4,5)P^ and PtdCho hydrolysis. Cook and 
Wakelam (1989) have demonstrated that down-regulation of PKC 
activity in Swiss 3T3 cells by chronic TPA treatment prevents 
bombesin-stimulated choline generation thus supporting the concept 
of PtdCho breakdown being secondary to prior activation of PKC,
However, it is possible that stimulated PtdCho hydrolysis
is induced by the activation of a receptor linked PLD and is a
parallel event to stimulated PtdIns(4 ,5 )P2 hydrolysis. Indeed in
permeabilised hepatocytes it has been demonstrated that the
stimulation of Ptdlns(4,5)?^ hydrolysis by poorly hydrolysed
24-
analogues of GTP was blocked at ’zero Ca * (Uhmg et al., 1986) 
whereas phosphatidic acid accumulation due to PtdCho hydrolysis was 
not (Bocckino et al., 1987). These reports suggest that agonist 
occupancy of its receptor may lead to differential activation of PIC 
and PLD catalysed hydrolysis of Ptdlns(4,5)P^ and PtdCho 
respectively, mediated either by the same G-protein or by two 
different G-proteins. In support of this model Besterman et al.
(1986) demonstrated that prior down-regulation of PKC by prolonged 
pretreatment of 3T3-L1 cells with phorbol esters almost totally 
abolished subsequent stimulation of PtdCho breakdown by phorbol 
esters but only partially attenuated subsequent stimulation by PDGF 
and serum. These observations suggest that in 3T3-L1 cells PDGF 
and serum act, at least partially, through a PKC independent 
mechanism.
These models may help explain the results obtained in the 
ras transformed fibroblasts. Over-expression of ras in NIH-3T3
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cells causes an amplification of some agonist stimulated inositol 
phosphate responses and therefore concomitant increases in DAG 
concentration. Increased DAG levels from Ptdlns(4,5)?^ 
hydrolysis will cause increased PKC activity which may therefore 
lead to both the desensitization of PtdIns(4 ,5 )P2 hydrolysis and 
to the stimulation of PLD catalysed hydrolysis of PtdCho:
Increased agonist stimulated PLD activity in ras transformed cells 
would then result in increased DAG levels potentiating PKC 
activity. Indeed, it has been suggested that elevated DAG levels 
may provide a continuous internal growth signal in transformed cells 
(Preiss et al., 1986). It may, therefore, be possible that in the 
ras transformed cells, PGF2a d°es indeed promote an amplified 
inositol phosphate response compared to NIH-3T3 cells but only when 
in early G^. However, the consequent enhanced DAG levels would 
cause increased PKC activity resulting in the very rapid 
desensitization of the agonist stimulated response. Enhanced PKC 
activity may also lead to enhanced PLD activity resulting in the 
2-fold increase in PGF2 ^-stimulated Cho levels observed in ras 
transformed cells compared to control cells (Table 5.2). It may
also be possible that p21---  functions in a G-protein-like manner
coupling certain receptors to PLD which would result in increased 
DAG generation and thus increased PKC activity. This could 
conceivably lead to the desensitization of the PGF^-stimulated 
inositol phosphate response in ras transformed cells.
PLD catalyses the cleavage of PtdCho to Cho and
phosphatidic acid. Given that Cho is such an abundant metabolite,
it is unlikely to possess any second messenger-like functions.
However, the phosphatidic acid produced could have many roles.
Putney et al_. (1980) proposed that phosphatidic acid could function 
24-
as a Ca ionophore and may therefore be involved in growth
2+factor-stimulated Ca entry into cells. It has also been
demonstrated that phosphatidic acid itself can act as a growth 
factor stimulating DNA synthesis in A431 carcinoma cells (Moolenaar 
et al., 1986). Phosphatidic acid is dephosphorylated to DAG due to 
the ubiquitous presence of phosphatidic acid-phosphohydrolase. The 
importance of this enzyme has been demonstrated by Billah et al. 
(1989). These authors showed that incubation of
fMet-Leu-Phe-stimulated human neutrophils with the phosphohydrolase 
inhibitor, propranolol, resulted in a decrease in the concentration 
of DAG and an increase in the concentration of phosphatidic acid.
In rat hepatocytes, vasopressin which activates PLD (Bocckino et 
al., 1987) causes both translocation and activation of the 
phosphohydrolase (Pollard & Brindley, 1984). These events may be 
relevant to the elevation of DAG and activation of PKC in long term 
responses of cells to stimuli such as growth factors. PLD could 
play an important role in the physiological regulation of 
agonist-induced events giving rise to sustained elevated levels of 
DAG. These elevated levels of DAG could then activate PKC over the 
15h period required for the progression of 3T3 cells through to the 
initiation of DNA synthesis. In addition the DAG generated from 
PtdCho may have a different acyl chain structure from that generated 
from the inositol phospholipids. Given that the fatty acid 
composition of DAG may influence its ability to activate PKC, 
coupled with the fact that different isoforms of PKC may be present, 
opportunities therefore exist for both the complex regulation of PKC 
and hence initiation of a series of diverse intracellular responses.
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6.2 Activation of inositol phospholipid breakdown by
PGF  without any stimulation of proliferation in
quiescent NIH-3T3 fibroblasts
In Chapter 3 stimulated changes in total inositol 
phosphates were determined. It was therefore important to 
demonstrate that PGF induced a characteristic inositol phosphate
*v\
response as observed in response to other agonists in other cell
types. As I n s d ^ ^ P ^  is the second messenger, it was important
to obtain conclusive evidence that it is generated following
stimulation with PGF . The results in Chapter 4 clearly
demonstrate that in NIH-3T3 cells P G F ^  stimulates the hydrolysis
of Ptdlns(4,5>P2 generating Ins(l,4,5)P3 . The second messenger
is generated rapidly (within 5 seconds) and is rapidly
metabolised. Lloyd et al. (1989) have shown that stimulation of
these cells with a maximal PGF_ concentration results in an
2a
2+
increase in intracellular free Ca . The effect of the
prostaglandin upon inositol phospholipid metabolism are thus similar
to those observed in response to bradykinin in NG115-401L cells
(Jackson et al., 1987) and A431 carcinoma cells (Tilly et al.,
1987). Whilst stimulation of NIH-3T3 cells with PGF_ induced
Zc*
Ptdlns(4,5)P^ breakdown, it was without effect upon DNA synthesis
in NIH-3T3 cells. Yet PGF^_, has been reported to be a potent
growth factor for both NIH-3T3 (Yu et al., 1988) and Swiss 3T3 cells
(MacPhee et al., 1984). The results in Chapter 4 confirm that the
prostaglandin is indeed a growth factor for Swiss 3T3 cells and for
the clone of NIH-3T3 cells used by Yu et al. (1988). No major
differences were observed in the stimulation of inositol phosphates
by PGF„ between the two clones of NIH-3T3 cells, nor were there 
J 2cx
any differences detected in Ka, Kd or PGF^^receptor number. 
Differences in responsiveness to other defined agonists were
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detected, most noticeably to bombesin. However, this may reflect a
different receptor number. Significantly, there is no difference
in the response to calf serum which is equally effective in
stimulating the proliferation of both cell types. NIH-3T3 cells
demonstrate the same rank order for the effectiveness of calf serum,
PDGF and bombesin in stimulating inositol phosphates and 
3
( H]thymidine incorporation, yet PGF which stimulated a
1 2-fold increase in inositol phosphate generation did not stimulate 
3
[ H]thymidine incorporation.
The results in Chapter 4, therefore, place a question upon 
the role of inositol phospholipid metabolism in growth factor 
stimulated cell proliferation. Taylor et al. (1988) have found 
that the proliferation of Swiss 3T3 cells can be inhibited by the 
addition of pertussis toxin. However, in this cell the toxin has 
no effect upon the stimulation of inositol phosphate generation. 
Tones et al. (1988) have found no evidence for a role of inositol 
phospholipid turnover in the proliferative response to serum in 
CH0-K1 cells. However, when these cells were stimulated with serum 
a 20-fold increase in PtdCho synthesis was observed. On addition 
of serum the concentration of phosphatidic acid increased rapidly, 
but at 3-4.5h after serum addition the levels of phosphatidic acid 
declined; at this time the cells were estimated to be in mid-Gl and 
the decrease in phosphatidic acid levels persisted throughout S and 
G2 phase. It is possible that the phosphatidic acid is hydrolysed 
to provide DAG for the activation of PKC. These results suggest 
the existence of an alternative growth factor-signalling pathway 
which is independent of PtdIns(4 ,5 )P2 hydrolysis. However, in 
NIH-3T3 cells PGF stimulated both PtdIns(4,5)P and PtdCho
4  0 \ 4
hydrolysis, yet is unable to induce proliferation in these cells.
It would appear that the cells lack a mechanism distal to the 
PGF^^ receptor, related to cell proliferation.
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Therefore, it appears that whilst mitogens can activate the
breakdown of inositol phospholipids, it is either, not obligatory
for the onset of mitosis, or in itself not a complete signal.
Consequently, some additional signal must be being generated in the
AmNIH-3T3 and Swiss 3T3 cells, but not in the NIH-3T3 cells, in
response to PGF n , either in early G or at a later stage in 
ZCa 1
the cell cycle, which is required for the onset of DNA synthesis and 
mitosis. The identity of this signal, however remains unclear.
6.3 Conclusion
Although much available evidence indicates a role for
T*&S
p21--- in the function of cellular growth factors and mitogens,
r as
high levels of p21--- have been found in non-dividing tissues.
Spandidos and Dimitrov (1985) used an immunoblotting method to 
examine ras protein expression in a variety of normal mouse tissues 
and demonstrated high levels of ras proteins in heart tissue as 
compared to lung, liver, spleen, kidney, brain and skeletal muscle 
tissues from the same animal. This indicates that cellular ras 
expression does not always correlate well with cell proliferation. 
The breakdown of PtdIns(4 ,5 )P2 may be a normal control reaction in 
non-proliferating cells and also a stimulus to proliferation. 
Possibly there is a threshold of signal intensity that has to be 
exceeded before proliferation is triggered in competent cells. 
Although P G F ^  stimulated a high level of inositol phosphates in 
NIH-3T3 cells there is no stimulation of mitogenesis. It is 
concluded that these cells lack a mechanism distal to the PGF_ . 
receptor, related to cell proliferation.
However, there is a clear association between tumour cell 
growth and expression of ras oncogenes and around 10-20% of all 
human cancers have been shown to contain ras genes with the majority 
of these being mutated. Approximately 1% have been detected as
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having amplified normal cellular genes. Thus it is likely that a 
greater understanding of what function ras gene products serve in 
the processes of signal transduction by growth factors will also be 
a major step forward in understanding the normal control mechanisms 
in this system and the molecular events that convert normal cells to 
tumours. The presence of ras oncogenes in at least 10% of human 
tumours certainly justifies the intense research dedicated to this 
gene family during the last decade.
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